Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AARD "C8orf85, LOC441376" ENSG00000205002 "Alanine and arginine rich domain containing protein" Q4LEZ3 8 116938199-116944487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 18.4;testis: 43.6" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 22.2;granulocytes: 13.9;Spermatocytes: 27.6" "Cancer enriched" "Detected in many" 8 "breast cancer: 27.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 19.8;JURKAT: 6.8;SK-BR-3: 11.2;U-2 OS: 5.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 4 "midbrain: 7.3" HPA068290 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA068290: " "unprognostic (5.81e-2)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" "unprognostic (7.28e-8)" "unprognostic (3.42e-2)" "unprognostic (4.32e-3)" "unprognostic (4.34e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (8.29e-2)" "unprognostic (8.57e-3)" "unprognostic (4.20e-1)" "unprognostic (2.23e-6)" "unprognostic (1.67e-1)" "unprognostic (9.78e-3)" "unprognostic (3.77e-2)" "unprognostic (5.27e-4)" 0.4 0.8 0.7 1.8 1.2 0.3 4.9 0.0 0.9 0.3 4.5 0.0 0.0 0.2 1.1 0.8 8.1 0.2 0.4 0.1 0.5 0.6 1.3 0.1 2.9 1.0 0.4 0.5 0.1 0.1 0.1 0.0 0.6 0.5 8.4 0.7 4.0 2.1 0.2 0.2 1.1 0.8 18.4 0.1 0.3 7.2 43.6 0.1 0.0 0.2 0.2 0.5 10.2 5.6 1.1 1.0 3.3 0.9 1.5 2.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.5 0.0 0.2 0.1 2.3 0.0 0.2 0.4 0.0 0.1 0.1 0.2 0.0 6.8 0.0 2.3 0.1 0.4 0.8 0.1 1.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 1.9 0.3 0.0 11.2 0.0 0.2 0.5 0.0 0.0 0.1 5.5 0.2 0.0 1.6 4.1 0.0 2.9 0.1 0.3 3.3 0.9 0.6 0.6 0.4 0.3 0.6 0.5 0.4 0.2 1.1 0.5 0.6 3.1 1.5 0.6 1.0 2.0 0.1 0.7 1.2 0.0 0.4 0.5 0.6 0.4 0.5 0.5 0.1 11.9 22.2 0.0 0.2 0.7 0.5 0.8 0.0 1.4 9.1 7.0 0.0 0.1 1.7 0.0 7.5 0.0 0.0 0.0 0.0 0.6 0.4 0.8 13.9 0.0 0.0 1.6 0.0 0.0 0.0 7.9 3.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 10.5 0.0 0.0 0.5 27.6 6.0 0.5 0.2 0.0 0.0 0.3 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449758 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 69.9" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5" "Region enriched" "Detected in many" 5 "basal ganglia: 347.3" "Region enriched" "Detected in all" 6 "basal ganglia: 205.1" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 13.3 3.0 12.5 3.7 32.0 0.6 9.3 2.6 14.4 4.5 11.7 10.4 3.1 4.2 6.2 4.4 13.8 5.3 7.3 69.9 10.4 8.3 5.3 2.4 2.6 2.0 15.0 8.6 10.1 5.7 1.1 7.7 4.8 9.7 13.8 4.6 4.6 3.1 16.3 2.2 1.1 4.8 13.5 8.8 4.7 9.6 5.9 16.0 0.0 1.0 0.2 2.6 9.5 8.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 1.6 0.1 0.1 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.2 2.7 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 18.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 3.1 6.5 0.6 2.2 2.0 0.0 0.6 0.1 2.2 0.0 0.1 0.0 0.1 1.5 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 12.5 32.0 2.6 14.4 10.4 8.3 15.0 8.6 9.7 16.0 0.0 0.0 0.0 0.1 0.2 16.5 56.0 2.5 0.0 0.0 7.0 0.0 1.1 0.0 11.5 0.7 0.4 0.5 0.0 6.3 3.1 2.3 0.1 0.0 0.0 0.2 0.0 0.0 2.5 0.0 1.1 19.0 0.0 0.0 1.8 0.3 0.8 0.6 59.6 69.3 0.7 1.5 64.7 12.2 0.7 5.6 0.6 10.4 0.0 1.2 0.0 ADORA2A "ADORA2, RDC8" ENSG00000128271 "Adenosine A2a receptor" P29274 22 24417879-24442360 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0" "Cell type enriched" "Detected in single" 25 "monocytes: 19.0" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 43.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.4;Karpas-707: 21.2;RPMI-8226: 15.0;SK-BR-3: 30.4;U-266/70: 21.2;U-266/84: 27.7;U-698: 21.7" "Region enriched" "Detected in some" 10 "basal ganglia: 357.5" "Region enriched" "Detected in single" 92 "basal ganglia: 166.0" "CAB001943, HPA065566, HPA075997" Enhanced Supported NA NA "CAB001943: , HPA065566: , HPA075997: AB_2732298" "unprognostic (7.30e-2)" "unprognostic (2.42e-2)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (1.88e-3)" "unprognostic (9.85e-2)" "unprognostic (3.63e-1)" "unprognostic (2.88e-2)" "unprognostic (4.57e-3)" "unprognostic (2.15e-3)" "unprognostic (1.87e-3)" "unprognostic (6.81e-4)" "unprognostic (1.50e-1)" "unprognostic (9.78e-3)" "unprognostic (1.30e-1)" "unprognostic (7.10e-3)" 1.0 2.4 1.9 10.4 43.9 28.1 1.5 3.4 3.8 0.8 2.0 1.7 0.3 5.4 1.4 1.4 1.0 0.9 2.4 3.5 2.4 1.8 3.5 4.3 5.1 14.8 2.6 1.6 1.2 0.8 0.0 2.1 1.4 2.3 1.6 0.8 3.3 2.7 1.5 1.2 0.9 2.6 0.7 1.3 7.5 2.8 2.0 5.7 59.0 1.3 0.9 8.6 3.8 1.3 17.7 1.1 13.7 9.0 2.2 22.8 11.2 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.2 9.5 0.5 1.0 1.7 0.1 15.4 1.0 0.3 1.0 0.3 0.9 0.0 0.0 1.8 2.7 0.2 0.0 2.2 0.2 0.3 7.7 0.1 0.0 2.9 0.0 0.2 3.4 2.2 0.1 21.2 0.0 0.2 5.3 1.6 0.6 2.0 0.0 0.2 0.7 15.0 0.0 0.1 1.5 8.9 0.4 30.4 0.1 0.4 0.4 1.5 0.2 0.9 1.5 0.2 0.1 21.2 27.7 21.7 4.8 5.2 0.1 3.0 0.8 4.8 8.6 2.6 20.1 9.6 16.1 16.9 1.1 17.7 22.8 18.3 13.7 2.2 9.0 1.1 21.4 11.2 1.9 43.9 3.4 3.8 2.4 1.8 2.6 1.6 2.3 5.7 0.0 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADRA2C "ADRA2L2, ADRA2RL2, ADRARL2" ENSG00000184160 "Adrenoceptor alpha 2C" P18825 4 3766348-3768526 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.1" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 12.2;Muller glia cells: 5.2;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 11.1;MCF7: 18.4;NTERA-2: 6.5;OE19: 7.3;SCLC-21H: 7.1;SH-SY5Y: 8.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 41.4" HPA057688 Uncertain NA NA "HPA057688: AB_2683503" "unprognostic (1.44e-2)" "unprognostic (2.21e-3)" "unprognostic (1.23e-1)" "unprognostic (2.02e-2)" "unprognostic (4.70e-2)" "unprognostic (1.11e-1)" "unprognostic (7.12e-2)" "unprognostic (6.69e-2)" "unprognostic (1.88e-1)" "unprognostic (3.71e-1)" "unprognostic (3.24e-2)" "unprognostic (9.08e-3)" "unprognostic (1.01e-2)" "unprognostic (6.00e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (6.48e-2)" 6.5 2.4 2.1 1.0 9.8 0.4 9.2 0.5 2.6 35.1 1.5 0.6 12.8 1.0 20.3 18.0 2.1 6.4 5.5 3.0 1.2 1.0 9.2 1.3 2.0 1.2 0.7 1.6 7.6 4.1 0.5 4.2 27.6 1.1 7.3 0.6 3.6 0.8 24.6 2.6 2.1 0.9 3.0 0.7 7.5 0.7 6.2 2.0 0.2 0.8 1.9 0.5 2.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.1 0.5 0.0 0.2 0.4 0.0 0.0 0.0 2.0 1.2 0.0 2.1 0.3 0.7 0.0 0.2 0.0 0.0 0.0 5.7 0.0 0.0 11.1 0.6 0.0 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.7 18.4 0.0 0.0 6.5 7.3 0.0 0.0 6.0 0.0 0.0 0.3 7.1 8.5 2.5 0.0 0.1 1.7 6.1 0.1 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 9.8 0.5 1.4 1.2 1.0 0.7 1.6 1.1 2.0 0.0 0.0 0.0 0.1 0.0 1.4 0.9 2.5 0.0 0.0 12.2 0.0 0.8 3.3 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.2 0.2 0.0 3.5 1.8 0.0 0.0 4.1 0.0 0.7 0.0 1.4 0.0 0.0 0.1 AGTR2 "AT2, MRX88" ENSG00000180772 "Angiotensin II receptor type 2" P50052 X 116170722-116174972 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 2: 17.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 3.0;lung cancer: 1.9" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HSkMC: 1.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "cerebellum: 3.8" NA NA "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (3.22e-2)" "unprognostic (4.37e-2)" 0.3 1.6 0.1 0.8 0.1 0.0 0.1 1.0 0.1 5.3 0.4 0.1 0.1 0.0 20.8 3.3 0.2 3.6 0.4 1.7 0.1 0.0 0.4 0.1 26.7 0.8 0.1 0.1 1.1 1.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 13.6 0.1 0.1 0.6 0.2 0.1 0.4 0.1 1.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH1A1 "ALDH1, PUMB1, RALDH1" ENSG00000165092 "Aldehyde dehydrogenase 1 family member A1" P00352 9 72900662-73080442 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 207.2" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3" "Cancer enhanced" "Detected in all" "liver cancer: 399.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 34.2" "Lineage enriched" "Detected in many" 30 "monocytes: 34.2" "Cell line enhanced" "Detected in some" "A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5" "Region enriched" "Detected in all" 6 "midbrain: 171.1" "HPA002123, CAB020690" Enhanced Approved Enhanced Cytosol NA NA 62000000 Cytosol "CAB020690: , HPA002123: AB_1844722" "unprognostic (8.46e-3)" "prognostic favorable (7.77e-5)" "unprognostic (5.59e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-2)" "unprognostic (8.71e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (4.53e-2)" "unprognostic (6.83e-2)" "unprognostic (4.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.24e-3)" "unprognostic (2.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-3)" 20.0 26.9 8.8 12.3 21.4 3.9 10.8 44.8 11.7 33.6 53.6 14.5 65.3 77.1 25.5 87.1 14.5 27.8 38.3 8.9 12.5 5.9 86.7 207.2 31.4 9.4 56.4 3.6 35.8 69.7 0.7 57.5 7.9 14.0 20.0 13.1 30.2 31.8 40.3 12.1 2.7 76.5 17.1 29.1 16.3 75.5 43.0 14.9 2.0 45.8 21.0 16.8 14.1 16.0 0.3 0.5 1.1 34.2 0.0 0.1 10.5 0.0 294.7 0.0 0.0 1.7 0.0 0.1 10.2 0.0 0.0 0.0 9.9 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 90.7 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.5 0.0 1.1 0.0 11.3 0.5 0.0 0.1 0.0 0.5 0.0 0.0 3.3 0.1 52.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.2 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.1 0.0 0.4 0.3 0.0 10.5 8.8 21.4 44.8 11.7 12.5 5.9 56.4 3.6 14.0 14.9 89.3 82.8 17.6 12.3 2.4 0.0 2.8 211.5 583.5 271.8 109.9 0.0 1.1 330.0 52.4 8.7 10.5 29.0 23.3 296.8 1.1 30.2 1.8 152.7 620.8 115.7 0.0 52.7 105.0 82.2 16.5 376.3 13.6 6.8 5.4 141.2 0.0 193.4 16.9 194.8 295.4 0.3 25.8 9.2 3.6 3.8 2.8 2.1 20.0 42.1 18.3 ALS2 ALS2CR6 ENSG00000003393 "ALS2, alsin Rho guanine nucleotide exchange factor" Q96Q42 2 201700554-201781189 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.8" "Cell type enhanced" "Detected in many" 6 "granulocytes: 45.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 66.8" "Group enriched" "Detected in many" 6 "basophil: 19.0;eosinophil: 5.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 19.0" "Cell line enhanced" "Detected in many" "HMC-1: 53.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 158.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA046588: AB_2679709" "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 6.9 5.3 8.2 4.2 14.7 7.8 8.1 66.8 15.6 5.9 5.6 10.1 5.5 7.4 10.3 10.7 4.7 6.7 6.4 19.9 8.3 7.3 10.4 18.3 7.9 4.1 6.8 11.0 6.8 5.6 8.8 16.8 7.2 13.6 6.6 6.0 8.5 5.2 5.5 12.2 6.9 8.4 7.4 8.3 5.3 6.7 6.1 9.0 3.5 7.5 5.9 4.5 5.5 5.3 1.2 1.0 19.0 1.2 1.7 1.8 0.7 5.1 3.6 8.8 8.2 6.0 6.5 6.6 9.2 12.4 12.2 14.2 8.4 5.1 0.6 4.0 9.6 8.3 5.3 5.0 9.3 15.5 1.7 5.1 12.2 3.5 4.8 7.4 9.6 53.0 5.6 5.2 10.2 8.8 9.5 12.3 4.9 5.8 3.7 9.2 4.1 3.4 12.7 7.3 3.2 5.5 2.8 4.9 1.8 7.7 7.1 4.1 5.4 5.3 5.8 8.2 22.1 3.7 4.0 7.3 10.8 5.2 3.7 4.6 4.1 5.6 2.1 7.9 1.9 6.8 19.0 0.7 5.5 1.7 1.2 1.8 1.2 1.2 1.2 1.0 1.2 1.3 1.5 0.6 1.7 0.8 0.5 1.8 0.7 8.2 14.7 66.8 15.6 8.3 7.3 6.8 11.0 13.6 9.0 11.9 18.4 1.9 3.3 4.7 14.7 26.3 7.6 13.4 3.4 8.7 27.5 4.6 0.0 5.6 13.0 7.7 5.2 0.0 2.8 2.4 5.9 3.8 45.1 17.1 4.9 7.9 4.6 15.4 3.5 5.3 7.2 5.3 0.0 1.0 6.7 6.8 5.9 3.7 7.8 4.8 14.7 0.0 4.1 6.5 2.8 5.3 5.6 4.3 3.8 3.3 ALX4 "FPP, KIAA1788, PFM, PFM2" ENSG00000052850 "ALX homeobox 4" Q9H161 11 44260444-44310166 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 10.5;retina: 14.4" "Group enriched" "Detected in some" 15 "Cardiomyocytes: 17.1;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.4;BJ: 4.5;HAP1: 6.3;HEK 293: 6.5;HEL: 8.8;K-562: 4.1;SiHa: 9.4" "Region enriched" "Detected in single" 8 "olfactory region: 11.1" "Region enriched" "Detected in single" 34 "olfactory region: 27.7" HPA001903 Supported Nucleoplasm NA NA Nucleoplasm "HPA001903: AB_2666495" "unprognostic (7.56e-5)" "unprognostic (1.69e-1)" "unprognostic (5.40e-2)" "unprognostic (2.74e-1)" "unprognostic (7.24e-3)" "unprognostic (2.63e-4)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-4)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-1)" "unprognostic (1.34e-6)" "unprognostic (3.62e-2)" "unprognostic (2.85e-1)" "unprognostic (2.02e-3)" "unprognostic (2.03e-1)" 1.6 0.1 0.6 0.0 1.6 0.0 10.5 0.7 1.6 2.0 0.1 1.4 0.0 0.0 2.4 2.4 0.5 0.8 0.3 0.9 1.3 0.7 0.3 0.0 0.5 0.0 0.4 2.2 0.2 0.1 0.2 0.3 0.0 0.3 2.0 0.0 14.4 5.6 0.1 3.1 2.8 0.0 1.1 0.2 0.1 0.1 2.5 0.5 0.0 0.4 4.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 0.0 4.5 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.3 0.0 0.0 1.3 6.5 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.7 1.6 1.3 0.7 0.4 2.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 4 "granulocytes: 25.4;Ito cells: 12.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HEL: 28.3;K-562: 15.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 28.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 25.4 0.0 0.1 0.0 0.0 12.3 2.2 1.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958700 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Leydig cells: 57.2;Muller glia cells: 36.1;Peritubular cells: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.2;RT4: 14.4;U-266/84: 18.6" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 29.1" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.9 12.4 7.9 3.7 9.5 3.2 2.3 7.9 9.4 4.3 2.2 0.6 3.5 1.9 4.7 7.6 5.1 5.9 3.9 3.6 8.3 3.9 2.0 1.3 4.4 6.3 4.2 9.8 5.8 7.6 3.5 4.4 5.4 3.5 3.3 0.5 2.4 3.3 4.2 1.5 4.9 2.4 6.5 3.0 14.2 2.6 8.6 1.1 0.0 3.8 0.9 1.6 5.1 4.0 1.0 1.5 1.4 1.9 6.8 4.0 0.8 1.0 2.9 1.4 1.3 2.2 1.7 5.7 1.3 3.5 1.4 2.0 1.6 1.4 1.3 1.5 2.9 1.2 1.4 2.9 0.2 1.1 0.7 0.8 1.4 3.0 1.1 1.6 1.1 2.3 1.3 0.4 0.9 0.5 0.8 1.0 1.3 0.2 19.2 0.4 2.7 0.5 2.1 1.7 0.5 1.3 0.8 0.8 9.1 0.1 14.4 2.9 3.5 0.7 1.0 1.3 1.3 1.1 1.1 1.4 2.6 2.7 2.3 1.3 5.3 18.6 1.0 2.9 2.6 0.8 1.0 0.9 0.1 2.1 1.9 0.8 1.0 1.1 3.2 1.5 0.7 0.8 0.8 1.4 6.8 1.8 0.0 4.0 0.8 7.9 9.5 7.9 9.4 8.3 3.9 4.2 9.8 3.5 1.1 0.0 2.2 0.0 4.9 4.9 9.4 1.2 0.0 0.0 1.2 0.0 11.8 2.7 0.0 0.7 0.8 8.0 0.0 0.0 1.9 4.6 7.0 2.2 5.7 0.0 4.9 3.2 1.2 1.3 5.4 0.9 57.2 7.9 10.1 0.0 0.0 36.1 4.2 0.0 73.9 0.0 6.6 12.9 13.9 1.4 1.1 3.1 1.8 4.1 0.0 4.1 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26309599-26663288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 83.1;epididymis: 47.3" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 13.7;Early spermatids: 7.9;Horizontal cells: 7.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.2;HDLM-2: 10.4;U-2 OS: 2.8;U-2197: 7.6" "Region enhanced" "Detected in many" "basal ganglia: 142.2" "Region enriched" "Detected in all" 5 "basal ganglia: 149.8" HPA041629 Uncertain NA NA "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 2.8 1.2 6.4 0.5 83.1 0.4 0.6 0.2 13.3 1.1 0.6 0.1 0.0 0.6 0.6 47.3 0.5 0.7 2.0 0.5 7.0 0.6 1.4 1.4 0.8 0.5 1.1 5.4 0.5 0.7 0.5 0.3 0.5 5.9 0.5 0.6 0.0 0.6 0.6 0.4 0.5 0.5 0.7 0.5 0.8 0.5 1.9 9.0 0.0 1.4 0.0 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 2.1 2.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.8 7.6 0.0 0.7 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 83.1 0.2 13.3 7.0 0.6 1.1 5.4 5.9 9.0 0.0 1.3 0.0 0.0 0.0 0.7 0.8 0.0 4.0 0.0 0.0 13.7 0.2 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.0 7.9 0.0 3.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.3 2.8 1.1 0.0 0.2 0.0 0.0 0.0 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 127.4;monocytes: 96.4;Peritubular cells: 113.8;Rod photoreceptor cells: 129.8;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favorable (8.15e-5)" "prognostic unfavorable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.8 4.0 2.2 4.5 16.7 22.8 22.7 13.7 11.4 8.8 6.9 10.3 5.7 0.0 2.3 11.6 7.4 4.9 7.9 11.2 10.7 5.4 5.3 3.3 3.1 0.3 25.8 3.3 4.0 11.8 8.8 11.0 9.4 11.2 10.6 2.9 0.5 18.7 15.7 12.0 2.0 0.0 2.0 6.6 2.0 3.8 6.2 11.5 6.1 9.1 5.3 2.5 3.6 14.4 3.8 9.8 1.8 0.3 10.6 8.3 6.4 5.0 6.5 7.0 0.8 0.0 12.7 0.4 7.3 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 3.0 2.6 0.0 6.9 12.8 3.8 58.3 5.1 0.0 2.3 1.8 41.2 24.2 0.0 4.2 7.8 9.0 0.0 0.0 13.5 41.5 17.5 3.3 1.1 11.3 20.5 3.2 0.0 6.2 3.9 6.2 127.4 12.8 5.0 96.4 0.0 7.7 14.2 0.0 113.8 11.7 129.8 142.3 59.0 3.9 16.1 8.9 10.6 12.5 1.1 2.4 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 5 "Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Group enriched" "Detected in some" 4 "BEWO: 9.0;HeLa: 4.0;SiHa: 11.2" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in all" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 9.0 0.8 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.3 4.0 0.3 0.7 0.4 0.3 0.8 1.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.5 0.3 11.2 0.4 0.0 1.1 0.0 0.3 0.6 0.2 1.5 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 0.0 1.0 0.0 0.1 0.0 2.5 0.4 0.0 5.3 1.2 0.0 0.0 0.8 0.0 0.1 25.0 0.3 0.0 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.2 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.2 3.1 0.0 0.7 30.7 34.3 0.1 0.5 0.0 0.0 0.2 ARID3B "BDP, DRIL2" ENSG00000179361 "AT-rich interaction domain 3B" Q8IVW6 15 74541177-74598131 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Late spermatids: 48.5;Rod photoreceptor cells: 50.3;Syncytiotrophoblasts: 53.5" "Cancer enhanced" "Detected in all" "testis cancer: 10.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 33.1;SuSa: 38.1;U-266/70: 20.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 7 "cerebellum: 67.3" HPA050320 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA050320: AB_2681085" "unprognostic (2.97e-1)" "unprognostic (5.91e-2)" "unprognostic (6.41e-2)" "unprognostic (8.15e-2)" "unprognostic (8.42e-2)" "unprognostic (1.13e-1)" "unprognostic (3.33e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (4.71e-2)" "unprognostic (3.52e-2)" "unprognostic (9.45e-3)" "unprognostic (2.20e-1)" 2.5 2.0 2.5 5.8 2.4 21.1 2.4 8.0 4.0 3.2 5.2 2.6 5.2 4.4 2.7 2.1 5.5 2.4 8.4 3.9 2.0 2.8 3.1 3.6 6.7 11.0 2.0 0.2 1.5 5.7 1.8 8.3 17.5 3.6 4.3 4.1 9.1 5.6 6.9 6.1 2.7 6.4 1.8 2.5 9.2 7.0 19.5 2.1 7.2 3.7 1.8 10.4 3.2 8.2 3.7 2.1 14.4 2.2 4.3 6.0 3.2 2.7 1.1 15.5 3.3 0.6 0.3 16.6 0.7 0.7 0.9 1.0 18.3 1.3 0.2 0.8 0.7 5.5 3.3 18.7 2.5 0.8 17.3 4.3 10.7 1.9 4.9 0.4 1.7 7.0 0.4 1.1 1.6 1.6 0.7 1.6 4.3 9.3 6.3 0.2 0.6 4.6 5.7 33.1 1.1 1.0 2.0 0.6 4.4 0.9 2.9 3.9 7.0 0.8 1.7 3.2 38.1 2.2 3.1 1.0 1.3 1.6 1.0 2.0 20.2 12.7 1.9 0.7 2.7 0.5 2.8 2.0 7.5 6.0 1.7 3.5 3.7 3.5 4.4 1.5 1.8 2.7 3.4 14.4 4.3 2.2 2.1 4.8 3.2 2.5 2.4 8.0 4.0 2.0 2.8 2.0 0.2 3.6 2.1 3.0 6.4 12.4 4.2 4.6 20.4 1.2 0.0 1.4 1.2 0.0 41.2 29.5 0.0 2.5 34.7 2.8 6.3 0.0 2.9 15.3 3.6 6.1 2.3 2.4 7.0 11.1 5.2 3.7 7.9 48.5 2.6 7.4 3.3 3.6 6.1 5.7 4.9 7.0 2.8 1.3 50.3 0.0 1.4 17.7 13.0 2.9 53.5 10.2 4.1 6.7 ASB4 ASB-4 ENSG00000005981 "Ankyrin repeat and SOCS box containing 4" Q9Y574 7 95478444-95540232 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Ciliated cells: 2.7;Early spermatids: 1.9;Late spermatids: 1.6" "Cancer enhanced" "Detected in some" "stomach cancer: 1.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 7.0;Hep G2: 11.4;SCLC-21H: 7.2" "Group enriched" "Detected in some" 4 "basal ganglia: 10.0;hypothalamus: 37.1" "Region enriched" "Detected in single" 7 "midbrain: 3.7" HPA055240 Uncertain NA NA "HPA055240: AB_2682753" "unprognostic (1.41e-1)" "unprognostic (3.67e-1)" "unprognostic (1.88e-2)" "unprognostic (2.66e-1)" "unprognostic (3.71e-1)" "unprognostic (2.85e-3)" "unprognostic (1.17e-1)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "unprognostic (2.92e-2)" "unprognostic (4.24e-1)" "unprognostic (9.13e-7)" "unprognostic (1.71e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-1)" "unprognostic (7.23e-2)" 0.3 28.6 0.7 0.1 1.1 0.3 0.2 0.1 1.3 0.1 0.1 1.3 0.1 0.2 0.1 0.3 0.1 0.2 0.4 2.6 0.7 0.6 0.1 1.0 0.4 0.1 1.7 0.5 0.1 0.4 0.0 40.1 1.3 0.2 0.2 0.0 0.1 0.3 0.1 20.7 0.2 0.2 0.1 1.6 0.1 0.4 0.2 0.1 0.2 0.2 2.5 0.4 0.1 0.1 1.0 0.6 1.3 0.3 0.9 0.7 0.0 0.3 7.0 0.3 2.5 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.8 1.3 0.2 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.5 11.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.3 0.1 0.6 0.0 0.2 0.2 0.3 0.2 0.2 1.6 0.2 0.2 0.0 0.2 0.2 7.2 0.0 0.1 0.4 0.7 0.3 0.1 0.3 0.3 0.4 0.4 0.1 0.2 0.8 0.2 0.4 0.2 0.4 0.2 0.3 0.3 0.5 0.6 0.1 0.7 1.0 0.6 0.5 0.2 1.0 0.7 0.7 1.3 0.9 0.3 0.6 0.3 0.0 0.7 1.1 0.1 1.3 0.7 0.6 1.7 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 2.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 AVPR2 "DIR, DIR3, V2R" ENSG00000126895 "Arginine vasopressin receptor 2" P30518 X 153902531-153907166 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes insipidus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 8.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 47.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 26 "intermediate monocyte: 6.2;non-classical monocyte: 5.3" "Lineage enriched" "Detected in single" 28 "monocytes: 6.2" "Cell line enhanced" "Detected in some" "EFO-21: 5.7;SCLC-21H: 6.6;U-266/84: 6.0;U-698: 6.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "cerebellum: 7.9" NA NA "unprognostic (3.05e-2)" "unprognostic (5.62e-2)" "unprognostic (1.99e-4)" "unprognostic (2.50e-4)" "unprognostic (2.76e-1)" "unprognostic (7.10e-6)" "unprognostic (3.80e-3)" "unprognostic (1.17e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-2)" "unprognostic (4.21e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.08e-2)" "unprognostic (1.87e-1)" "unprognostic (4.38e-1)" "unprognostic (9.83e-2)" 8.9 0.1 0.0 0.1 0.0 0.9 7.1 1.2 0.0 2.1 1.5 0.7 2.7 0.0 0.8 2.6 1.4 6.3 0.0 0.0 4.7 0.0 1.9 1.1 0.0 0.1 0.6 0.2 0.0 0.1 1.1 0.0 1.2 0.8 4.3 2.2 1.3 1.0 0.0 0.0 1.2 0.0 1.9 0.2 1.8 2.1 0.0 0.2 0.0 6.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 2.8 5.7 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.2 2.2 0.9 0.0 0.1 2.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 2.7 0.0 0.1 1.4 1.6 0.2 0.0 0.1 2.5 1.1 2.5 0.1 0.0 6.6 1.2 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 1.1 6.0 6.3 0.0 1.6 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 3.0 2.2 0.0 0.0 0.9 0.0 1.4 0.0 1.4 0.0 47.1 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 BARHL2 ENSG00000143032 "BarH like homeobox 2" Q9NY43 1 90711539-90717237 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 29.3" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 22.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 42 "cerebellum: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5" "Region enriched" "Detected in some" 5 "cerebellum: 14.5" "Region enriched" "Detected in many" 20 "cerebellum: 48.3" NA NA "unprognostic (1.83e-1)" "unprognostic (1.73e-1)" "unprognostic (6.80e-2)" "unprognostic (3.10e-1)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 8.9 1.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.1 3.6 0.0 0.0 0.0 0.0 0.0 BSX BSX1 ENSG00000188909 "Brain specific homeobox" Q3C1V8 11 122977570-122981720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.9;pituitary gland: 1.7;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "HDLM-2: 1.5;SCLC-21H: 2.7;SH-SY5Y: 2.0" "Region enriched" "Detected in single" 5 "hypothalamus: 5.3" "Region enriched" "Detected in single" 8 "hypothalamus: 4.5" HPA015654 Uncertain NA NA "HPA015654: AB_1845470" 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 1.7 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.8 0.0 4.9 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991101-67996431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 31.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 110.1" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 11.1 6.8 10.7 6.2 9.3 3.5 17.3 8.8 11.5 29.0 8.3 5.7 8.3 4.1 15.4 8.1 6.5 8.1 6.6 8.9 7.7 6.3 6.3 9.1 6.2 3.1 7.4 5.0 6.3 10.4 5.2 3.6 33.3 5.2 7.8 7.5 5.7 5.3 4.0 6.9 3.7 6.1 11.8 5.5 5.1 6.6 4.8 4.4 1.1 6.9 4.5 6.8 11.0 11.7 3.6 5.2 9.5 6.3 3.2 3.0 2.2 5.3 5.3 5.3 6.5 3.8 9.8 4.2 2.2 6.4 3.9 6.4 3.1 7.0 7.1 5.1 1.8 7.0 2.8 12.0 4.8 9.6 12.8 12.1 4.6 2.0 9.7 6.1 3.9 8.5 5.3 5.8 3.8 8.9 4.4 18.4 6.3 9.8 11.1 3.8 7.1 0.7 5.2 6.0 13.0 5.6 1.7 5.8 9.5 4.9 3.6 3.9 7.2 3.4 31.5 11.5 6.8 8.9 4.6 3.4 3.4 3.5 2.4 4.6 22.3 16.3 6.3 8.5 6.9 5.9 9.5 3.8 6.3 3.0 3.6 1.0 3.6 1.1 2.4 5.2 0.8 0.5 1.2 1.5 3.2 6.3 0.2 0.5 2.2 10.7 9.3 8.8 11.5 7.7 6.3 7.4 5.0 5.2 4.4 0.0 1.7 3.7 5.6 4.2 8.6 4.4 5.1 18.7 2.3 10.4 9.8 23.3 19.9 9.6 0.6 13.6 8.0 0.0 8.1 18.2 27.4 13.3 12.7 13.1 15.0 4.8 3.5 11.1 7.5 1.4 3.4 8.9 8.5 27.9 13.0 29.6 8.9 10.5 4.9 15.0 13.6 6.5 10.3 6.0 3.6 7.3 12.8 4.6 9.5 6.0 CA8 "CALS, CARP" ENSG00000178538 "Carbonic anhydrase 8" P35219 8 60187347-60281412 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.0;brain: 26.8;parathyroid gland: 56.8" "Cell type enhanced" "Detected in many" 11 "Intestinal endocrine cells: 33.7;Mucus-secreting cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 20 "basophil: 41.0" "Lineage enriched" "Detected in many" 20 "granulocytes: 41.0" "Cell line enhanced" "Detected in some" "HEK 293: 11.6;JURKAT: 11.4;K-562: 21.0;NB-4: 12.1;OE19: 18.4" "Region enriched" "Detected in some" 37 "cerebellum: 1413.4" "Region enriched" "Detected in all" 9 "cerebellum: 163.0" "HPA024748, CAB025545, CAB047309" Enhanced NA NA "CAB025545: , CAB047309: , HPA024748: AB_1846003" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "unprognostic (4.43e-2)" "unprognostic (3.46e-3)" "unprognostic (6.67e-2)" "unprognostic (3.19e-1)" "unprognostic (3.85e-2)" "unprognostic (3.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.79e-5)" "unprognostic (3.23e-2)" "unprognostic (1.68e-2)" "unprognostic (2.12e-1)" "unprognostic (1.71e-2)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" 2.3 1.5 9.2 1.1 11.6 1.1 6.5 26.8 6.9 6.3 2.2 3.6 0.6 1.8 2.8 12.8 0.9 2.5 1.0 3.8 7.8 6.0 7.4 0.6 1.6 1.0 4.2 5.3 0.7 3.0 56.8 9.8 8.1 3.4 3.3 3.1 1.5 6.6 0.9 2.0 0.9 1.7 1.3 1.9 1.3 5.9 9.3 6.2 1.7 0.7 1.3 1.0 1.3 2.1 0.1 2.0 41.0 0.0 0.0 0.0 0.0 0.0 2.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.1 0.0 11.6 4.9 0.0 0.0 3.9 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 11.4 21.0 0.2 0.0 0.0 3.3 12.1 0.2 18.4 0.0 0.0 0.0 0.2 0.4 0.9 5.3 0.0 0.0 1.1 0.0 2.4 4.9 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 41.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.2 11.6 26.8 6.9 7.8 6.0 4.2 5.3 3.4 6.2 0.0 3.7 0.0 0.2 0.9 0.9 3.3 0.0 1.4 6.8 3.5 0.0 7.7 3.3 4.0 7.7 5.3 0.4 0.0 5.4 0.3 3.4 1.8 0.0 0.0 7.4 0.0 33.7 0.0 2.7 3.6 1.4 0.2 6.8 0.0 16.7 2.3 1.5 2.9 1.4 0.0 0.8 0.0 0.4 3.6 4.5 0.4 1.1 0.0 2.3 0.1 CACNA1S "CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5" ENSG00000081248 "Calcium voltage-gated channel subunit alpha1 S" Q13698 1 201039512-201112566 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 83.1" "Cell type enhanced" "Detected in some" 21 "Cardiomyocytes: 1.4;Cone photoreceptor cells: 5.9;Early spermatids: 1.4;Late spermatids: 3.3;Rod photoreceptor cells: 1.2" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "BEWO: 5.5;HSkMC: 7.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 13 "olfactory region: 5.3" "CAB009507, HPA048892, HPA056815" Enhanced NA NA "CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242" "unprognostic (2.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.52e-3)" "unprognostic (4.53e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-3)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (7.36e-2)" "unprognostic (1.57e-1)" 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CBLN1 ENSG00000102924 "Cerebellin 1 precursor" P23435 16 49277917-49281831 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 106.6" "Group enriched" "Detected in some" 6 "Early spermatids: 80.9;Late spermatids: 214.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.5" "Region enriched" "Detected in many" 12 "cerebellum: 106.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "NTERA-2: 16.7;SCLC-21H: 53.2" "Region enriched" "Detected in many" 9 "cerebellum: 688.3" "Region enriched" "Detected in all" 15 "cerebellum: 300.1" "Secreted in brain" NA NA 2900000 "unprognostic (1.39e-2)" "unprognostic (1.88e-2)" "unprognostic (1.53e-1)" "unprognostic (3.16e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.65e-3)" "unprognostic (1.18e-2)" "unprognostic (6.31e-2)" "unprognostic (1.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.04e-2)" "unprognostic (7.68e-2)" "unprognostic (2.45e-1)" "unprognostic (1.06e-2)" "prognostic favorable (7.10e-4)" "unprognostic (1.60e-2)" 9.9 0.8 0.9 0.1 1.0 0.0 1.2 106.6 4.9 2.0 0.4 0.4 0.4 0.6 5.9 1.4 0.8 0.9 9.0 4.2 0.7 9.2 0.2 0.7 0.1 0.9 4.5 1.0 0.5 2.4 0.0 0.9 0.4 4.6 0.3 0.4 1.1 0.7 3.0 0.5 0.3 0.5 1.5 2.3 0.1 0.5 16.0 0.4 0.2 0.6 0.6 2.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 1.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.2 1.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 106.6 1.4 0.7 9.2 4.5 1.0 4.6 0.4 0.0 0.0 0.0 0.0 0.0 3.3 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 80.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.6 12.7 0.0 0.0 214.3 2.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.4 0.0 1.5 25.8 4.4 17.6 4.5 0.1 0.0 0.0 0.0 0.0 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell type enhanced" "Detected in some" 8 "Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 47 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 5.0 10.9 0.3 4.2 8.6 1.7 2.2 0.5 2.0 1.8 0.9 2.6 1.9 0.3 0.6 2.3 1.1 12.7 0.4 0.0 3.5 0.8 2.8 0.3 0.7 18.9 1.0 2.1 1.7 7.0 1.5 0.8 0.5 14.2 2.1 0.6 0.0 0.5 0.1 1.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.6 0.3 0.6 0.4 6.6 6.1 1.2 2.5 0.2 9.9 2.3 2.0 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.5 0.0 1.0 0.5 2.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 3.6 0.2 0.8 0.8 0.0 1.4 0.5 0.3 0.0 1.2 0.0 0.1 0.5 0.7 0.0 0.4 0.5 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" A6NI56 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.8" "Cell type enhanced" "Detected in many" 19 "Cone photoreceptor cells: 7.9;Early spermatids: 36.6;Spermatocytes: 12.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.5;SCLC-21H: 26.6;U-266/70: 4.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 5.4" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 1.5 0.6 1.5 1.1 1.6 0.5 4.5 1.4 1.0 0.7 2.6 1.3 0.4 0.0 1.5 0.7 0.2 0.7 0.9 1.2 0.4 0.4 2.5 0.5 1.3 1.1 0.0 3.9 0.6 2.9 0.0 1.2 0.8 1.2 2.9 1.2 0.2 0.7 3.4 3.7 10.8 2.8 0.6 0.2 0.6 0.7 0.0 0.8 0.1 0.0 1.1 0.0 7.5 0.3 0.2 0.5 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.3 0.1 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.5 0.0 3.8 0.2 0.0 0.1 2.2 0.1 0.1 0.0 0.1 26.6 0.4 0.1 0.1 1.1 0.1 0.8 1.9 0.0 0.4 0.1 0.3 0.0 4.8 1.2 0.0 0.0 3.8 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.3 0.5 2.5 1.4 0.0 3.5 7.9 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.1 0.0 0.7 6.4 0.0 0.0 0.8 4.4 1.4 0.5 1.7 0.0 0.0 3.2 0.0 0.0 0.4 0.2 3.9 0.0 1.0 12.0 1.3 0.4 0.0 0.0 0.0 0.1 CCL1 "I-309, P500, SCYA1, SISe, TCA3" ENSG00000108702 "C-C motif chemokine ligand 1" P22362 17 34360328-34363231 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2" "Cell type enriched" "Detected in some" 4 "granulocytes: 9.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Group enriched" "Detected in some" 4 "classical monocyte: 2.0;intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 20 "monocytes: 2.0" "Cell line enriched" "Detected in some" 41 "HMC-1: 128.7" "Region enriched" "Detected in single" 4 "hippocampal formation: 2.2" HPA049861 Uncertain "Secreted to blood" NA NA 84400 "HPA049861: AB_2680919" "unprognostic (6.52e-2)" "unprognostic (4.81e-3)" "unprognostic (5.84e-2)" "unprognostic (5.01e-1)" "unprognostic (6.04e-1)" "unprognostic (2.71e-1)" "unprognostic (1.37e-1)" 0.1 0.0 0.2 0.2 2.5 0.0 0.1 0.1 0.9 0.1 0.5 0.1 0.1 0.0 0.1 0.8 0.1 0.2 0.4 0.1 0.5 0.3 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 7.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 1.8 0.1 6.7 0.1 3.2 0.5 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 2.5 0.1 0.8 0.5 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCP2 ENSG00000157211 "CUB domain containing protein 2" Q5VXM1 1 54132968-54153770 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.4" HPA031143 Uncertain "Secreted - unknown location" NA NA "HPA031143: AB_10611819" "unprognostic (1.08e-1)" "unprognostic (5.16e-2)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-2)" "unprognostic (4.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.86e-2)" "unprognostic (2.57e-1)" "unprognostic (1.33e-1)" "unprognostic (1.67e-2)" "unprognostic (7.67e-6)" "unprognostic (2.37e-1)" "unprognostic (1.48e-1)" "unprognostic (5.12e-1)" "unprognostic (2.21e-2)" 0.5 0.3 0.1 0.1 0.5 0.3 0.9 0.1 0.6 1.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.2 0.0 2.2 0.2 0.1 0.6 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.7 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 57.9" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in all" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" NA NA 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: AB_2686328" "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 57.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.6 0.3 0.0 0.0 1.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.6 4.3 0.0 0.1 0.0 0.0 0.0 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "Cystic fibrosis transmembrane conductance regulator" P13569 7 117465784-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 103.0" "Cell type enriched" "Detected in many" 5 "Ductal cells: 325.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 5 "olfactory region: 6.3" "CAB001951, HPA021939, HPA079652" Enhanced NA NA "CAB001951: , HPA021939: AB_1846578, HPA079652: " "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.4 0.2 0.4 10.5 0.4 0.0 0.3 0.3 0.3 2.5 19.8 0.1 0.8 10.5 0.6 2.1 0.4 0.4 15.8 0.3 0.4 0.3 1.1 1.4 5.7 0.1 0.5 0.1 0.3 103.0 0.0 0.3 0.1 0.1 1.5 12.5 0.1 22.4 0.1 0.3 1.1 24.2 0.3 0.7 0.3 0.6 0.9 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.3 0.4 0.3 0.5 0.1 0.1 0.1 6.0 48.7 0.0 1.7 0.0 0.4 1.2 43.3 9.4 23.9 0.0 0.0 0.0 0.0 325.5 2.9 0.0 19.4 0.0 3.7 0.0 0.1 3.6 1.1 0.2 0.0 0.0 6.9 0.0 0.0 1.6 0.3 0.0 0.0 11.8 11.5 0.6 21.5 37.7 0.0 0.0 0.0 0.0 0.3 1.8 0.4 0.0 0.0 0.0 64.4 3.9 CGA "FSHA, GPHa, GPHA1, HCG, LHA, TSHA" ENSG00000135346 "Glycoprotein hormones, alpha polypeptide" P01215 6 87085498-87095406 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "pituitary gland: 398.8;placenta: 489.3" "Cell type enriched" "Detected in some" 30 "Syncytiotrophoblasts: 71349.9" "Cancer enhanced" "Detected in many" "testis cancer: 13.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 28 "BEWO: 73.5;SuSa: 141.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 69.2" "CAB023350, HPA029698" Enhanced "Secreted to blood" NA NA "CAB023350: AB_617281, HPA029698: AB_2673153" "unprognostic (1.66e-1)" "unprognostic (2.10e-1)" "unprognostic (3.22e-5)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.69e-2)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (4.32e-2)" "unprognostic (8.32e-2)" "unprognostic (9.15e-3)" 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 398.8 489.3 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.6 0.0 0.1 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.2 1.9 3.5 1.5 1.1 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 141.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.1 1.0 1.7 0.5 0.7 1.3 0.8 1.4 0.6 2.2 1.2 2.1 3.5 1.1 1.5 1.9 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 1223.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2346.5 0.1 1.5 0.0 0.0 567.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 71349.9 0.0 0.0 0.3 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678778-60868028 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5" "Cell line enhanced" "Detected in many" "AF22: 26.3;SCLC-21H: 24.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 110.3" HPA053075 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.9 2.2 7.0 7.9 11.2 25.1 4.1 47.1 9.0 2.3 5.7 13.4 3.1 5.9 2.6 3.2 5.1 3.2 3.1 4.1 8.1 4.3 3.6 3.6 4.7 7.0 8.1 3.3 1.4 6.4 12.4 9.9 5.6 9.9 2.9 5.5 6.4 5.7 2.8 10.3 5.7 6.6 2.4 7.5 6.1 4.5 4.3 12.2 1.6 5.4 2.2 7.3 2.9 5.9 12.2 0.6 12.6 0.6 0.0 5.5 0.4 3.9 2.0 26.3 4.6 0.1 0.0 8.3 0.2 0.0 0.9 0.8 4.9 3.7 7.6 0.5 0.0 1.2 2.4 13.5 3.9 0.8 2.9 7.2 17.9 3.3 6.4 1.1 5.4 3.3 0.5 3.0 0.0 4.4 1.6 3.9 6.2 1.3 6.8 0.6 4.0 8.4 6.2 18.0 3.9 0.9 17.6 6.2 2.4 2.0 4.5 24.0 11.9 0.7 3.0 7.3 9.7 5.3 5.1 4.5 0.3 4.3 0.3 2.1 7.3 4.2 11.9 1.5 0.6 6.7 10.4 0.3 12.6 2.6 0.1 3.3 8.0 2.9 0.9 0.1 12.2 5.5 2.0 7.1 0.0 0.6 0.6 0.2 0.4 7.0 11.2 47.1 6.5 8.1 4.3 8.1 3.3 9.9 12.2 29.8 17.4 46.9 22.3 27.0 32.3 30.7 30.6 20.1 23.9 15.7 227.8 7.1 1.7 15.6 11.9 29.6 17.6 0.0 9.7 5.5 7.1 31.3 38.3 9.5 11.9 66.7 83.8 27.0 12.9 7.6 0.9 10.3 20.3 19.8 30.6 155.9 13.9 22.6 0.4 4.2 196.3 0.0 4.4 4.9 3.4 28.2 5.1 13.8 21.7 25.1 CHI3L1 "GP39, YKL40" ENSG00000133048 "Chitinase 3 like 1" P36222 1 203178931-203186749 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Inflammatory response" Antimicrobial "Asthma, Cancer-related genes, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 336.4" "Cell type enriched" "Detected in many" 7 "Hofbauer cells: 335.7" "Cancer enriched" "Detected in all" 8 "glioma: 1313.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 490 "neutrophil: 81.3" "Lineage enriched" "Detected in single" 490 "granulocytes: 81.3" "Cell line enhanced" "Detected in some" "ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 14 "olfactory region: 10.7" HPA077365 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 25100000 230000000 "Golgi apparatus" Vesicles "HPA077365: " "unprognostic (2.11e-3)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.01e-3)" "unprognostic (8.81e-2)" "unprognostic (2.09e-1)" "unprognostic (1.48e-1)" "unprognostic (4.46e-2)" "unprognostic (1.30e-1)" "unprognostic (7.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-2)" "unprognostic (3.43e-2)" "unprognostic (1.14e-2)" "unprognostic (9.39e-3)" 19.0 0.8 20.3 53.4 58.0 81.6 23.9 1.2 69.4 4.3 2.1 5.0 0.0 0.9 4.3 25.5 3.5 10.2 1.9 2.6 9.1 17.8 11.9 336.4 10.0 12.4 32.3 3.6 4.5 2.5 0.8 22.9 4.7 66.4 1.5 1.6 9.1 19.3 1.1 10.5 10.0 2.2 3.3 23.5 2.9 1.7 3.4 6.5 0.9 2.0 1.7 14.6 61.5 4.0 0.0 0.0 81.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 40.7 90.8 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 80.6 0.0 0.2 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.4 0.0 38.1 0.2 0.0 0.0 0.2 4.8 0.0 37.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.3 0.0 0.1 0.0 0.0 0.1 20.3 58.0 1.2 28.9 9.1 17.8 32.3 3.6 66.4 6.5 6.0 39.7 0.0 19.4 3.8 0.0 0.8 2.5 4.0 15.9 26.2 0.0 1.2 0.0 49.4 0.0 0.4 0.0 0.0 0.0 0.9 2.2 2.2 0.0 28.7 335.7 0.0 0.0 0.0 0.3 0.0 0.9 3.9 13.5 1.8 0.0 40.4 3.1 0.0 0.0 0.1 1.8 0.0 1.7 0.0 0.0 1.0 0.7 0.0 0.0 1.6 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHRNA6 ENSG00000147434 "Cholinergic receptor nicotinic alpha 6 subunit" Q15825 8 42752620-42796392 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;retina: 5.1" "Cell type enhanced" "Detected in single" 19 "Rod photoreceptor cells: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 3.4" "Lineage enriched" "Detected in single" 8 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "Daudi: 7.9;HDLM-2: 5.0;HMC-1: 2.4;JURKAT: 2.3;RPMI-8226: 2.0;U-698: 6.9" "Group enriched" "Detected in some" 7 "midbrain: 24.1;thalamus: 7.0" "Region enriched" "Detected in all" 6 "midbrain: 93.1" NA NA "unprognostic (1.91e-1)" "unprognostic (7.49e-2)" "unprognostic (2.66e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (7.60e-4)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (7.73e-2)" "unprognostic (6.24e-2)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (2.63e-1)" "unprognostic (3.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.27e-3)" "unprognostic (3.66e-2)" 0.1 2.2 0.6 0.6 0.6 0.0 0.9 8.3 3.8 1.2 0.1 1.7 1.4 0.0 0.9 0.0 0.1 1.7 0.2 0.1 0.8 1.6 1.1 0.1 0.4 0.7 4.3 1.7 0.6 0.3 0.0 0.5 0.2 3.6 0.1 0.1 5.1 1.3 1.5 0.1 0.1 0.2 0.0 0.8 0.2 0.1 1.3 0.0 2.0 0.8 0.0 2.8 0.2 0.1 0.4 0.1 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.3 0.0 0.1 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.6 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.6 8.3 3.8 0.8 1.6 4.3 1.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell type enriched" "Detected in single" 11 "Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 72 "RH-30: 43.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNE ACHRE ENSG00000108556 "Cholinergic receptor nicotinic epsilon subunit" Q04844 17 4897774-4903074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 53.3;pituitary gland: 19.0" "Cell type enriched" "Detected in many" 5 "Late spermatids: 132.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "gdT-cell: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "HEL: 6.0;HMC-1: 15.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 13 "basal ganglia: 5.7" NA NA "unprognostic (2.00e-3)" "unprognostic (1.56e-1)" "unprognostic (3.94e-2)" "unprognostic (4.35e-3)" "unprognostic (6.55e-2)" "unprognostic (2.27e-3)" "unprognostic (7.80e-4)" "unprognostic (7.75e-2)" "unprognostic (3.24e-1)" "unprognostic (1.34e-1)" "unprognostic (3.69e-2)" "unprognostic (6.58e-2)" "unprognostic (8.42e-4)" "unprognostic (1.39e-3)" "unprognostic (1.26e-1)" "unprognostic (5.83e-2)" "unprognostic (5.70e-2)" 0.3 0.1 0.1 0.4 0.1 0.4 0.1 0.3 0.4 0.1 0.2 0.1 0.1 0.3 0.4 0.8 0.2 0.1 0.4 53.3 0.1 0.0 0.1 1.3 0.3 0.2 0.3 0.1 0.3 0.6 0.3 19.0 0.4 0.2 0.1 0.0 0.5 0.5 0.1 1.0 0.8 0.1 0.2 0.1 0.7 0.1 0.2 0.1 0.1 0.1 1.4 0.2 0.1 0.1 1.0 0.3 1.0 0.4 1.6 5.9 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 6.0 0.0 0.7 0.5 0.0 15.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.0 5.9 0.2 0.0 0.0 0.0 2.1 0.2 1.0 0.1 1.6 0.2 1.6 0.4 0.3 0.0 1.5 0.1 0.1 0.3 0.4 0.1 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 1.1 1.4 0.8 6.3 2.5 0.0 0.0 1.8 3.9 0.4 1.7 0.1 27.7 1.4 0.0 0.0 0.8 6.2 2.6 0.9 8.1 5.9 3.1 3.2 0.0 3.7 1.8 132.7 0.9 5.7 0.0 8.2 0.0 1.2 0.8 0.0 0.4 1.1 10.0 0.0 0.5 4.3 3.0 1.0 9.3 3.2 0.1 0.6 COL27A1 "FLJ11895, KIAA1870, MGC11337" ENSG00000196739 "Collagen type XXVII alpha 1 chain" Q8IZC6 9 114155560-114312511 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9;cervix, uterine: 41.9" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 73.9;Extravillous trophoblasts: 60.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 56.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 30.2;Hep G2: 25.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 23 "cerebellum: 141.7" "HPA021884, HPA048471" Uncertain "Secreted to extracellular matrix" NA NA "HPA021884: AB_2670857, HPA048471: AB_2680407" "unprognostic (4.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (7.11e-4)" "unprognostic (4.13e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (6.25e-2)" "unprognostic (1.71e-1)" "unprognostic (1.09e-3)" "unprognostic (3.31e-1)" "unprognostic (3.41e-2)" "unprognostic (2.97e-2)" "unprognostic (9.48e-2)" "unprognostic (6.21e-3)" "unprognostic (3.50e-3)" 4.7 4.2 6.0 4.2 4.6 0.1 4.1 56.9 5.7 41.9 4.4 2.6 5.7 2.9 25.9 17.0 3.6 6.4 6.3 3.3 4.9 1.7 11.0 16.5 4.4 2.9 5.8 1.8 13.1 12.9 0.7 2.2 9.0 8.6 9.8 1.0 9.6 4.1 11.3 4.0 11.9 3.5 8.4 7.3 3.0 9.7 2.7 5.1 2.8 6.1 5.2 3.2 5.7 17.9 0.9 0.4 2.0 0.2 0.5 0.3 0.1 2.0 4.1 9.8 3.5 0.7 1.1 30.2 4.7 3.2 3.4 2.9 4.3 0.1 0.0 1.2 2.3 2.6 4.9 3.3 4.4 1.9 0.0 0.4 0.0 3.4 25.5 1.0 0.0 10.9 2.7 1.2 4.2 1.9 1.9 5.1 4.0 0.0 1.0 1.9 0.9 0.0 1.8 3.5 8.0 1.1 13.6 9.9 1.9 8.1 2.2 0.1 0.1 0.2 0.1 0.5 3.9 0.9 3.1 4.7 3.0 6.1 0.4 7.3 0.5 0.0 0.0 2.5 0.0 4.6 0.6 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.9 0.3 0.2 2.0 0.5 0.1 0.4 0.2 0.1 6.0 4.6 56.9 5.7 4.9 1.7 5.8 1.8 8.6 5.1 3.0 16.5 1.5 4.6 24.2 0.6 24.9 73.9 0.0 6.8 8.7 5.9 0.7 3.3 9.2 1.1 3.6 0.0 0.0 4.3 60.6 14.4 5.3 0.0 35.8 5.2 1.6 4.6 6.2 1.0 0.9 17.8 0.6 21.9 0.0 1.6 6.1 5.4 0.8 4.2 5.7 1.0 25.8 35.4 0.2 1.9 19.6 1.9 0.0 2.2 1.6 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549606-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "basal ganglia: 7.6" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 380000000 Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 6.4 6.9 4.0 8.8 4.4 9.7 15.3 4.4 3.5 5.3 5.8 3.3 8.1 3.7 6.2 16.4 4.8 5.2 8.0 13.1 4.5 4.4 10.4 22.3 15.6 28.1 5.8 2.3 5.1 15.0 6.5 10.4 6.9 8.1 8.1 5.1 4.7 18.5 12.5 4.3 8.4 7.2 6.7 10.0 12.6 6.1 3.5 4.4 5.5 5.9 4.9 5.1 5.5 5.2 0.8 0.4 3.2 1.6 0.7 0.6 0.2 1.8 0.6 0.4 0.4 5.6 6.7 1.4 1.3 4.5 0.6 1.7 0.2 2.2 2.4 0.5 2.8 0.7 0.8 0.1 1.7 1.9 2.2 0.6 1.5 0.3 0.3 3.4 1.6 0.8 4.9 3.3 1.6 2.5 4.0 1.9 1.0 1.4 4.4 1.3 0.1 1.0 1.8 0.4 0.4 0.6 0.5 0.7 1.6 4.0 0.9 0.3 0.8 0.5 1.8 2.1 1.1 1.0 1.7 2.9 2.3 0.2 3.1 1.4 1.3 0.4 0.7 1.6 2.2 1.6 1.8 0.8 1.5 0.2 0.9 0.4 0.5 0.4 0.3 0.4 0.8 0.3 0.6 3.2 0.7 1.6 0.4 0.4 0.2 4.0 4.4 4.4 3.5 4.5 4.4 5.8 2.3 8.1 4.4 8.9 16.0 29.6 25.9 27.0 5.8 5.1 30.6 26.8 20.5 22.7 39.3 20.5 36.5 15.7 2.6 28.2 17.1 0.0 16.9 19.2 19.6 41.9 43.8 58.7 42.5 3.2 22.2 45.4 70.4 3.0 19.5 43.1 6.8 23.4 21.5 19.9 17.2 21.0 23.0 38.3 40.1 12.9 14.4 7.5 9.8 21.7 21.4 17.5 16.9 25.3 CTXN3 ENSG00000205279 "Cortexin 3" Q4LDR2 5 127649044-127658630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 21.9;kidney: 58.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 121.0" "Cancer enriched" "Detected in single" 8 "renal cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 4.5;NTERA-2: 1.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory region: 50.2" NA NA "unprognostic (7.32e-2)" "unprognostic (9.88e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (6.20e-3)" 0.6 0.6 2.2 0.5 9.4 0.5 0.6 0.2 19.1 0.6 0.6 0.7 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 7.9 4.8 58.1 0.6 0.6 0.6 12.6 4.6 0.5 0.5 0.5 5.9 0.5 21.9 0.9 0.6 0.0 0.7 0.6 9.1 0.5 0.5 0.5 0.5 0.5 0.6 0.6 1.0 0.0 0.5 0.3 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.2 19.1 7.9 4.8 12.6 4.6 21.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 19.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 DACH1 DACH ENSG00000276644 "Dachshund family transcription factor 1" Q9UI36 13 71437966-71867192 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 70.5;Horizontal cells: 82.6;Late spermatids: 80.3;Muller glia cells: 155.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 15 "basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9" "Cell line enhanced" "Detected in some" "AF22: 8.2;HAP1: 12.8;HEK 293: 9.6;HL-60: 20.7;NB-4: 9.2;SCLC-21H: 21.3;SH-SY5Y: 17.1;THP-1: 15.0" "Region enriched" "Detected in many" 5 "basal ganglia: 34.7" "Region enriched" "Detected in all" 5 "basal ganglia: 34.0" "HPA012672, HPA012938" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA012672: AB_1847466, HPA012938: " "unprognostic (3.16e-1)" "unprognostic (5.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.36e-1)" "unprognostic (4.21e-2)" "unprognostic (5.63e-2)" "unprognostic (2.22e-2)" "unprognostic (8.08e-3)" "unprognostic (2.12e-2)" "unprognostic (2.50e-1)" "unprognostic (3.04e-3)" "unprognostic (4.37e-1)" "unprognostic (2.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-1)" "unprognostic (5.17e-2)" 4.9 12.2 0.6 3.8 15.5 5.7 9.2 1.8 2.9 11.4 5.4 0.0 3.5 5.4 6.3 4.1 0.9 2.9 15.8 3.0 0.2 10.2 1.9 10.2 0.3 0.0 1.5 0.9 1.8 7.3 24.4 7.3 4.9 7.9 3.5 19.6 1.9 6.9 3.6 0.6 9.6 2.1 2.9 7.8 1.8 6.1 6.6 6.1 0.0 1.2 0.2 2.1 10.2 0.0 7.5 9.2 0.2 4.9 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.8 0.0 0.0 0.0 9.6 0.1 0.0 0.0 0.2 20.7 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.5 9.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.3 17.1 0.0 0.0 0.0 0.0 0.5 15.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.1 4.7 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 4.9 0.0 7.5 0.0 0.1 0.0 1.1 0.0 2.9 1.4 10.4 1.6 0.0 1.4 0.0 7.0 3.9 0.0 5.0 0.5 70.5 17.3 1.1 0.0 0.0 0.0 0.8 9.2 4.7 0.0 0.2 82.6 32.7 1.8 1.6 80.3 3.1 1.1 0.0 0.0 13.3 155.3 0.5 0.0 1.8 3.5 4.8 12.9 1.4 21.1 7.0 1.1 0.0 0.0 3.7 1.8 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell type enriched" "Detected in single" 43 "Ito cells: 17.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 206.1" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 38 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.2 206.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCX "DBCN, DC, LISX, SCLH, XLIS" ENSG00000077279 Doublecortin O43602 X 111293779-111412429 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.1;testis: 6.4" "Cell type enriched" "Detected in some" 12 "Rod photoreceptor cells: 22.7" "Cancer enriched" "Detected in some" 5 "glioma: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 34.6;SH-SY5Y: 14.2" "Region enriched" "Detected in many" 9 "olfactory region: 90.9" "Region enriched" "Detected in all" 5 "olfactory region: 130.1" HPA036121 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA036121: AB_2674950" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (7.36e-2)" "unprognostic (4.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.00e-2)" "unprognostic (7.18e-2)" "unprognostic (3.24e-2)" "unprognostic (2.33e-3)" "unprognostic (3.67e-1)" "unprognostic (4.90e-4)" "unprognostic (5.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" 0.8 1.1 7.0 0.7 9.2 0.7 3.2 0.7 17.1 0.7 0.6 0.9 0.0 0.7 4.1 3.6 0.6 0.6 0.8 0.7 4.2 5.4 0.5 0.5 0.6 0.7 2.5 6.7 0.6 0.8 0.5 1.0 0.6 3.7 0.5 0.8 0.0 2.2 0.6 0.5 0.7 0.7 0.6 3.0 0.6 1.2 6.4 2.3 0.0 0.6 0.0 0.5 0.6 0.3 0.3 0.4 0.6 0.2 0.7 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 34.6 14.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.7 0.0 0.4 0.1 0.0 7.0 9.2 0.7 10.8 4.2 5.4 2.5 6.7 3.7 2.3 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.2 0.0 1.4 0.0 22.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DHH "HHG-3, MGC35145" ENSG00000139549 "Desert hedgehog" O43323 12 49089421-49094819 "Disease related genes, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Cell type enhanced" "Detected in single" 17 "Endothelial cells: 1.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 4 "midbrain: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;EFO-21: 7.3;HUVEC TERT2: 2.9;K-562: 12.2;TIME: 6.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "midbrain: 2.1" "Secreted in male reproductive system" NA NA "unprognostic (7.56e-2)" "unprognostic (2.05e-3)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (2.36e-4)" "unprognostic (1.29e-1)" "unprognostic (7.22e-3)" "unprognostic (8.21e-2)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" 0.9 0.4 0.2 1.2 0.6 0.1 1.4 0.3 0.6 0.6 0.5 0.2 0.3 0.3 1.0 0.9 0.5 0.6 1.7 0.9 0.2 0.2 0.6 0.2 0.9 0.2 5.2 0.0 0.4 0.2 0.2 0.8 1.5 1.2 0.7 0.2 1.3 0.7 0.8 0.6 0.3 0.5 1.0 1.2 0.3 0.3 35.7 0.0 0.0 0.4 1.3 0.2 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.9 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.6 0.2 0.2 5.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 DLX1 ENSG00000144355 "Distal-less homeobox 1" P56177 2 172084740-172089677 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 4.7;brain: 17.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "prostate cancer: 11.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 48.7;U-138 MG: 13.0;WM-115: 14.4" "Group enriched" "Detected in many" 5 "basal ganglia: 29.8;olfactory region: 101.7" "Region enriched" "Detected in many" 5 "olfactory region: 106.7" HPA045884 Approved NA NA "HPA045884: AB_10960361" "unprognostic (2.14e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (7.92e-3)" "unprognostic (8.86e-2)" "unprognostic (2.80e-2)" "unprognostic (2.03e-1)" "unprognostic (5.74e-2)" "unprognostic (2.04e-1)" "unprognostic (7.40e-9)" "unprognostic (2.22e-1)" "unprognostic (9.19e-2)" "unprognostic (1.25e-1)" "unprognostic (5.91e-3)" 0.6 4.7 8.9 1.0 7.4 0.4 0.9 0.1 15.5 0.4 1.2 0.5 0.0 0.4 0.4 0.4 0.6 0.4 0.8 0.6 5.5 17.3 0.4 0.5 0.4 0.5 0.8 9.5 0.6 0.5 0.6 0.1 0.4 0.0 2.2 1.3 0.1 0.9 0.7 0.4 0.6 0.8 0.8 0.2 0.4 0.5 0.6 1.4 0.0 1.6 0.4 1.3 0.5 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.2 48.7 0.7 1.5 0.1 1.3 2.2 2.5 1.3 0.4 0.1 0.0 2.9 2.4 2.7 3.6 2.7 0.5 1.9 0.1 12.2 7.3 5.4 1.9 0.0 3.0 6.0 0.0 0.9 0.6 1.0 1.9 0.0 2.4 4.2 0.0 2.1 2.6 0.0 0.8 0.0 0.0 8.5 0.1 6.2 0.0 0.4 1.6 4.2 0.0 2.2 0.2 6.2 0.2 1.9 3.6 2.6 13.0 0.0 6.3 6.1 0.0 0.0 0.0 5.5 7.5 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.9 7.4 0.1 15.5 5.5 17.3 0.8 9.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099439-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 1.5;Early spermatids: 4.3;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AN3-CA: 39.6;HEK 293: 25.2" "Group enriched" "Detected in many" 4 "basal ganglia: 13.8;olfactory region: 36.1" "Region enriched" "Detected in many" 5 "olfactory region: 43.5" HPA056965 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056965: AB_2683291" "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.7 3.2 4.5 0.7 5.4 1.2 1.2 0.1 10.9 0.4 0.7 1.1 0.0 0.6 0.5 0.4 0.4 0.5 0.7 0.7 4.3 7.5 0.5 0.6 0.5 0.4 0.4 4.1 0.4 0.4 0.4 0.2 0.6 0.0 1.0 0.6 0.0 1.7 0.7 0.4 1.9 1.2 0.5 0.1 0.4 0.5 2.5 3.4 1.4 1.5 1.5 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.6 0.2 0.2 1.1 2.1 0.5 0.3 0.1 0.2 0.1 0.0 1.2 0.9 1.9 2.0 1.3 0.1 0.1 0.0 25.2 0.6 4.1 0.9 0.1 0.2 0.1 0.0 1.8 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.6 2.3 0.6 0.3 0.1 0.1 2.8 0.0 1.5 0.2 0.0 0.0 0.2 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 0.1 10.9 4.3 7.5 0.4 4.1 0.0 3.4 0.0 0.0 0.0 0.1 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.7 0.0 0.3 0.0 0.2 0.0 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 40.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 24.2" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 24.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 0.0 0.0 0.0 0.0 0.1 40.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 31.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRD3 ENSG00000151577 "Dopamine receptor D3" P35462 3 114128652-114199407 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 8.3;testis: 4.2" "Group enriched" "Detected in some" 39 "Early spermatids: 5.5;Late spermatids: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Region enriched" "Detected in some" 5 "basal ganglia: 7.5" "Region enriched" "Detected in many" 12 "basal ganglia: 25.2" NA NA "unprognostic (2.32e-1)" 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 2.0 0.6 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 DUOX1 "LNOX1, NOXEF1, THOX1" ENSG00000137857 "Dual oxidase 1" Q9NRD9 15 45129933-45165576 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 48.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.5" HPA023544 Approved NA NA "HPA023544: AB_1847878" "unprognostic (2.85e-2)" "prognostic favorable (4.31e-6)" "unprognostic (2.49e-2)" "unprognostic (8.84e-3)" "unprognostic (1.44e-2)" "unprognostic (3.27e-2)" "unprognostic (1.23e-1)" "unprognostic (2.57e-2)" "unprognostic (5.87e-2)" "unprognostic (6.02e-3)" "unprognostic (5.13e-2)" "unprognostic (1.19e-1)" "unprognostic (8.91e-3)" "unprognostic (2.23e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (3.03e-1)" 0.4 5.2 0.5 0.4 0.8 0.0 2.0 1.2 0.9 18.9 0.6 2.4 43.3 0.1 2.2 37.8 38.3 6.0 6.2 1.1 0.6 0.1 0.2 0.1 48.7 0.1 1.0 0.5 1.2 0.1 1.8 0.9 2.5 0.9 4.8 0.0 4.3 9.8 19.2 0.8 34.2 0.3 1.6 0.5 0.1 18.0 1.0 1.1 0.7 31.9 35.9 31.9 6.2 13.1 0.2 1.5 0.5 0.5 0.1 0.4 0.0 4.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.6 0.0 3.2 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 16.8 0.0 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 19.3 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.0 0.1 0.3 0.0 1.1 0.2 0.2 0.0 0.0 0.1 0.1 1.5 0.2 0.0 0.5 0.8 1.2 0.9 0.6 0.1 1.0 0.5 0.9 1.1 77.4 116.2 6.7 13.0 9.8 20.8 2.0 10.2 38.8 34.2 3.5 7.9 3.8 0.0 3.4 0.5 2.9 2.7 0.0 4.8 0.6 5.2 5.8 8.1 1.7 1.1 6.4 20.8 8.6 5.1 0.0 3.1 5.8 15.1 1.8 3.4 4.1 3.3 4.2 3.5 0.3 2.6 0.0 2.7 2.8 2.3 15.7 3.1 10.1 2.3 23.7 DUSP5 HVH3 ENSG00000138166 "Dual specificity phosphatase 5" Q16690 10 110497838-110511544 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Basal glandular cells: 372.8;Urothelial cells: 958.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.4;non-classical monocyte: 8.8;plasmacytoid DC: 13.3" "Group enriched" "Detected in many" 19 "dendritic cells: 13.3;monocytes: 8.8;T-cells: 3.4" "Cell line enhanced" "Detected in many" "hTERT-HME1: 87.7;Karpas-707: 34.0;U-266/70: 48.5" "Region enhanced" "Detected in many" "cerebellum: 68.0" "Region enriched" "Detected in many" 5 "cerebellum: 41.9" NA NA "unprognostic (1.25e-1)" "unprognostic (3.57e-1)" "unprognostic (5.19e-2)" "unprognostic (1.03e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (8.30e-6)" "unprognostic (1.70e-2)" "unprognostic (4.60e-2)" "unprognostic (2.91e-2)" "unprognostic (1.20e-2)" "unprognostic (4.20e-3)" "unprognostic (3.79e-1)" "unprognostic (3.78e-3)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" 13.7 11.0 2.8 12.4 5.1 14.5 11.2 19.8 5.2 15.1 12.5 3.3 7.7 5.4 9.1 8.8 55.5 5.6 24.2 11.3 5.2 3.3 9.1 13.1 12.1 9.3 2.9 2.8 6.5 3.9 5.5 8.0 45.1 5.6 15.6 12.4 21.0 9.4 10.0 1.8 6.5 17.6 10.3 7.1 11.4 10.2 13.1 2.1 4.8 7.8 21.9 47.8 31.6 14.3 0.2 13.3 0.4 8.8 0.0 3.4 0.5 4.4 3.0 0.6 1.5 2.4 10.2 2.2 10.6 24.0 5.7 6.9 1.9 6.0 0.5 2.0 2.5 12.2 1.4 0.6 5.5 9.3 12.7 0.3 2.4 0.5 1.1 9.1 0.6 3.2 3.9 7.6 18.2 87.7 2.5 3.5 0.2 0.4 34.0 17.0 1.2 0.1 1.8 2.0 0.4 4.6 0.0 1.3 7.8 19.5 8.7 0.3 0.8 0.7 1.7 3.5 5.7 0.9 0.7 5.5 1.9 1.3 4.6 5.0 48.5 8.6 1.2 7.5 3.3 1.3 0.4 0.2 0.0 3.4 2.0 1.2 0.2 1.8 1.0 0.9 0.0 0.0 1.1 0.1 0.0 8.8 13.3 0.0 0.5 2.8 5.1 19.8 5.2 5.2 3.3 2.9 2.8 5.6 2.1 3.0 8.5 17.2 372.8 58.6 8.2 28.2 7.6 0.0 18.2 33.2 5.9 30.4 5.0 26.2 1.0 35.0 36.5 0.0 4.2 9.9 26.3 104.8 3.5 4.0 9.3 0.0 46.8 165.1 18.3 1.9 1.4 20.8 150.1 76.7 7.8 2.5 31.7 14.0 0.7 0.3 10.6 0.0 31.1 1.0 9.1 89.1 114.9 25.9 7.6 958.4 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847678 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0" "Cell type enriched" "Detected in some" 5 "Melanocytes: 11.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Group enriched" "Detected in some" 10 "midbrain: 11.4;pons and medulla: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8" "Region enriched" "Detected in single" 5 "midbrain: 5.9" "Region enriched" "Detected in some" 5 "midbrain: 23.9" "CAB014884, HPA073141" Enhanced Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "CAB014884: , HPA073141: AB_2686573" "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 5.6 0.1 0.0 0.1 0.4 0.0 2.7 0.9 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 11.4 0.0 0.1 0.0 0.1 0.0 0.0 8.8 0.1 0.1 0.2 0.7 0.1 20.1 10.0 0.1 0.1 2.7 0.1 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.5 0.2 14.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 4.2 0.4 0.5 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 8.8 0.9 9.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.2 0.1 11.4 0.0 8.8 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 2.3 0.0 0.0 0.0 0.0 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell type enhanced" "Detected in single" 16 "Spermatocytes: 1.2" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA045646: AB_2679404, HPA069809: AB_2686205" "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavorable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.5 27.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.9 0.0 5.9 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 3.5 0.0 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 8.1 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 11 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.4 1.8 18.6 8.8 1.5 0.2 6.2 1.9 2.8 2.3 2.9 4.9 9.0 13.8 5.0 2.5 3.8 3.4 23.2 1.8 2.5 24.8 7.1 39.5 5.6 8.0 2.9 13.4 26.4 0.5 5.4 2.2 4.0 5.7 4.1 22.1 37.2 11.0 0.0 2.5 21.7 8.8 19.5 12.3 2.9 33.4 8.2 19.8 2.2 9.5 25.1 18.6 5.8 5.5 12.6 6.6 4.2 5.2 0.4 0.1 3.9 3.6 3.8 16.5 21.4 24.7 3.5 13.8 2.1 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 17.9 64.9 30.6 6.3 9.3 105.3 20.1 30.6 22.7 21.6 15.7 129.6 2.3 14.9 15.8 13.9 14.5 25.2 116.8 16.1 3.2 3.3 11.2 23.1 28.8 6.5 20.6 40.0 20.3 22.1 13.3 2.0 11.5 0.0 11.8 25.9 13.2 25.6 22.4 2.1 10.5 166.4 12.9 4.7 8.6 53.0 14.6 3.4 42.8 28.3 11.5 EPHA8 "EEK, Hek3" ENSG00000070886 "EPH receptor A8" P29322 1 22563564-22603594 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 5.2;Early spermatids: 2.5;Horizontal cells: 3.2;Late spermatids: 3.9;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 37.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 25.0" "CAB009660, HPA031433" Uncertain "Intracellular and membrane" NA NA "CAB009660: AB_2099696, HPA031433: AB_10601371" "unprognostic (8.58e-2)" "unprognostic (8.59e-2)" "unprognostic (3.72e-1)" "unprognostic (1.15e-2)" "unprognostic (4.69e-4)" "unprognostic (3.58e-1)" "unprognostic (7.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.75e-2)" "unprognostic (9.80e-2)" "unprognostic (2.10e-1)" "unprognostic (9.84e-14)" "unprognostic (2.14e-3)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (8.68e-2)" 0.2 9.4 1.6 0.2 3.1 0.2 0.1 1.8 3.9 0.2 0.2 2.2 0.0 1.7 0.1 0.3 0.2 0.1 0.2 0.2 2.0 2.6 0.1 0.1 0.2 0.2 2.1 4.1 0.1 8.3 0.2 1.7 0.1 5.3 0.2 0.2 1.6 0.8 0.2 0.3 0.4 0.2 0.1 1.3 10.3 0.2 3.5 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.9 2.0 2.6 2.1 4.1 5.3 0.6 0.0 0.0 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 8.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 73.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 131.0;Enterocytes: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "A-431: 46.7;BEWO: 46.2;CAPAN-2: 44.0;SK-BR-3: 54.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 13.6" HPA041143 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 1.7 3.0 2.0 6.4 3.3 0.0 12.4 6.9 2.5 11.6 31.5 1.2 23.9 38.7 4.6 10.1 53.3 5.3 21.7 1.0 1.3 1.6 30.4 38.3 18.0 0.4 1.7 0.5 3.9 11.6 1.8 4.3 39.6 3.6 8.4 6.0 2.7 26.2 17.6 0.7 22.8 73.3 2.4 2.4 0.5 18.0 7.2 1.5 0.9 29.5 29.4 33.7 6.9 19.2 0.2 6.4 0.7 0.1 0.1 0.1 0.1 46.7 14.3 0.0 0.3 0.5 3.2 46.2 4.1 4.2 6.1 2.6 10.7 44.0 0.1 17.1 4.3 1.1 24.8 0.1 24.8 1.4 0.1 0.9 0.0 5.3 19.2 3.5 0.0 0.0 1.7 16.6 1.8 4.3 2.5 0.0 0.0 0.3 0.2 0.7 15.0 0.1 0.2 0.5 14.6 4.6 0.1 0.1 0.3 21.7 11.7 0.1 0.1 14.6 54.0 0.1 3.2 20.4 0.0 0.3 2.5 5.8 1.5 0.3 0.1 0.2 0.1 1.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 6.4 0.0 0.1 2.0 3.3 6.9 2.5 1.3 1.6 1.7 0.5 3.6 1.5 131.0 60.0 7.3 23.9 17.5 0.8 3.6 53.5 33.5 51.2 85.5 0.0 43.8 23.2 45.5 1.0 3.0 200.0 0.0 70.5 25.8 7.1 28.6 6.9 55.5 4.3 0.0 42.1 0.6 1.3 1.7 16.7 3.2 13.5 3.6 61.8 8.9 66.1 98.2 11.0 84.7 0.7 0.0 5.1 0.7 4.1 21.3 77.3 21.0 62.0 26.8 ESR2 "ER-beta, Erb, NR3A2" ENSG00000140009 "Estrogen receptor 2" Q92731 14 64084232-64338112 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 19.1;testis: 30.2;vagina: 14.3" "Group enriched" "Detected in many" 9 "Early spermatids: 48.9;Late spermatids: 62.8;Rod photoreceptor cells: 41.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;U-266/70: 10.8;U-698: 17.6" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 17.8" CAB079300 Enhanced NA NA "CAB079300: " "unprognostic (7.63e-3)" "unprognostic (2.28e-3)" "unprognostic (8.27e-3)" "unprognostic (5.41e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (8.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.65e-1)" "unprognostic (3.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (5.89e-2)" 2.1 9.4 0.2 2.3 0.8 1.0 3.7 0.8 0.6 1.3 2.9 0.6 0.2 1.4 1.7 0.7 1.7 1.1 0.6 1.0 1.1 0.4 1.4 0.7 1.3 2.8 0.2 0.2 19.1 2.5 0.0 1.6 0.7 1.4 2.2 1.5 0.5 1.5 0.9 1.4 1.2 1.5 0.6 1.0 3.0 1.3 30.2 0.6 5.0 0.6 0.2 2.9 1.8 14.3 2.4 4.0 1.1 0.3 0.4 1.3 0.2 0.7 0.3 0.7 0.7 0.0 0.1 1.3 0.1 0.0 0.1 0.1 0.2 0.8 2.9 0.1 0.0 0.3 1.0 0.9 0.0 0.1 0.7 0.3 0.3 0.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.3 1.2 0.6 4.1 0.2 0.7 0.4 0.2 0.7 0.6 0.4 0.5 0.4 0.3 0.1 1.4 2.5 0.7 0.5 0.2 1.1 0.4 0.8 0.0 0.4 0.5 1.0 0.2 0.1 10.8 3.2 17.6 0.2 0.1 0.7 0.3 0.3 1.0 0.8 0.2 0.6 1.7 0.6 1.1 0.1 2.4 1.3 1.0 1.1 0.4 0.2 4.0 0.5 0.2 0.2 0.8 0.8 0.6 1.1 0.4 0.2 0.2 1.4 0.6 6.0 0.0 2.7 2.5 0.2 1.4 0.8 0.0 2.7 1.2 0.0 5.9 0.6 0.0 0.1 48.9 0.6 0.0 0.0 0.6 0.4 0.3 0.9 1.1 0.0 0.1 0.0 0.0 0.0 0.0 62.8 0.9 0.0 1.7 0.0 0.6 1.6 0.4 0.0 1.1 0.0 41.7 0.0 0.8 6.0 0.8 0.1 0.9 0.5 0.4 1.7 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152003 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 65.9;liver: 80.5;testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 370.3;Late spermatids: 1080.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5" "Group enriched" "Detected in many" 11 "NK-cells: 1.5;T-cells: 4.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.4;MCF7: 25.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 8 "basal ganglia: 24.7" HPA057167 Enhanced NA NA "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 3.3 2.3 4.0 0.8 4.7 0.9 6.3 0.9 4.0 5.1 1.6 1.9 6.5 0.8 3.1 11.0 8.3 4.9 1.9 2.6 2.6 2.5 65.9 80.5 1.2 2.0 2.7 1.9 13.1 4.3 6.2 8.8 2.3 2.7 3.8 0.9 4.8 7.6 7.8 0.6 5.1 0.8 2.4 1.5 2.4 1.1 45.0 1.9 1.1 4.0 3.9 12.9 3.8 6.2 0.2 0.0 0.2 0.2 1.5 4.8 1.0 5.2 1.8 5.3 10.1 2.0 0.6 5.3 5.4 12.0 7.5 3.3 9.0 2.6 0.2 9.1 1.3 8.8 4.7 9.4 7.6 5.2 0.2 8.4 0.1 1.0 13.8 8.0 0.2 0.3 2.7 26.4 1.6 0.3 3.9 5.4 5.7 0.7 0.2 0.9 25.5 1.5 0.1 11.1 0.2 4.0 0.4 6.3 0.2 6.5 2.0 1.4 7.6 3.4 16.1 2.5 17.6 15.6 0.3 0.3 2.1 11.7 0.4 3.9 0.2 0.1 0.2 0.1 0.2 3.0 0.1 0.2 0.0 4.8 0.0 4.6 0.0 1.3 2.9 0.0 0.2 2.9 3.6 0.2 1.5 0.1 0.0 0.7 1.0 4.0 4.7 0.9 4.0 2.6 2.5 2.7 1.9 2.7 1.9 0.0 0.0 0.5 9.8 3.7 1.8 0.9 5.1 2.7 0.0 3.5 3.9 4.8 33.2 8.0 370.3 1.0 0.0 0.0 5.6 7.9 5.7 10.1 9.2 156.9 0.7 0.0 1.2 1.8 5.1 1080.2 27.0 0.6 10.1 0.0 0.0 2.6 4.6 0.0 39.6 120.8 0.8 0.0 3.8 9.3 5.9 2.0 7.9 0.9 0.0 8.3 EXPH5 SLAC2-B ENSG00000110723 "Exophilin 5" Q8NEV8 11 108505431-108593738 "Disease related genes, Predicted intracellular proteins" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.9;placenta: 45.1;skin 1: 23.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 137.0;Basal keratinocytes: 95.7;Ciliated cells: 87.0;Club cells: 88.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 14 "cerebellum: 74.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.4;hTERT-HME1: 10.6;RT4: 18.5;SK-BR-3: 9.0" "Group enriched" "Detected in many" 4 "cerebellum: 23.5;cerebral cortex: 6.7" "Region enriched" "Detected in many" 10 "cerebellum: 64.1" NA NA "unprognostic (1.34e-3)" "unprognostic (8.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (3.42e-6)" "unprognostic (2.91e-1)" "prognostic favorable (1.46e-4)" "unprognostic (4.57e-3)" "prognostic favorable (5.12e-4)" "unprognostic (1.26e-1)" "unprognostic (3.03e-1)" "unprognostic (5.56e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.18e-2)" "unprognostic (2.57e-1)" "unprognostic (3.36e-1)" "unprognostic (4.51e-1)" 0.7 0.6 0.8 1.2 2.7 0.1 2.6 74.9 1.1 3.3 3.3 1.4 0.0 0.5 0.9 2.5 9.8 1.5 0.3 0.7 1.1 0.8 3.4 6.7 4.7 0.0 1.6 1.0 0.8 1.4 9.3 2.2 45.1 5.4 1.6 3.8 0.7 6.2 0.1 0.6 23.1 1.1 0.6 2.6 0.6 2.8 1.7 2.4 0.6 1.9 7.1 5.2 1.7 1.9 0.7 0.9 3.0 0.6 3.2 2.2 0.5 3.5 0.4 0.2 0.1 0.0 0.0 3.0 0.2 0.1 0.0 0.6 0.9 5.5 0.0 0.2 0.2 0.8 7.4 5.2 1.9 0.2 0.1 1.6 1.5 0.7 0.0 0.5 0.7 0.1 0.1 3.1 0.0 10.6 0.5 0.0 1.2 2.6 0.0 2.9 0.6 0.9 0.0 0.2 5.8 2.2 0.0 0.1 0.0 0.6 18.5 1.3 0.8 0.9 9.0 0.2 1.1 6.0 0.1 0.1 0.0 2.2 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 2.0 0.6 0.5 0.7 0.3 0.3 0.7 1.1 0.4 0.5 0.7 2.1 2.2 3.0 3.2 0.4 0.9 0.3 0.5 0.8 2.7 74.9 1.1 1.1 0.8 1.6 1.0 5.4 2.4 137.0 48.9 0.0 11.5 95.7 0.5 3.3 5.1 87.0 88.7 19.2 13.7 31.0 3.3 4.4 6.2 2.9 12.0 0.0 4.2 3.9 6.1 19.8 1.1 21.3 3.5 0.0 4.7 1.3 0.6 1.6 0.6 3.3 5.0 1.8 33.3 0.5 3.9 11.5 0.0 3.7 1.6 0.0 1.6 1.1 0.2 63.1 45.7 1.8 19.9 16.0 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765723 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.6" "Group enriched" "Detected in some" 4 "Sertoli cells: 64.7;Smooth muscle cells: 58.7" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.0;BJ hTERT+: 19.0;BJ hTERT+ SV40 Large T+ RasG12V: 18.3;HHSteC: 5.3;HSkMC: 6.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 6.9" "HPA036112, HPA060342" Enhanced NA NA "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 11.4 12.5 2.2 1.0 4.0 0.5 11.2 0.5 8.6 13.0 3.8 1.1 4.8 1.1 7.8 7.0 6.5 6.7 4.9 7.7 2.0 1.8 4.3 1.0 14.6 2.4 2.7 5.8 7.7 1.5 2.5 6.1 51.6 1.9 9.7 2.2 6.0 6.5 11.8 7.3 2.5 1.9 3.7 1.3 0.5 3.0 2.9 0.5 0.0 8.7 5.2 1.4 5.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 7.0 19.0 3.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.0 0.5 8.6 2.0 1.8 2.7 5.8 1.9 0.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.9 4.5 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 2.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 64.7 58.7 3.5 6.0 0.6 0.5 0.0 0.0 0.0 FAM71C MGC39520 ENSG00000180219 "Family with sequence similarity 71 member C" Q8NEG0 12 99647753-99650046 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 31.7" "Group enriched" "Detected in some" 33 "Early spermatids: 314.0;Late spermatids: 312.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" "Region enriched" "Detected in many" 4 "cerebellum: 18.6" NA NA "unprognostic (6.82e-2)" "unprognostic (3.58e-2)" "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 314.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 312.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.7 0.0 0.0 0.0 0.0 0.0 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 61.0;skin 1: 35.1" "Group enriched" "Detected in some" 7 "Basal glandular cells: 5.4;Basal keratinocytes: 16.0;Early spermatids: 12.8;Extravillous trophoblasts: 18.5;Late spermatids: 5.5;Melanocytes: 6.8;Suprabasal keratinocytes: 17.1;Urothelial cells: 13.7" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Region enriched" "Detected in some" 34 "cerebellum: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 17.3;EFO-21: 10.4;HaCaT: 25.0;HBEC3-KT: 11.4;hTCEpi: 34.7" "Region enriched" "Detected in single" 18 "cerebellum: 35.9" "Region enriched" "Detected in some" 66 "cerebellum: 442.8" CAB033680 Enhanced NA NA "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.4 0.0 0.4 0.4 1.7 0.0 2.2 61.0 0.4 2.4 0.4 0.4 0.4 0.0 0.4 1.0 11.8 0.5 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.4 0.0 0.4 0.4 0.9 0.9 0.0 0.4 3.8 3.2 0.4 35.1 0.4 0.4 0.4 0.4 0.0 2.7 0.4 0.4 0.4 0.4 1.9 1.0 4.9 0.2 0.6 0.1 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 17.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.1 25.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 1.7 61.0 0.4 0.4 0.0 0.4 0.4 0.9 0.4 0.0 0.0 0.0 5.4 16.0 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 12.8 0.0 0.0 0.0 0.0 18.5 0.4 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 17.1 0.8 0.0 0.0 13.7 FBXO15 "FBX15, MGC39671" ENSG00000141665 "F-box protein 15" Q8NCQ5 18 74073353-74147865 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 56.2;Early spermatids: 27.6;Spermatocytes: 46.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 5 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "GAMG: 3.9;JURKAT: 5.5;SCLC-21H: 5.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "basal ganglia: 13.1" NA NA "unprognostic (1.69e-2)" "unprognostic (1.97e-1)" "unprognostic (6.34e-6)" "unprognostic (1.65e-2)" "unprognostic (4.20e-1)" "unprognostic (6.77e-2)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (3.38e-2)" "unprognostic (1.00e-2)" "unprognostic (9.62e-2)" "unprognostic (4.46e-5)" "unprognostic (4.64e-2)" "unprognostic (3.35e-2)" "unprognostic (1.62e-4)" "unprognostic (2.87e-1)" 0.6 1.8 3.1 0.4 7.6 0.6 1.3 1.6 4.1 1.9 0.5 6.3 4.0 0.7 0.8 5.5 0.9 9.4 1.0 0.5 3.3 2.9 3.4 1.7 1.9 0.9 2.2 3.2 1.2 1.1 2.4 7.1 0.6 3.8 1.0 0.4 3.0 1.5 2.4 0.9 1.0 0.6 0.4 2.6 1.2 0.9 19.2 3.4 0.8 2.0 0.0 0.6 0.8 0.5 0.9 0.3 0.0 0.3 0.0 4.2 1.1 0.0 0.3 0.4 0.5 0.2 0.5 0.3 0.3 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.1 3.9 1.6 0.1 0.0 0.8 1.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.7 0.7 0.0 5.5 0.1 0.4 0.3 0.4 0.3 0.2 1.2 0.7 2.1 0.7 0.0 0.0 0.7 0.1 5.6 1.7 0.3 0.0 2.1 1.0 0.1 1.0 0.0 0.7 0.1 0.0 0.1 0.3 2.5 2.2 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 1.6 0.6 0.0 0.9 4.2 2.6 0.0 0.0 0.3 0.3 0.1 1.1 3.1 7.6 1.6 3.9 3.3 2.9 2.2 3.2 3.8 3.4 6.0 0.6 0.0 0.8 0.2 5.6 0.4 0.0 56.2 5.7 1.8 0.0 0.4 3.3 0.4 27.6 0.5 0.0 0.0 0.2 0.6 0.2 0.2 0.0 0.2 3.2 4.8 0.0 0.6 0.3 14.2 1.1 0.1 0.0 0.0 0.0 7.2 0.1 0.0 1.4 4.4 10.4 0.0 0.4 46.1 7.2 0.0 0.3 0.0 0.0 0.5 FERD3L "bHLHa31, N-TWIST, NATO3" ENSG00000146618 "Fer3 like bHLH transcription factor" Q96RJ6 7 19144782-19145421 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;pituitary gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 160 "SCLC-21H: 15.9" "Region enhanced" "Detected in some" "thalamus: 1.0" "Region enriched" "Detected in many" 18 "midbrain: 34.7" HPA043494 Uncertain NA NA "HPA043494: AB_10964193" 0.3 0.4 1.4 0.0 0.1 0.0 0.5 0.0 2.7 0.2 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.2 0.0 0.9 1.1 1.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.4 1.3 1.4 0.1 0.2 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.8 1.1 1.5 1.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Cell type enriched" "Detected in single" 5 "Spermatocytes: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 58.8;SCLC-21H: 25.7" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in some" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064639: AB_2685308, HPA073693: AB_2686626" "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 58.8 1.4 1.0 0.0 0.0 0.0 0.0 0.1 25.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698232-69704642 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "gallbladder: 62.4" "Cell type enriched" "Detected in some" 5 "Cholangiocytes: 38.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CAPAN-2: 47.6" "Region enhanced" "Detected in single" "basal ganglia: 0.8" "Region enriched" "Detected in single" 19 "basal ganglia: 0.9" HPA036082 Approved "Secreted to blood" NA NA 133000 "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.4 38.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.0 0.0 0.1 1.6 FGF20 ENSG00000078579 "Fibroblast growth factor 20" Q9NP95 8 16992169-17002181 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 11 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;CAPAN-2: 10.5;OE19: 2.5" "Region enhanced" "Detected in some" "midbrain: 0.7" "Region enriched" "Detected in some" 5 "cerebellum: 3.4" "Secreted in other tissues" NA NA "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (5.57e-3)" "unprognostic (3.95e-2)" "unprognostic (1.59e-3)" "unprognostic (1.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.65e-2)" "unprognostic (9.32e-2)" "unprognostic (9.95e-2)" "unprognostic (3.92e-1)" "unprognostic (4.08e-2)" 0.2 2.0 1.9 0.2 1.6 0.0 1.1 9.0 3.7 3.9 0.1 4.0 0.1 0.4 0.1 2.5 0.1 0.8 1.2 0.3 2.3 2.1 0.1 0.1 0.1 0.5 2.9 2.4 2.5 0.2 0.0 0.9 0.5 2.7 0.6 0.2 0.8 3.8 0.6 0.1 0.0 0.2 0.1 4.2 3.6 2.2 0.8 1.1 0.1 0.5 0.1 1.6 0.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.4 0.0 1.2 3.3 0.5 1.6 0.0 10.5 0.0 0.0 0.0 0.4 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 9.0 3.7 2.3 2.1 2.9 2.4 2.7 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FIBCD1 FLJ14810 ENSG00000130720 "Fibrinogen C domain containing 1" Q8N539 9 130902438-130939286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;parathyroid gland: 10.7;testis: 9.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 11 "hippocampal formation: 19.2" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 5.7" "Lineage enriched" "Detected in single" 11 "monocytes: 5.7" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2" "Group enriched" "Detected in many" 4 "basal ganglia: 18.2;hippocampal formation: 75.0" "Region enriched" "Detected in many" 4 "hippocampal formation: 81.5" HPA055353 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055353: AB_2682791" "unprognostic (1.18e-3)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (5.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.62e-1)" "unprognostic (4.16e-5)" "unprognostic (1.83e-3)" "unprognostic (3.14e-1)" "unprognostic (1.28e-1)" "unprognostic (2.05e-2)" "unprognostic (4.45e-2)" "unprognostic (1.42e-6)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (6.68e-3)" "unprognostic (2.77e-1)" 0.0 8.5 1.7 0.1 1.1 0.0 1.1 0.1 3.0 0.0 1.8 0.3 0.0 0.5 0.0 1.4 0.4 0.0 5.0 2.0 19.2 1.2 0.0 0.0 5.3 0.0 0.6 0.0 0.4 0.0 10.7 0.0 1.7 1.5 1.0 1.4 1.1 1.6 0.0 0.0 0.0 1.6 2.1 0.0 0.8 0.1 9.5 0.8 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.2 0.2 2.3 0.8 0.0 0.0 0.0 0.0 5.0 5.9 0.3 0.8 0.0 2.5 0.0 1.8 0.2 4.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 0.2 0.0 0.1 2.7 0.0 9.4 0.0 0.0 0.6 0.0 0.0 21.2 0.0 2.2 1.5 15.0 0.5 0.0 4.4 0.3 16.5 0.0 0.1 0.0 0.7 0.0 0.5 0.7 1.3 8.2 0.0 0.9 11.3 0.1 9.2 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 1.7 1.1 0.1 1.0 19.2 1.2 0.6 0.0 1.5 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 7.7 0.0 0.3 14.5 0.1 4.7 0.0 27.4 0.4 1.8 0.7 0.0 0.0 0.9 3.2 0.0 0.0 0.0 25.9 0.6 0.0 0.0 0.0 12.2 0.8 16.7 3.5 3.2 0.0 0.1 0.0 0.3 1.1 15.1 0.0 3.3 0.0 4.7 1.7 FOXA1 HNF3A ENSG00000129514 "Forkhead box A1" P55317 14 37589984-37596059 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 47.0;prostate: 44.4" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 103.5;Glandular cells: 100.2;Intestinal endocrine cells: 81.2;Urothelial cells: 133.4" "Cancer enhanced" "Detected in many" "prostate cancer: 127.0" "Region enriched" "Detected in single" 6 "midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.6;MCF7: 36.1;PC-3: 25.2;RT4: 33.8;SK-BR-3: 34.2;T-47d: 48.4" "Group enriched" "Detected in some" 15 "hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1" "Region enriched" "Detected in single" 6 "midbrain: 6.1" "CAB011595, HPA050505" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB011595: AB_2104842, HPA050505: AB_2681148" "unprognostic (1.61e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.78e-1)" "unprognostic (1.71e-1)" "unprognostic (3.01e-1)" "unprognostic (1.54e-2)" "unprognostic (6.30e-2)" "unprognostic (0.00e+0)" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.69e-2)" "prognostic favorable (1.00e-4)" 0.1 0.0 0.1 6.1 0.1 0.0 23.5 0.1 0.3 1.5 9.4 0.1 0.1 4.6 0.1 0.5 7.2 1.3 6.5 0.1 0.1 0.3 0.4 47.0 13.2 0.1 2.0 0.1 0.6 0.2 0.0 1.1 0.1 0.2 44.4 6.0 0.2 9.4 0.7 0.1 0.7 5.1 2.4 0.1 0.1 13.0 0.6 0.1 0.2 0.1 4.4 9.9 12.5 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 7.4 0.9 0.0 0.5 0.0 0.0 8.4 4.7 1.1 0.0 0.0 8.3 0.0 1.4 16.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.0 36.1 0.0 0.1 0.0 11.0 25.2 0.0 0.4 0.1 3.5 33.8 4.3 0.0 1.6 34.2 0.0 0.0 48.4 0.1 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.3 2.0 0.1 0.2 0.1 26.8 38.7 0.0 103.5 0.9 0.0 1.1 25.5 52.2 37.5 3.5 0.0 0.0 0.0 1.8 0.3 0.3 14.7 0.0 2.1 0.0 0.0 100.2 2.3 27.6 0.0 0.0 81.2 1.3 1.2 0.5 0.0 0.1 3.3 1.8 34.4 0.0 3.1 21.0 0.0 0.0 0.0 0.0 0.1 0.5 1.3 0.1 0.0 0.0 25.3 133.4 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22581005-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.4;pancreas: 47.9;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2" "Region enhanced" "Detected in single" "midbrain: 1.1" "Region enriched" "Detected in single" 7 "midbrain: 4.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: AB_2685736" "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favorable (6.28e-4)" "prognostic favorable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.2 0.0 0.2 1.3 0.2 0.0 0.2 0.2 0.3 9.7 4.5 0.2 0.2 2.2 1.8 0.2 0.2 3.8 13.1 0.2 0.2 0.1 0.2 44.4 15.9 0.2 1.4 0.2 3.4 47.9 0.0 0.4 0.3 0.4 0.5 6.0 0.2 0.2 0.2 0.2 0.0 1.8 0.2 0.2 0.2 20.7 0.3 0.2 0.2 2.2 0.2 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.7 0.0 0.0 16.2 0.0 0.0 0.0 0.0 6.3 0.0 7.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.2 15.1 0.0 0.0 0.0 0.5 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 1.4 0.2 0.4 0.2 89.3 60.1 0.0 1.0 0.0 0.0 0.3 48.4 17.4 22.7 0.0 0.0 0.0 0.0 21.4 0.0 0.0 4.9 0.0 31.8 0.0 0.0 0.6 4.6 51.3 0.0 0.0 27.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 82.6 0.0 24.8 2.9 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 33.6 0.0 FOXD3 "Genesis, HFH2" ENSG00000187140 "Forkhead box D3" Q9UJU5 1 63323041-63325126 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "Melanocytes: 5.0" "Group enriched" "Detected in some" 6 "melanoma: 9.9;testis cancer: 3.5" "Group enriched" "Detected in some" 11 "midbrain: 1.9;pons and medulla: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 13.8;SK-MEL-30: 11.2;WM-115: 17.2" "Region enriched" "Detected in single" 13 "olfactory region: 2.1" "Region enriched" "Detected in single" 22 "olfactory region: 18.3" CAB022455 Uncertain NA NA "CAB022455: " "unprognostic (1.39e-1)" "unprognostic (3.23e-3)" "unprognostic (2.33e-3)" "unprognostic (4.63e-2)" "unprognostic (7.79e-2)" "unprognostic (8.22e-2)" "unprognostic (3.83e-2)" "unprognostic (1.29e-1)" "unprognostic (9.92e-2)" "unprognostic (3.28e-1)" "unprognostic (3.00e-2)" "unprognostic (8.56e-2)" "unprognostic (5.83e-2)" 1.1 2.0 0.0 2.9 0.0 0.2 1.6 0.0 0.1 4.2 9.3 0.0 1.8 1.3 0.7 3.1 8.7 0.8 7.3 3.3 0.1 0.0 0.3 0.2 0.1 0.1 1.9 0.0 1.1 0.3 0.0 0.2 0.0 1.9 4.6 1.2 7.7 2.2 3.9 5.9 2.0 2.7 1.7 0.5 0.1 2.3 2.7 0.0 0.0 0.4 2.0 0.4 5.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.2 0.0 0.0 0.3 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 0.0 11.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.5;TIME: 1.1;U-266/70: 2.5" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in some" 44 "cerebellum: 189.6" CAB022462 Approved NA NA "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 10.8;HEL: 34.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA048871, HPA058412, CAB078176" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710" "unprognostic (1.28e-1)" "prognostic favorable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favorable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.4 0.0 3.8 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.6 0.0 0.5 0.2 1.7 10.8 1.2 0.3 0.8 1.4 7.4 34.9 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.3 0.0 0.3 9.0 0.1 0.4 0.8 0.0 0.0 4.3 5.2 3.8 0.5 2.6 0.2 4.7 5.0 3.7 1.2 6.6 0.0 1.8 0.3 0.1 0.0 0.0 6.5 0.9 1.3 3.8 0.0 0.0 0.0 6.3 1.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 0.0 0.0 0.0 1.4 0.2 3.8 1.1 0.0 0.0 0.0 0.0 9.8 0.0 6.6 4.2 4.3 0.3 0.0 0.0 4.7 0.1 0.2 0.8 0.0 0.0 3.0 4.8 2.9 0.0 0.3 3.6 0.6 0.2 0.0 0.0 0.0 3.9 4.2 0.0 0.0 0.0 5.4 0.0 0.8 3.2 4.7 0.1 0.5 0.0 0.0 0.3 GFY Goofy ENSG00000261949 "Golgi associated olfactory signaling regulator" I3L273 19 49423749-49428818 "Predicted membrane proteins" "Olfaction, Sensory transduction" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 2.1;testis: 4.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 3.9;SCLC-21H: 9.2;T-47d: 2.5;U-266/84: 5.6" "Region enriched" "Detected in single" 14 "olfactory region: 1.8" "Region enriched" "Detected in many" 7 "cerebellum: 14.5" NA NA "unprognostic (8.04e-2)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (8.99e-2)" "unprognostic (8.85e-2)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (9.62e-3)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.0 0.0 3.9 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.9 0.0 0.1 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 15.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Cell line enhanced" "Detected in many" "Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: AB_2732564" "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 6.1 7.4 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.5 1.1 18.4 1.2 0.1 4.2 0.3 6.9 5.9 0.0 3.8 6.3 0.1 18.8 3.7 0.0 0.2 0.4 0.9 8.8 0.0 0.1 0.3 0.0 0.2 1.6 0.2 0.2 0.2 0.2 0.5 6.1 5.0 0.1 0.1 1.0 0.2 0.4 0.2 6.9 0.1 8.6 0.4 2.1 1.8 0.2 0.2 1.0 0.7 9.7 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 3.0 5.1 0.0 10.1 9.4 6.7 3.4 0.0 13.4 7.9 3.5 15.7 0.4 1.7 0.4 3.6 4.4 1.4 0.0 2.7 2.8 5.6 4.9 5.7 1.3 0.9 3.2 0.0 0.6 0.3 2.2 0.9 1.3 13.5 0.0 0.2 0.9 1.2 2.0 2.8 3.8 3.1 6.5 13.9 1.9 5.3 6.6 0.5 1.3 1.2 12.9 GNAT3 "GDCA, gustducin" ENSG00000214415 "G protein subunit alpha transducin 3" A8MTJ3 7 80458671-80512020 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 14.5" "Cell type enriched" "Detected in single" 22 "Early spermatids: 2.2" "Group enriched" "Detected in some" 6 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 8.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "olfactory region: 1.8" NA NA "unprognostic (2.01e-1)" 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pituitary gland: 27.0;retina: 79.9" "Group enriched" "Detected in some" 9 "Bipolar cells: 509.6;Cone photoreceptor cells: 877.7;Rod photoreceptor cells: 442.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "Daudi: 8.5;NTERA-2: 10.3;U-698: 25.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 10.4" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.8 1.6 0.9 1.4 2.0 0.5 0.8 6.9 1.6 1.1 1.0 0.8 0.8 2.3 2.7 0.8 0.8 1.0 1.1 5.4 1.0 1.3 0.8 0.8 0.8 1.4 1.1 0.8 3.5 0.8 3.2 27.0 0.8 1.6 1.6 0.4 79.9 2.6 1.8 1.5 0.6 1.6 4.1 0.9 0.9 0.9 0.8 0.8 0.8 1.2 1.0 1.8 2.1 0.8 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 5.0 0.8 0.6 0.9 0.5 2.9 0.6 1.6 1.1 1.1 0.3 8.5 0.0 3.1 0.1 0.3 4.9 0.2 1.5 0.7 1.1 2.2 2.7 0.7 0.5 0.6 1.4 1.2 0.2 1.5 2.1 5.3 1.4 1.1 0.8 0.7 0.4 0.4 0.4 0.5 10.3 0.0 0.3 0.4 1.7 0.5 0.3 0.2 0.8 1.2 0.2 0.0 0.6 1.7 0.0 0.5 2.6 1.3 2.1 2.5 3.8 0.7 0.5 25.9 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 6.9 1.5 1.0 1.3 1.1 0.8 1.6 0.8 0.0 0.0 0.0 0.4 0.3 509.6 4.6 0.0 0.0 0.0 0.0 877.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.1 69.9 0.0 0.0 0.0 0.0 3.4 0.0 1.7 0.0 0.0 58.9 0.2 0.0 3.2 0.0 442.8 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702709 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 115.9" "Group enriched" "Detected in many" 5 "B-cells: 132.4;Cardiomyocytes: 52.7;Distal tubular cells: 104.5;Hofbauer cells: 49.0;Horizontal cells: 160.5;Melanocytes: 49.0;Muller glia cells: 53.2" "Cancer enhanced" "Detected in all" "glioma: 21.9" "Region enriched" "Detected in all" 5 "basal ganglia: 115.9" "Group enriched" "Detected in many" 4 "memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 4 "B-cells: 23.9;dendritic cells: 19.9" "Cell line enhanced" "Detected in many" "Daudi: 10.5;REH: 31.0;SK-MEL-30: 14.3;U-266/70: 29.8;U-266/84: 13.7" "Region enriched" "Detected in many" 6 "basal ganglia: 1142.7" "Region enriched" "Detected in all" 6 "basal ganglia: 484.6" HPA057790 Supported Supported NA NA "HPA057790: AB_2683527" "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favorable (3.05e-4)" "prognostic favorable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favorable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favorable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.1 4.8 19.8 4.5 115.9 5.4 4.1 9.7 28.2 2.6 3.8 23.4 0.8 4.7 4.8 4.9 11.1 6.5 3.3 22.5 20.3 11.4 6.0 2.2 3.0 8.0 20.0 10.0 10.0 7.2 5.4 4.6 1.4 20.9 7.1 3.0 12.2 22.8 5.7 2.9 1.7 4.9 3.4 28.5 11.0 5.8 5.5 22.0 0.1 3.7 0.4 8.2 3.4 1.4 23.9 19.9 5.0 0.6 0.0 0.5 1.3 0.1 0.0 1.5 3.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 10.5 0.5 0.1 0.1 0.1 1.7 0.0 0.0 0.0 1.4 0.2 0.0 1.2 0.8 0.0 6.3 0.2 0.2 0.0 0.1 0.1 0.0 1.2 0.1 6.8 0.0 1.0 0.2 0.6 1.2 0.2 0.6 31.0 0.0 2.8 0.1 0.0 0.0 4.5 0.0 0.0 14.3 1.1 0.2 2.6 0.0 0.0 1.5 0.1 0.1 29.8 13.7 2.2 0.1 3.3 7.9 1.1 0.6 3.2 0.1 0.2 0.4 23.9 0.2 0.1 2.5 20.5 0.5 0.3 5.0 0.0 0.0 19.9 0.0 1.3 19.8 115.9 9.7 20.0 20.3 11.4 20.0 10.0 20.9 22.0 6.0 3.4 132.4 10.1 2.3 5.4 52.7 10.2 5.3 5.7 8.7 7.9 0.5 104.5 10.7 4.3 12.1 0.5 0.0 4.2 0.9 1.7 8.1 12.7 11.6 49.0 160.5 5.8 14.7 7.2 7.4 2.3 6.6 49.0 12.6 2.6 53.2 3.9 1.5 2.5 15.8 10.2 6.5 8.0 1.7 2.9 1.8 2.9 2.2 1.7 6.7 GPR151 "GALR4, PGR7" ENSG00000173250 "G protein-coupled receptor 151" Q8TDV0 5 146513103-146516190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 1.5;brain: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "thalamus: 36.8" "Region enriched" "Detected in many" 7 "thalamus: 4.6" HPA065728 Supported NA NA "HPA065728: " "unprognostic (2.09e-1)" "unprognostic (2.30e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-2)" 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 9.6;SuSa: 8.1" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in some" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA049862: AB_2680920, HPA054678: AB_2682570" "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538137-100542018 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 62.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Group enriched" "Detected in many" 7 "basal ganglia: 62.7;thalamus: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HSkMC: 4.9;SCLC-21H: 6.1" "Region enriched" "Detected in many" 11 "basal ganglia: 643.5" "Region enriched" "Detected in some" 34 "basal ganglia: 223.4" HPA007488 Approved NA NA "HPA007488: AB_2667844" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.7 0.6 1.2 0.5 62.7 0.2 10.9 0.0 6.8 0.1 0.3 0.8 0.0 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.9 0.8 0.3 13.1 0.2 0.3 0.7 1.1 3.8 0.1 4.6 0.5 0.2 7.0 0.6 0.5 0.3 0.7 0.1 0.3 0.1 0.5 0.3 0.5 13.7 0.4 0.2 32.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 62.7 0.0 6.8 0.9 0.8 0.7 1.1 7.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 75.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 12.1 0.1 0.0 12.6 0.2 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 5.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 0.0 19.9 3.7 0.7 1.0 9.4 14.6 5.1 1.4 9.1 3.5 0.0 0.1 1.7 1.1 0.1 3.6 9.6 0.0 8.2 0.0 2.3 0.2 7.0 0.0 18.9 25.4 75.7 2.5 26.9 0.0 0.3 31.5 1.7 5.4 25.1 0.8 1.7 5.8 1.1 1.8 10.3 77.6 8.2 0.1 0.1 0.9 0.2 34.6 21.8 0.3 GRID2 "GluD2, GluR-delta-2" ENSG00000152208 "Glutamate ionotropic receptor delta type subunit 2" O43424 4 92303622-93810157 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 45.1;testis: 38.2" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 94.0;Early spermatids: 359.2;Late spermatids: 508.8;Muller glia cells: 141.0" "Cancer enriched" "Detected in single" 7 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-2 OS: 12.9;U-266/70: 5.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 130.6" "HPA056253, HPA058538" Enhanced NA NA "HPA056253: AB_2683079, HPA058538: AB_2683747" "unprognostic (2.78e-1)" "unprognostic (1.29e-4)" "unprognostic (7.23e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (3.50e-2)" "unprognostic (3.34e-1)" "unprognostic (6.92e-2)" "unprognostic (7.96e-3)" "unprognostic (4.36e-2)" "unprognostic (9.31e-2)" "unprognostic (7.38e-3)" 0.6 3.5 8.0 0.6 13.6 0.6 0.6 45.1 7.0 1.1 0.7 2.8 0.0 0.8 0.7 0.9 0.6 0.9 0.6 0.7 6.2 3.4 0.8 0.6 0.7 0.6 7.6 6.4 3.7 0.6 0.6 0.3 0.6 7.2 0.6 0.7 0.6 0.6 0.9 0.6 0.6 0.8 0.6 9.0 0.7 0.6 38.2 7.9 0.0 0.7 0.0 0.6 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 12.9 0.0 0.0 5.8 0.0 0.6 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 13.6 45.1 7.0 6.2 3.4 7.6 6.4 7.2 7.9 0.0 0.0 0.0 0.0 0.0 94.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 359.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 508.8 4.6 0.0 0.0 0.0 0.0 141.0 0.0 0.0 1.1 0.0 3.9 6.5 0.7 3.4 2.0 0.0 0.0 0.0 0.0 0.0 GRIN2C "GluN2C, NMDAR2C" ENSG00000161509 "Glutamate ionotropic receptor NMDA type subunit 2C" Q14957 17 74842023-74861504 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 15.9;Hofbauer cells: 9.4;Muller glia cells: 18.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.3" "Region enriched" "Detected in many" 5 "cerebellum: 43.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 11.3;RPMI-8226: 4.0;SCLC-21H: 5.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 13 "cerebellum: 65.6" NA NA "unprognostic (7.21e-3)" "unprognostic (4.68e-2)" "unprognostic (9.38e-3)" "unprognostic (2.24e-5)" "unprognostic (3.42e-1)" "unprognostic (1.53e-2)" "unprognostic (1.84e-1)" "unprognostic (1.82e-2)" "unprognostic (1.78e-1)" "unprognostic (2.95e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-3)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (1.51e-2)" "unprognostic (1.14e-1)" 1.0 1.4 7.8 0.5 9.1 1.0 0.5 43.6 8.9 0.5 0.5 2.4 0.0 0.5 0.5 0.5 0.4 0.6 0.6 13.2 4.5 1.4 0.3 0.2 0.3 0.3 3.2 4.5 0.4 0.2 0.5 0.0 2.7 4.2 0.3 0.4 0.3 14.2 0.5 0.6 0.4 0.6 0.5 1.0 0.4 0.3 2.7 0.9 0.0 12.4 0.0 0.3 0.4 0.0 0.2 1.3 0.3 0.1 0.2 0.7 0.0 0.0 0.4 0.4 0.1 0.1 0.0 11.3 0.0 0.0 0.0 0.0 1.4 0.2 0.5 0.1 0.0 0.1 0.4 0.1 0.0 0.0 1.0 0.3 0.2 0.3 0.3 0.0 0.8 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.3 0.0 1.7 0.1 0.1 0.1 0.1 0.1 0.3 0.9 4.0 0.0 0.3 5.2 0.4 2.2 0.2 0.8 0.8 0.7 0.1 0.2 0.4 2.0 0.5 0.2 1.1 0.1 0.2 0.5 0.7 0.2 0.1 0.1 0.3 0.7 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.3 0.2 0.3 0.2 0.0 1.3 0.2 0.0 7.8 9.1 43.6 6.3 4.5 1.4 3.2 4.5 4.2 0.9 0.0 0.0 0.0 0.0 0.1 2.5 15.9 2.5 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 9.4 1.6 0.0 1.3 0.3 4.3 0.0 0.0 1.7 0.0 0.0 18.3 0.0 0.0 0.4 0.0 2.4 0.0 1.0 3.0 2.5 0.0 0.6 0.0 0.0 0.0 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018645-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "brain: 101.6" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 1.8;Early spermatids: 3.4;Intestinal endocrine cells: 2.9;Late spermatids: 1.5;Spermatogonia: 4.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Region enriched" "Detected in many" 21 "cerebellum: 101.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 6.5;SCLC-21H: 26.0" "Region enhanced" "Detected in all" "cerebellum: 83.5" "Region enriched" "Detected in all" 4 "cerebellum: 252.6" CAB022096 Enhanced NA NA "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.2 0.1 0.4 0.3 4.9 0.2 0.2 101.6 7.2 0.6 0.1 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.5 0.9 0.2 0.3 0.3 0.2 0.3 0.4 0.2 3.5 0.1 0.0 0.3 4.3 0.3 0.2 0.1 0.1 0.2 0.3 0.6 0.8 0.7 1.1 0.1 0.2 1.6 0.5 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.9 101.6 1.0 0.5 0.9 0.3 0.4 4.3 0.5 0.0 0.0 0.0 0.3 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 4.0 0.0 0.1 0.0 0.0 0.1 HCRT "OX, PPOX" ENSG00000161610 "Hypocretin neuropeptide precursor" O43612 17 42184060-42185452 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 84.3" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 1.8;Intestinal endocrine cells: 2.9;Kupffer cells: 1.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;Karpas-707: 1.0;RPMI-8226: 3.7" "Region enriched" "Detected in some" 5 "hypothalamus: 110.5" "Region enriched" "Detected in some" 57 "hypothalamus: 152.0" "HPA064801, CAB079778" Enhanced Supported "Secreted to blood" NA NA "CAB079778: , HPA064801: " "unprognostic (3.34e-2)" "unprognostic (7.76e-5)" "unprognostic (3.21e-2)" "unprognostic (3.01e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 0.9 0.0 0.0 1.1 0.2 0.9 0.0 0.0 0.7 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.4 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 2.7 0.4 2.3 0.5 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.0 0.0 0.0 0.8 0.8 0.4 0.9 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.7 0.8 0.2 0.0 0.1 0.0 2.3 0.5 0.0 1.2 0.4 2.2 1.5 0.9 1.6 0.4 2.7 1.4 1.3 0.1 0.4 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.9 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.7 0.1 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 71.1;placenta: 20.2;testis: 32.5" "Group enriched" "Detected in some" 149 "Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.2" "Group enriched" "Detected in many" 27 "granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2" "Cell line enriched" "Detected in some" 4 "K-562: 77.0" "Region enriched" "Detected in all" 5 "cerebellum: 55.9" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.3 0.2 0.2 0.4 0.2 71.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.3 1.0 0.2 0.2 0.3 0.9 5.4 0.5 0.2 0.0 0.6 0.2 0.0 0.3 20.2 1.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.3 2.8 0.2 32.5 0.0 17.1 0.3 0.2 0.5 1.4 4.8 0.0 0.1 2.1 0.1 2.9 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.1 0.8 0.0 2.3 1.1 0.1 0.0 8.2 3.3 1.0 2.9 0.0 0.0 1.2 4.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1388.7 0.0 0.0 724.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.3 1114.5 5.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 7.2 3.3 0.0 0.5 0.0 0.0 0.0 HENMT1 "C1orf59, FLJ30525, HEN1" ENSG00000162639 "HEN methyltransferase 1" Q5T8I9 1 108648290-108661526 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;testis: 45.2" "Group enriched" "Detected in many" 4 "Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 15 "cerebellum: 18.1" "HPA028464, HPA028497" Uncertain Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA028464: AB_10600103, HPA028497: AB_10601552" "unprognostic (1.82e-1)" "prognostic favorable (2.56e-4)" "prognostic favorable (9.95e-4)" "unprognostic (2.92e-3)" "unprognostic (1.91e-1)" "unprognostic (3.88e-3)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.95e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.53e-1)" "unprognostic (2.43e-1)" "unprognostic (2.18e-1)" "unprognostic (1.65e-1)" 3.5 2.2 6.7 5.1 10.2 7.7 5.5 3.6 11.6 6.1 4.4 4.2 1.4 3.4 2.8 3.4 1.9 1.8 4.5 3.1 9.5 10.1 1.8 1.4 4.9 9.8 8.2 5.6 3.8 1.5 0.6 3.9 3.8 10.7 2.7 6.6 1.3 2.4 2.6 2.0 2.6 5.2 2.5 6.9 8.0 3.2 45.2 2.5 10.3 1.7 1.2 7.3 5.5 1.6 5.4 10.6 18.2 12.0 22.9 28.8 15.9 5.8 3.0 0.2 0.0 0.2 0.2 0.0 1.4 0.5 3.5 0.5 8.8 9.3 0.0 3.2 2.6 0.0 0.0 0.0 0.0 2.2 1.9 0.0 15.0 11.3 0.0 3.0 8.8 13.4 2.9 0.1 0.7 0.0 0.0 0.7 25.7 0.0 6.7 0.1 14.9 23.6 26.4 8.7 4.7 1.3 10.3 0.0 0.5 0.0 6.4 14.7 0.0 12.6 3.5 0.0 0.9 0.0 19.8 0.1 0.0 11.7 6.4 0.0 4.1 5.1 0.0 0.0 34.8 0.1 16.0 8.8 18.2 28.8 10.1 26.0 5.4 14.2 26.0 10.6 2.9 11.8 21.7 8.6 22.9 12.0 8.5 13.1 15.9 6.7 10.2 3.6 11.6 9.5 10.1 8.2 5.6 10.7 2.5 0.0 0.6 0.0 1.4 1.4 3.8 1.5 17.8 1.4 1.2 5.2 0.0 10.4 3.3 2.8 8.7 2.6 3.9 0.0 1.2 16.4 3.1 0.6 6.9 0.4 14.0 0.0 4.7 6.7 11.7 17.0 4.6 8.5 1.7 7.2 2.5 2.0 1.9 6.8 2.8 0.7 2.6 6.5 2.8 118.4 74.4 1.4 4.3 38.3 5.6 2.5 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell type enhanced" "Detected in some" 17 "Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.8 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.2 4.1 0.2 1.9 0.2 2.3 6.9 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.4 1.9 0.1 0.3 1.0 0.0 3.6 3.4 0.0 2.8 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.1 1.0 0.7 0.0 5.5 0.7 1.2 0.0 0.2 0.0 1.1 0.3 0.0 0.0 2.8 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.7 3.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 4.6 6.2 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.4 0.3 HOXA3 "HOX1, HOX1E" ENSG00000105997 "Homeobox A3" O43365 7 27106184-27152581 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 9.2;Mucus-secreting cells: 14.6;Proximal tubular cells: 11.0;Undifferentiated cells: 13.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "pons and medulla: 6.6" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 19.1;CACO-2: 12.3;CAPAN-2: 32.9;HEK 293: 14.7;WM-115: 17.6" "Region enriched" "Detected in single" 31 "pons and medulla: 2.9" "Region enriched" "Detected in single" 34 "pons and medulla: 5.0" HPA029157 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029157: AB_10601020" "unprognostic (1.32e-1)" "unprognostic (3.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.85e-3)" "unprognostic (2.94e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.61e-2)" "unprognostic (6.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-2)" "unprognostic (5.82e-2)" 5.3 2.6 0.5 11.0 0.5 0.0 8.9 0.5 0.5 3.9 13.7 0.7 9.8 3.9 7.5 7.2 6.9 16.0 4.7 4.7 0.5 0.0 9.9 1.5 5.2 3.5 1.3 0.5 5.5 0.6 5.4 0.5 0.5 6.6 5.6 4.9 0.5 0.5 4.2 7.2 3.8 7.8 3.6 4.7 2.5 6.3 2.7 0.5 6.7 2.5 9.8 2.7 9.4 6.0 0.5 1.3 3.8 1.1 1.3 0.5 0.3 5.7 6.8 0.0 19.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 12.3 32.9 0.9 9.5 0.5 2.6 7.7 0.3 0.8 0.0 0.2 14.7 0.2 0.1 9.9 0.6 0.3 0.3 1.2 0.0 1.5 1.8 0.0 1.8 0.8 0.6 0.1 0.7 0.3 0.0 0.5 0.0 1.6 4.2 6.8 2.2 0.0 5.6 2.6 2.8 0.0 1.0 0.0 2.7 0.3 0.5 0.4 8.1 0.0 1.0 2.0 1.5 0.0 0.0 0.3 0.6 1.2 17.6 1.7 0.2 0.7 0.5 0.2 0.0 0.5 0.3 0.5 1.3 0.1 0.0 0.3 3.8 1.3 1.1 0.1 0.5 0.3 0.5 0.5 0.5 0.5 0.5 0.0 1.3 0.5 6.6 0.5 0.0 0.0 0.0 3.0 1.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 6.5 1.4 5.0 0.0 0.0 0.0 1.1 2.2 1.1 0.0 0.1 0.0 4.1 9.2 0.3 7.3 0.6 0.0 3.3 0.0 14.6 0.0 0.0 7.0 0.0 11.0 0.0 0.0 4.2 1.2 0.4 1.1 0.0 0.0 13.6 2.6 HOXA4 "HOX1, HOX1D" ENSG00000197576 "Homeobox A4" Q00056 7 27128507-27130799 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Distal tubular cells: 13.3;Ito cells: 12.3;Proximal tubular cells: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 18 "pons and medulla: 26.7" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 19.1;HEK 293: 14.5;REH: 13.4;WM-115: 19.0" "Region enriched" "Detected in single" 47 "pons and medulla: 11.9" "Region enriched" "Detected in single" 60 "pons and medulla: 24.6" HPA060088 Approved Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA060088: AB_2684200" "unprognostic (3.37e-2)" "unprognostic (6.27e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.32e-1)" "unprognostic (4.22e-1)" "unprognostic (1.31e-1)" "unprognostic (7.39e-2)" "unprognostic (4.23e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (3.38e-1)" "unprognostic (3.59e-4)" "unprognostic (3.93e-2)" 8.9 6.2 0.4 2.2 0.3 0.2 11.6 0.3 1.2 2.7 7.5 0.4 8.2 3.5 3.9 10.3 27.5 18.1 5.7 4.8 0.3 0.0 9.6 2.0 10.5 3.0 1.4 0.3 8.8 1.1 17.6 0.3 0.5 26.7 4.1 1.7 0.3 0.7 5.6 29.8 3.5 5.2 4.9 25.8 5.5 9.3 1.6 0.4 0.3 2.3 3.4 1.2 5.5 10.9 0.9 1.4 0.1 0.5 0.1 0.3 0.2 6.0 2.0 0.0 19.1 0.0 0.0 1.2 0.5 0.6 2.0 2.0 3.8 1.2 1.6 0.1 1.8 1.8 2.6 0.7 0.3 1.6 0.0 14.5 0.0 0.6 8.7 2.2 2.0 3.6 2.1 1.6 6.8 0.5 0.0 6.7 0.5 0.0 0.0 6.5 1.6 0.0 7.1 0.0 2.1 4.7 13.4 2.9 0.1 9.6 1.4 0.9 0.0 1.9 0.0 7.0 0.7 0.4 1.0 8.8 0.0 3.1 5.0 0.1 0.0 0.0 0.7 4.1 3.3 19.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.1 0.5 1.4 0.0 0.2 0.4 0.3 0.3 1.2 0.3 0.0 1.4 0.3 26.7 0.4 0.0 0.0 0.0 2.9 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.4 1.9 0.7 0.0 0.0 0.5 0.3 0.6 0.0 0.0 0.2 0.0 2.9 12.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 10.1 0.0 0.0 2.1 0.2 2.7 1.1 0.1 0.0 2.0 2.4 HOXA5 "HOX1, HOX1C" ENSG00000106004 "Homeobox A5" P20719 7 27141052-27143668 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 42.0" "Cell type enhanced" "Detected in many" 7 "Ito cells: 16.0;Paneth cells: 15.9;Proximal tubular cells: 21.3;Undifferentiated cells: 18.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 46 "pons and medulla: 16.3" "Group enriched" "Detected in some" 4 "basophil: 3.0;neutrophil: 1.6;NK-cell: 2.5" "Group enriched" "Detected in many" 5 "granulocytes: 3.0;NK-cells: 2.5" "Cell line enhanced" "Detected in many" "AN3-CA: 33.1;HEK 293: 56.5;RPTEC TERT1: 12.8" "Region enriched" "Detected in single" 88 "pons and medulla: 23.0" "Region enriched" "Detected in single" 22 "pons and medulla: 5.5" NA NA "unprognostic (2.43e-1)" "unprognostic (3.98e-3)" "unprognostic (2.99e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.87e-1)" "unprognostic (7.80e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.02e-2)" "unprognostic (5.54e-2)" "unprognostic (2.31e-1)" "unprognostic (5.47e-2)" "unprognostic (3.00e-2)" "unprognostic (4.37e-2)" "unprognostic (3.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.00e-1)" 6.8 42.0 0.2 2.1 0.2 1.2 10.9 0.2 0.3 1.9 6.6 1.0 16.0 1.1 6.0 25.0 12.3 22.1 2.5 1.4 0.2 0.0 16.8 1.8 23.9 1.5 0.2 0.2 9.3 1.3 2.0 0.5 0.3 16.3 3.9 3.3 0.2 0.2 7.1 5.6 3.4 6.8 3.0 19.4 4.4 5.6 2.6 0.2 0.2 1.3 0.2 0.2 6.6 3.3 0.2 0.4 3.0 0.5 2.5 0.2 0.1 1.9 1.0 0.0 33.1 0.0 0.0 0.1 0.5 0.4 0.6 0.5 0.6 3.4 1.0 4.9 1.0 0.7 2.6 1.8 0.1 0.6 0.4 56.5 0.7 0.4 1.9 0.3 1.2 0.8 3.7 0.2 1.1 1.9 0.0 7.3 1.9 0.1 0.0 1.1 0.6 0.0 0.3 0.0 0.7 1.0 4.5 0.1 0.0 12.8 2.6 3.9 0.0 2.5 0.0 1.1 0.1 0.4 0.4 2.9 0.1 0.4 2.0 1.3 0.0 0.0 1.1 0.2 3.6 3.6 3.0 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.2 0.2 0.1 1.6 2.5 0.5 0.4 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 16.3 0.2 0.0 0.6 0.0 3.8 3.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 5.1 9.3 0.0 0.0 0.0 1.3 2.2 0.0 0.0 0.6 0.0 8.6 16.0 4.1 0.0 0.3 0.9 1.7 1.0 8.4 0.0 0.0 15.9 0.0 21.3 0.0 0.0 3.3 0.2 0.7 2.5 0.1 0.0 18.1 5.0 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.8" "Group enriched" "Detected in many" 5 "Distal tubular cells: 111.0;Proximal tubular cells: 39.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 14 "pons and medulla: 9.2" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.7" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.7" "Cell line enhanced" "Detected in many" "HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7" "Region enriched" "Detected in single" 12 "pons and medulla: 1.4" "Region enriched" "Detected in single" 10 "pons and medulla: 2.9" HPA074048 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA074048: AB_2686655" "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 6.5 14.5 0.2 4.8 0.2 0.0 11.2 0.3 0.6 7.3 10.0 0.2 7.9 0.0 5.0 15.4 3.0 12.2 0.5 0.2 0.2 0.0 25.4 0.4 2.6 3.5 0.2 0.2 6.2 0.2 0.3 0.2 1.3 9.2 8.2 7.2 0.2 0.2 8.9 27.8 8.2 6.1 8.1 14.3 3.7 3.2 2.7 0.2 1.6 0.9 0.2 1.1 11.4 6.7 0.2 0.9 0.0 0.0 7.7 1.6 0.2 6.9 2.4 0.0 7.5 0.0 0.0 0.4 2.5 4.3 5.2 6.0 3.6 2.7 4.8 7.0 1.9 0.2 4.8 19.7 0.0 3.1 0.0 12.4 0.3 2.8 0.1 0.5 0.4 0.2 4.1 0.2 0.6 7.0 0.0 9.8 8.4 0.0 0.0 1.9 1.2 0.0 1.1 0.3 5.0 0.7 2.5 4.6 0.0 24.4 4.8 19.7 0.0 13.6 0.0 0.0 1.4 0.2 1.9 0.8 0.0 4.7 14.0 2.4 0.0 0.1 0.1 0.0 9.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 7.7 0.0 0.6 0.4 0.2 0.2 0.2 0.3 0.6 0.2 0.0 0.2 0.2 9.2 0.2 0.0 0.0 0.0 7.5 8.0 0.0 0.3 0.0 0.0 0.0 12.2 0.0 0.4 111.0 0.0 15.9 2.2 3.0 0.0 0.0 4.6 2.7 4.0 0.0 0.0 0.2 0.0 15.5 0.0 0.0 2.1 0.6 0.5 3.3 0.0 11.2 0.0 0.1 10.4 0.0 39.0 0.0 0.0 7.3 0.4 0.2 10.8 0.2 0.9 15.7 2.6 HOXB2 "HOX2, HOX2H" ENSG00000173917 "Homeobox B2" P14652 17 48540894-48544989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 53.1" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 50.6;Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 6 "pons and medulla: 12.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.0;EFO-21: 20.3;HEK 293: 23.0;HMC-1: 45.9;WM-115: 20.1" "Region enriched" "Detected in single" 34 "pons and medulla: 4.7" "Region enriched" "Detected in single" 29 "pons and medulla: 5.4" HPA047857 Supported Nucleoplasm NA NA Nucleoplasm "HPA047857: AB_2680184" "unprognostic (8.58e-3)" "unprognostic (4.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (7.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.75e-2)" "unprognostic (2.60e-1)" "unprognostic (3.24e-1)" "unprognostic (3.04e-3)" "unprognostic (4.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (2.89e-1)" 9.2 11.0 0.2 6.3 0.3 1.9 24.2 0.3 0.2 14.5 15.4 0.4 53.1 2.4 6.9 32.5 19.3 12.2 12.8 4.5 0.5 0.1 25.6 2.8 6.4 4.4 2.0 0.3 6.4 1.6 8.9 0.9 1.7 12.9 8.2 1.7 0.8 0.6 33.2 6.1 3.7 6.4 7.5 19.4 6.8 6.7 2.7 0.2 2.4 3.0 3.9 2.6 7.9 16.3 0.8 6.0 5.0 0.4 2.2 9.5 1.3 0.0 0.7 21.0 0.0 4.8 5.6 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 20.3 5.8 0.0 0.0 3.1 0.0 0.0 0.1 23.0 7.9 0.8 0.0 8.5 0.0 45.9 3.5 0.0 9.1 3.6 0.2 3.3 0.0 15.5 0.0 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.4 0.0 15.0 1.8 0.0 0.0 1.5 0.0 12.0 1.5 11.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 8.2 0.0 20.1 5.0 0.4 0.0 4.2 0.4 1.3 0.2 6.2 4.7 1.9 0.8 9.5 3.9 0.0 2.2 0.3 6.0 7.3 1.3 0.2 0.3 0.3 0.2 0.5 0.1 2.0 0.3 12.9 0.2 3.0 1.4 5.2 6.2 6.3 0.0 0.8 0.0 1.4 2.3 50.6 0.0 14.4 132.6 0.8 0.6 5.6 0.0 0.0 0.2 23.9 18.1 7.9 20.7 0.0 6.8 0.0 2.4 21.5 12.6 0.9 0.0 11.9 11.8 6.4 1.3 0.0 0.1 1.1 0.0 17.2 0.0 0.0 30.9 1.7 6.8 5.0 20.8 27.4 0.7 21.3 HOXB3 "HOX2, HOX2G" ENSG00000120093 "Homeobox B3" P14651 17 48548870-48604912 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4" "Group enriched" "Detected in many" 5 "Collecting duct cells: 94.2;Early spermatids: 27.9;Ito cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.7;EFO-21: 18.1;HEK 293: 21.9;RPTEC TERT1: 17.0;U-251 MG: 19.5" "Region enriched" "Detected in single" 40 "pons and medulla: 9.3" "Region enriched" "Detected in single" 29 "pons and medulla: 12.9" "CAB009860, HPA064990" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009860: AB_2119262, HPA064990: AB_2685398" "unprognostic (5.88e-2)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (7.04e-2)" "unprognostic (8.39e-3)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (3.09e-2)" "unprognostic (4.32e-3)" "unprognostic (8.14e-2)" "unprognostic (8.27e-2)" "unprognostic (3.17e-1)" "unprognostic (7.60e-2)" "unprognostic (7.85e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.45e-6)" 8.3 4.5 1.0 7.3 1.1 0.2 8.0 1.0 1.0 11.3 16.4 1.0 56.7 2.3 10.1 44.9 5.5 17.7 3.6 1.7 1.0 0.0 16.3 1.6 4.8 1.6 1.0 1.0 2.8 1.7 6.7 1.0 3.8 2.6 4.1 4.9 1.0 1.0 68.4 4.0 2.9 11.3 3.5 4.8 6.5 7.8 3.7 1.0 1.0 1.8 1.0 1.1 6.4 5.2 0.1 2.8 1.7 0.9 1.4 1.1 0.4 3.3 7.0 4.7 2.2 3.9 5.5 1.2 0.1 0.0 0.1 0.1 3.2 20.7 1.7 18.1 14.8 2.3 0.1 1.0 0.3 0.0 5.3 21.9 5.1 3.1 0.0 6.4 0.0 13.6 6.4 0.0 6.1 0.4 2.8 6.4 6.7 6.9 0.1 3.8 0.1 0.3 0.1 0.1 6.7 0.7 0.0 3.4 0.7 17.0 3.1 0.0 0.0 0.7 0.0 3.3 3.8 6.6 1.4 7.2 2.2 7.1 1.2 19.5 1.8 2.1 0.1 4.6 0.0 3.8 1.7 0.1 0.0 0.9 0.1 0.4 0.0 0.5 1.1 0.3 0.1 0.8 1.0 0.0 1.4 0.9 2.8 1.1 0.4 1.0 1.1 1.0 1.0 1.0 0.0 1.0 1.0 2.6 1.0 0.0 3.4 0.0 2.3 2.3 0.0 0.8 0.0 0.0 1.2 94.2 0.0 2.5 6.6 0.2 27.9 7.7 7.4 0.0 0.0 0.7 5.1 3.6 8.1 0.2 0.6 0.0 2.4 27.6 2.1 7.9 0.3 1.0 5.0 0.0 6.3 0.0 0.4 3.5 0.4 0.6 0.0 0.0 3.3 4.5 9.2 1.3 0.3 1.3 9.7 4.7 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575513-48580111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 13.3" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4" "Region enriched" "Detected in single" 36 "pons and medulla: 3.7" "Region enriched" "Detected in single" 23 "pons and medulla: 7.5" HPA057432 Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA057432: AB_2683437" "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 4.4 2.4 0.0 1.5 0.0 0.0 2.9 0.0 0.0 4.2 8.1 1.2 2.3 13.3 2.7 8.5 1.5 0.4 0.0 0.0 5.7 0.7 3.6 0.6 0.0 0.0 0.7 1.8 0.0 1.0 0.6 1.1 0.0 4.8 0.8 0.9 4.3 2.0 2.4 3.0 3.9 0.5 0.6 0.2 1.3 1.7 0.3 2.4 0.0 0.1 0.6 0.7 0.1 0.1 0.3 0.0 0.1 4.9 3.9 1.9 0.0 0.0 0.2 0.1 2.2 2.0 3.1 23.4 1.5 0.4 0.1 4.1 0.0 0.0 8.0 11.3 7.6 0.7 0.0 5.0 0.0 14.4 3.8 0.0 5.7 0.0 0.8 6.6 5.2 11.4 0.2 5.6 0.0 1.8 0.0 0.0 2.1 0.0 0.0 4.4 1.6 4.6 1.9 0.0 0.0 0.6 0.0 2.9 1.6 0.4 1.5 2.5 0.3 0.2 0.8 0.2 1.9 4.0 0.7 1.6 0.0 2.2 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.2 0.5 0.0 0.1 0.2 0.1 0.0 0.6 0.0 2.4 0.0 0.1 0.0 0.0 1.7 0.9 3.4 0.0 0.8 0.0 1.4 0.0 61.1 0.0 18.4 10.0 0.1 0.0 7.1 0.8 0.0 0.0 11.0 9.7 0.4 3.5 0.0 3.2 0.0 0.0 15.4 1.8 0.0 0.3 1.9 5.0 0.0 2.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 5.2 0.2 21.8 1.6 5.0 10.5 1.5 2.6 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 21.5;RPTEC TERT1: 16.1" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 128 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.8 0.0 2.5 2.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.2 2.7 0.6 0.0 0.2 0.0 0.0 0.0 21.5 0.9 5.6 0.0 4.2 0.0 1.2 1.4 0.0 2.9 0.0 0.8 1.4 0.1 1.6 0.0 3.3 0.0 0.0 0.0 0.0 2.7 1.7 0.0 1.0 0.0 16.1 1.6 0.0 0.0 0.1 0.0 2.3 0.1 0.4 0.0 5.3 0.7 2.1 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 50.6 0.0 0.0 21.6 0.0 0.6 2.4 8.9 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.5 0.0 4.1 9.2 5.0 0.0 0.0 0.0 1.7 0.0 13.9 0.0 0.0 3.5 0.4 0.4 0.0 0.0 1.0 7.2 10.8 0.3 0.0 0.0 11.5 0.0 HOXB6 "HOX2, HOX2B" ENSG00000108511 "Homeobox B6" P17509 17 48595751-48604992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 73.7;seminal vesicle: 56.7" "Group enriched" "Detected in many" 8 "Collecting duct cells: 129.1;Distal tubular cells: 96.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 32.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.5" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.0" "Cell line enhanced" "Detected in many" "EFO-21: 13.4;HEK 293: 36.8;RPTEC TERT1: 25.0;TIME: 13.9" "Region enriched" "Detected in single" 60 "pons and medulla: 10.6" "Region enriched" "Detected in single" 25 "pons and medulla: 14.6" HPA042063 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA042063: AB_10796470" "unprognostic (5.01e-2)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.80e-3)" "unprognostic (5.64e-2)" "unprognostic (2.06e-3)" "unprognostic (3.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.97e-2)" "unprognostic (6.64e-2)" "unprognostic (2.50e-3)" "unprognostic (2.53e-3)" "unprognostic (5.76e-2)" "unprognostic (7.11e-2)" "unprognostic (4.19e-3)" 5.2 4.3 0.3 18.1 0.3 0.0 3.8 0.3 0.3 12.0 8.5 0.3 73.7 0.5 7.2 30.5 0.4 8.7 0.3 0.3 0.3 0.0 26.6 0.4 3.4 0.3 0.3 0.3 0.6 0.6 1.9 0.3 1.5 0.9 4.3 3.8 0.3 0.3 56.7 1.0 0.6 8.2 1.8 10.0 1.7 5.9 1.8 0.3 0.3 0.3 0.3 0.3 4.2 10.0 1.5 0.2 0.0 0.0 0.0 1.0 0.3 2.3 5.5 0.0 2.9 2.5 2.7 0.0 0.0 0.0 0.0 0.0 2.9 3.6 0.0 13.4 6.5 0.9 0.0 0.6 0.2 0.0 0.1 36.8 3.2 9.1 0.0 3.8 0.2 8.6 3.3 0.1 5.3 0.1 2.0 2.5 0.2 2.1 0.0 7.3 0.1 0.0 0.1 0.0 9.1 2.2 0.0 6.2 0.3 25.0 1.2 0.0 0.0 2.0 0.0 3.6 0.0 0.9 1.2 13.9 0.5 2.9 2.3 10.1 0.0 0.0 0.0 0.4 0.0 4.5 0.0 0.0 0.0 0.7 0.0 0.2 1.4 0.4 1.0 0.2 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.9 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.2 0.0 0.0 0.0 129.1 0.0 0.2 96.2 0.1 0.6 2.2 14.0 0.0 1.6 1.6 2.6 0.3 0.0 0.0 1.4 0.0 7.5 4.9 14.7 0.0 0.9 1.7 0.0 0.0 7.5 0.0 0.9 14.1 0.0 2.1 0.0 0.0 2.1 4.2 6.8 1.0 0.2 1.0 10.3 0.6 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 14 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 16.9 7.4 0.0 0.1 5.3 8.0 0.0 0.0 0.0 0.1 0.3 11.3 0.3 0.3 30.4 7.1 8.8 2.5 0.0 0.0 0.0 7.8 5.5 2.6 5.8 0.0 4.4 0.0 5.5 5.2 2.3 5.2 0.0 1.3 16.0 5.3 2.8 0.1 16.8 4.4 0.3 0.1 0.0 26.5 0.0 0.0 14.4 1.9 24.2 5.7 0.0 0.0 5.7 0.0 28.8 0.4 1.4 1.6 13.7 0.0 9.3 7.5 13.1 0.9 2.2 0.0 0.1 0.0 21.3 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 0.0 0.0 3.7 0.8 4.8 0.0 0.3 0.0 0.0 0.0 82.0 0.0 6.2 126.0 0.0 0.1 2.2 102.1 0.0 1.1 14.9 8.2 0.7 4.7 0.0 8.8 0.0 35.1 1.3 7.8 0.0 0.6 2.8 23.6 2.8 73.3 0.0 0.5 56.1 0.0 27.8 0.0 0.0 8.0 1.4 23.4 1.8 1.5 1.0 65.0 3.1 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;ovary: 31.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 3.5;Leydig cells: 2.8;Proximal tubular cells: 2.4;Sertoli cells: 6.5;Spermatocytes: 2.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 27 "pons and medulla: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 14.1;HDLM-2: 18.1;HEK 293: 19.9;SH-SY5Y: 16.9" "Region enriched" "Detected in single" 24 "pons and medulla: 9.9" "Region enriched" "Detected in single" 13 "pons and medulla: 3.7" HPA053910 Supported Nucleoplasm NA NA Nucleoplasm "HPA053910: AB_2682305" "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 16.2 4.4 0.7 3.2 0.7 0.0 17.9 0.7 0.7 1.3 2.3 0.6 1.4 0.9 11.5 17.8 6.0 20.9 1.0 1.0 0.7 0.7 15.4 0.8 0.9 3.2 1.1 0.0 31.6 0.7 0.0 0.7 5.8 29.7 2.4 0.0 0.3 0.7 1.3 8.1 4.2 9.2 4.4 10.5 1.2 2.6 8.3 0.9 0.0 1.0 0.0 1.8 2.1 3.4 1.1 0.5 0.0 0.0 0.0 1.1 0.0 3.0 3.1 0.0 14.1 5.9 3.0 0.0 1.4 1.5 1.4 1.0 0.1 2.6 12.2 0.1 10.7 0.0 2.7 0.2 0.3 0.9 18.1 19.9 0.1 1.4 0.0 0.7 1.4 0.4 7.8 1.4 8.5 1.4 0.0 0.2 4.0 0.6 0.0 5.4 0.1 1.7 0.3 0.1 0.5 0.0 3.9 4.5 0.0 6.1 0.0 0.0 16.9 2.2 0.7 7.9 0.7 10.6 0.7 0.0 7.4 4.2 0.6 7.5 3.2 3.5 6.3 0.4 1.3 7.7 0.0 0.0 0.0 0.8 0.0 0.8 1.1 0.0 0.8 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.7 0.7 0.7 0.7 0.7 0.7 1.1 0.0 29.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.4 0.0 6.5 0.0 2.8 0.4 0.0 0.2 0.7 0.0 0.0 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54032853-54035358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;ovary: 13.4" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Region enriched" "Detected in single" 14 "pons and medulla: 8.8" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 59 "T-cells: 5.9" "Cell line enhanced" "Detected in many" "AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3" "Region enriched" "Detected in single" 40 "pons and medulla: 4.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.8 1.6 0.2 1.0 0.2 0.0 1.8 0.2 0.6 0.2 1.6 0.2 0.2 0.3 0.5 5.3 1.7 8.0 1.5 0.2 0.2 0.0 1.5 0.2 0.2 0.3 0.4 0.2 13.4 0.2 0.0 0.2 1.4 8.8 0.2 0.0 0.8 0.2 0.2 4.2 2.1 4.6 2.5 2.6 0.2 3.9 2.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.9 2.2 0.0 8.5 5.1 6.2 0.0 0.5 0.4 1.0 0.7 3.6 0.5 0.0 0.6 2.5 0.0 1.4 0.2 0.0 0.3 2.7 3.0 0.0 1.0 0.1 0.2 0.0 0.1 5.8 0.6 4.1 0.4 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.0 0.1 0.0 1.5 0.3 0.0 0.0 0.0 1.2 0.0 0.0 9.3 0.6 0.2 4.4 1.2 1.7 0.1 0.0 1.5 0.9 3.2 0.3 0.0 0.0 0.0 0.2 0.2 3.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.4 0.2 8.8 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 2.1 3.2 0.6 0.6 0.2 0.0 0.0 0.0 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6" "Group enriched" "Detected in some" 5 "Collecting duct cells: 8.7;Distal tubular cells: 13.3;Early spermatids: 12.5;Leydig cells: 3.7;Peritubular cells: 4.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HSkMC: 9.5;RPTEC TERT1: 9.9;SCLC-21H: 14.2;SH-SY5Y: 9.5;SK-MEL-30: 3.9" "Region enriched" "Detected in single" 36 "pons and medulla: 3.8" "Region enriched" "Detected in single" 32 "pons and medulla: 6.7" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" No NA Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: AB_2685083" "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 6.2 1.1 0.4 3.2 0.4 0.2 19.6 0.2 0.2 8.7 3.6 0.0 22.5 0.3 25.9 36.4 1.1 4.8 2.0 0.4 0.8 0.5 8.5 0.2 0.3 0.8 1.5 0.0 7.0 0.3 0.2 0.2 0.2 0.5 2.1 0.4 0.0 0.6 22.6 0.7 0.7 0.4 4.0 7.2 1.9 0.3 3.6 0.0 0.0 0.4 0.2 0.3 1.7 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 9.9 0.5 14.2 9.5 0.1 0.1 3.9 0.2 0.0 0.0 0.6 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.8 0.5 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 13.3 0.0 12.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 1.6 0.0 0.0 0.3 0.7 0.5 1.1 0.0 0.0 0.5 0.0 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151222-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.0;seminal vesicle: 26.2" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Region enriched" "Detected in some" 7 "pons and medulla: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1" "Region enriched" "Detected in single" 28 "pons and medulla: 8.2" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA054383: AB_2682470, HPA070349: AB_2686258" "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 3.4 4.9 0.5 0.5 0.5 0.0 4.0 0.5 0.7 2.8 3.4 0.5 13.8 0.2 15.6 21.0 0.5 7.9 0.5 0.5 0.5 0.0 10.2 0.5 0.5 0.6 1.1 0.5 9.7 0.5 0.0 0.5 0.5 7.6 1.5 0.8 0.5 0.5 26.2 1.3 1.0 3.5 5.3 3.7 4.4 0.4 1.5 0.5 0.5 0.8 0.5 0.5 2.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 1.8 0.0 0.1 0.4 0.0 0.6 0.5 0.0 0.0 9.3 1.6 0.4 0.1 1.5 0.0 0.2 0.0 22.1 0.2 0.0 0.0 0.3 0.0 0.0 5.0 1.5 0.0 0.2 0.1 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 16.4 2.6 1.3 2.2 0.3 0.0 6.1 0.4 0.0 0.0 2.8 0.2 0.1 1.4 1.2 0.0 0.0 0.0 1.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.0 1.1 0.5 7.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 3.7 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 4.4 0.0 1.7 0.0 0.6 0.0 0.1 0.0 2.8 5.3 0.0 6.5 0.5 0.2 0.2 0.5 0.0 0.0 1.2 0.0 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.7;lymphoid tissue: 97.9" "Cell type enhanced" "Detected in many" 14 "B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 40.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8" "Group enriched" "Detected in some" 13 "cerebellum: 61.1;hippocampal formation: 29.7" "Region enriched" "Detected in single" 37 "cerebellum: 96.7" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" Yes NA 208000 14000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 8.8 2.4 4.1 48.0 5.8 19.5 7.8 40.1 4.3 4.7 4.8 4.6 0.9 3.8 5.4 2.9 3.4 9.7 5.6 5.1 4.9 2.1 2.5 3.9 14.7 58.0 5.8 2.3 3.7 1.7 0.7 1.4 3.0 6.7 3.5 5.9 3.4 13.5 1.5 1.8 6.1 19.2 3.3 7.8 38.2 5.0 2.2 5.5 97.9 3.7 2.4 54.8 8.7 5.4 43.3 37.1 75.7 35.0 49.3 60.5 66.5 0.0 0.0 0.0 0.0 8.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.4 9.3 23.8 0.4 0.0 0.0 0.2 0.0 0.2 1.6 1.4 5.0 0.0 0.0 0.7 9.9 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.1 0.1 0.1 0.1 0.4 0.0 28.3 2.4 11.7 0.8 15.8 0.7 52.7 27.4 75.7 43.1 35.0 48.6 43.3 45.1 47.1 37.1 39.9 60.5 48.6 69.1 49.3 33.7 28.0 47.0 66.5 4.1 5.8 40.1 4.3 4.9 2.1 5.8 2.3 6.7 5.5 3.0 10.0 169.7 0.1 7.2 0.0 1.2 10.2 8.1 3.4 1.8 0.0 0.2 0.0 0.1 1.3 4.9 0.0 70.0 0.2 0.2 6.6 0.1 25.5 2.4 16.6 0.0 0.0 36.2 59.0 0.7 10.0 30.8 27.0 0.0 0.3 0.4 0.0 0.3 17.0 0.3 0.6 6.5 3.7 2.1 4.7 3.1 0.3 92.0 0.0 0.0 INS "IDDM1, IDDM2" ENSG00000254647 Insulin P01308 11 2159779-2161341 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism" Hormone "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 193 "pancreas: 514.0" "Cell type enriched" "Detected in some" 21 "Pancreatic endocrine cells: 2404.6" "Cancer enriched" "Detected in single" 7166 "pancreatic cancer: 1751.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "EFO-21: 53.7;U-2 OS: 70.4;U-698: 22.2" "Region enriched" "Detected in single" 13 "midbrain: 1.7" "CAB000048, HPA004932, CAB012098, CAB053843" Enhanced "Secreted to blood" NA NA 437000 "CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816" "unprognostic (7.61e-2)" 0.4 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 514.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.6 0.1 0.1 0.1 0.1 1.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 5.4 0.0 2.4 22.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.2 0.0 0.0 2404.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.5 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.7 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 4.2 43.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.6 12.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 17.7 3.1 0.0 0.0 1.3 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296533-68432162 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.3;Fibroblasts: 8.2;Leydig cells: 6.4;Peritubular cells: 12.7;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 55.3;hTERT-RPE1: 83.9;U-138 MG: 38.5;WM-115: 21.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 4 "basal ganglia: 6.1" HPA051813 Uncertain NA NA 42000 "HPA051813: AB_2681622" "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 4.5 2.9 0.4 3.5 0.9 0.0 2.9 0.5 3.6 41.9 1.5 0.9 3.5 0.6 59.6 11.4 2.6 8.0 3.4 9.0 0.5 0.5 4.9 0.7 1.3 0.5 0.8 0.5 15.7 0.8 0.2 1.5 2.2 1.3 4.5 1.4 1.5 0.9 8.9 1.9 2.1 1.6 30.2 0.9 4.0 1.3 3.4 0.7 0.2 1.8 5.8 0.7 5.6 7.4 1.7 1.3 1.8 1.0 0.8 1.5 0.1 0.0 0.0 0.1 0.2 1.8 0.0 0.0 3.7 7.1 0.8 0.2 0.0 0.0 0.0 0.2 55.3 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.0 0.0 4.8 0.0 3.1 0.6 0.0 1.5 0.1 83.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 8.7 0.0 0.1 2.3 38.5 0.2 0.8 0.0 0.0 0.0 0.0 5.7 0.0 21.3 1.6 1.0 0.9 1.2 0.9 1.5 0.8 1.1 1.0 0.7 1.7 1.3 1.2 1.8 0.8 0.8 1.3 1.0 0.1 0.4 0.9 0.5 3.6 0.5 0.5 0.8 0.5 1.3 0.7 0.0 0.0 0.0 0.6 0.7 1.3 10.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.3 0.3 1.0 0.0 0.0 0.0 0.1 8.2 0.4 0.0 0.8 0.3 0.0 0.0 2.5 0.6 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 12.7 0.0 1.9 19.4 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.4 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell type enhanced" "Detected in many" 11 "B-cells: 42.0;Erythroid cells: 70.0;monocytes: 36.1;T-cells: 59.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 39.1;HEL: 62.0;JURKAT: 32.6;MOLT-4: 72.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" NA NA 100000 "Plasma membrane" "HPA074961: AB_2732273" "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favorable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.2 13.9 0.0 9.0 11.3 4.8 10.2 0.0 0.0 7.2 0.0 39.1 4.2 5.3 3.2 0.1 5.8 0.0 0.7 62.0 0.2 0.0 0.9 27.4 1.5 9.9 0.0 0.3 0.0 4.7 0.5 32.6 0.0 10.5 3.0 0.0 72.3 19.2 0.8 0.0 0.0 15.9 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.4 0.0 18.1 4.9 1.5 0.9 0.1 1.8 20.5 15.2 4.1 0.8 13.6 20.8 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 0.0 7.9 42.0 0.2 0.2 2.4 0.8 5.1 1.4 3.4 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.2 2.9 0.3 17.4 0.0 5.8 0.0 0.0 1.8 21.0 0.0 0.6 22.7 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.6 0.4 0.9 0.5 0.3 59.7 0.0 0.2 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.9" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 2.3 0.3 2.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 6.0 48.3 15.4 0.1 0.0 0.0 0.0 0.0 4.0 10.3 1.8 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.4 0.1 14.0 2.1 29.9 0.0 0.0 8.0 117.5 0.9 0.0 185.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.3 45.3 0.0 0.1 JUNB ENSG00000171223 "JunB proto-oncogene, AP-1 transcription factor subunit" P17275 19 12791496-12793315 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Smooth muscle cells: 2844.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 101.1" "Group enriched" "Detected in all" 5 "granulocytes: 101.1;monocytes: 27.0" "Cell line enhanced" "Detected in many" "HDLM-2: 106.6;U-266/70: 45.7;U-266/84: 67.8" "Group enriched" "Detected in many" 5 "amygdala: 25.2;basal ganglia: 16.8;cerebral cortex: 31.3;hippocampal formation: 24.3;olfactory region: 15.1" "Region enriched" "Detected in single" 20 "cerebellum: 17.1" "CAB004464, HPA019149" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB004464: AB_2130023, HPA019149: AB_1852053" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.79e-1)" "unprognostic (9.78e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (7.20e-2)" "unprognostic (7.06e-2)" "unprognostic (3.77e-1)" "unprognostic (1.02e-1)" 83.4 95.3 8.7 57.2 16.6 153.1 29.0 8.3 16.0 57.6 33.1 29.2 13.0 20.7 26.6 23.7 84.8 128.6 103.5 46.4 10.2 9.9 20.4 54.5 76.2 23.1 10.3 7.1 108.1 25.0 10.5 43.8 44.4 21.5 63.8 9.7 47.3 37.8 84.3 54.3 66.0 32.9 33.6 15.7 25.7 39.7 15.3 11.6 12.2 27.1 71.9 53.3 71.7 37.9 4.7 12.7 101.1 27.0 2.6 6.5 12.7 8.9 1.8 0.5 1.1 2.0 5.0 1.8 3.9 3.4 1.9 1.8 1.1 5.3 3.1 13.8 1.4 5.9 17.0 0.4 5.9 0.2 106.6 1.7 3.0 6.8 1.5 2.7 4.1 14.3 6.3 17.4 1.7 1.3 3.9 0.9 2.2 8.0 5.7 0.6 26.9 2.8 24.9 0.3 6.1 7.0 3.8 1.3 6.4 1.3 11.3 4.2 6.4 17.1 10.5 4.9 0.3 1.8 4.6 3.0 5.7 3.3 11.4 4.9 45.7 67.8 2.8 6.7 10.6 1.5 3.5 17.4 18.5 5.2 27.0 5.3 4.7 5.7 6.5 12.7 4.4 4.1 4.3 101.1 2.6 24.7 1.1 5.5 12.7 8.7 16.6 8.3 16.0 10.2 9.9 10.3 7.1 21.5 11.6 107.2 621.9 699.4 682.5 1300.3 80.0 296.2 231.8 71.0 126.3 146.5 37.3 100.9 41.4 570.4 6.9 1195.0 682.0 70.0 486.4 175.7 1823.6 1011.1 495.7 64.4 1063.7 20.6 1445.6 268.2 528.1 10.3 754.8 1027.7 848.6 461.7 904.4 381.1 718.1 736.4 247.5 63.6 159.5 1144.8 2844.2 7.1 9.8 1577.0 368.2 643.4 570.8 396.1 KANK3 "ANKRD47, FLJ46061" ENSG00000186994 "KN motif and ankyrin repeat domains 3" Q6NY19 19 8322584-8343262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 58.3;Ito cells: 34.4;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 1.0;NK-cells: 3.6;T-cells: 3.5" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.3;TIME: 16.8;U-266/70: 6.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "olfactory region: 34.0" HPA051153 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA051153: AB_2681365" "unprognostic (1.56e-1)" "unprognostic (1.63e-4)" "unprognostic (1.54e-2)" "unprognostic (8.95e-3)" "unprognostic (1.07e-1)" "unprognostic (2.84e-3)" "unprognostic (1.82e-3)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-2)" "unprognostic (1.34e-2)" "unprognostic (4.77e-1)" "prognostic favorable (1.69e-5)" "unprognostic (5.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.86e-1)" "unprognostic (3.24e-1)" 23.3 3.6 5.2 3.8 4.8 1.2 13.2 2.7 6.5 3.8 5.6 1.6 2.9 4.0 5.4 6.2 4.7 5.2 3.4 9.6 6.2 2.9 7.7 2.3 19.0 6.3 4.4 1.6 3.1 3.1 1.6 3.5 18.3 4.8 3.3 1.2 6.4 3.4 2.8 15.5 3.5 4.0 3.5 2.8 21.0 3.1 2.5 5.0 0.3 7.9 3.0 1.6 2.5 6.7 0.5 0.3 1.0 0.3 3.6 3.5 0.7 0.1 0.7 0.3 0.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.8 0.2 0.0 2.7 0.0 0.1 0.1 0.6 2.9 0.0 0.8 1.6 0.4 0.4 0.5 0.1 0.2 1.5 0.0 0.9 0.0 0.0 0.0 9.3 0.7 0.0 0.4 0.0 0.5 0.0 0.5 0.6 0.6 0.3 1.5 0.0 0.8 0.1 0.2 0.0 0.1 0.0 0.8 0.1 0.0 0.6 0.0 16.8 0.1 1.6 0.4 0.1 6.9 0.2 0.3 0.2 0.1 0.2 0.8 0.3 0.1 3.5 0.1 1.6 0.3 1.9 0.6 0.1 0.5 0.8 1.3 1.0 3.6 0.1 0.3 1.3 0.7 5.2 4.8 2.7 6.5 6.2 2.9 4.4 1.6 4.8 5.0 6.0 5.6 0.0 0.2 2.3 0.2 0.8 0.0 0.0 0.0 0.0 3.9 0.3 5.0 0.2 4.0 58.3 0.0 0.0 1.6 0.2 1.7 0.8 0.0 0.8 0.4 0.0 0.0 34.4 1.6 4.1 0.6 0.7 5.0 0.0 0.0 0.2 0.4 0.0 0.4 0.3 0.7 19.4 2.5 1.1 3.1 1.1 0.2 2.5 0.0 0.5 KBTBD12 "FLJ46299, KLHDC6" ENSG00000187715 "Kelch repeat and BTB domain containing 12" Q3ZCT8 3 127915232-127987671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 8.5;Early spermatids: 25.7;Exocrine glandular cells: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 3.1;neutrophil: 1.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 1.8;RT4: 2.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 14.9" NA NA "unprognostic (3.60e-2)" "unprognostic (2.19e-2)" "unprognostic (3.37e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (3.01e-1)" "unprognostic (3.35e-2)" "unprognostic (4.69e-3)" "unprognostic (3.62e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-2)" "unprognostic (1.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (5.70e-2)" "unprognostic (9.49e-2)" 0.6 0.5 2.1 1.2 2.7 0.6 0.5 2.6 2.6 0.4 1.5 0.8 1.0 1.1 0.7 1.3 1.4 1.2 1.1 13.1 2.2 0.7 1.1 0.4 0.5 0.5 0.7 2.2 0.5 3.7 0.4 0.5 0.5 1.6 0.8 1.5 1.4 1.7 0.8 44.5 0.7 1.0 1.0 0.5 0.4 1.9 0.9 1.2 0.0 0.4 16.6 0.7 1.0 0.4 0.3 0.4 3.1 0.3 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.4 0.3 0.1 0.6 0.2 0.1 0.2 0.0 0.1 0.1 1.8 2.4 0.5 0.2 0.2 0.1 0.0 0.2 0.3 0.1 0.6 0.3 0.2 0.5 0.1 0.4 0.4 0.0 0.2 0.1 0.3 3.1 0.3 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.2 1.5 0.2 0.1 0.4 0.0 0.0 2.1 2.7 2.6 2.6 2.2 0.7 0.7 2.2 1.6 1.2 3.0 3.0 0.0 0.0 0.1 1.7 8.5 0.0 1.4 2.3 1.8 5.9 0.0 1.7 0.2 25.7 0.0 1.1 0.0 8.0 0.0 0.2 0.0 0.0 0.0 0.1 1.6 2.4 0.0 0.0 1.3 0.0 0.7 0.0 0.0 5.3 1.0 3.6 5.8 0.0 0.0 0.6 0.0 0.3 5.4 7.2 0.3 0.0 0.0 2.3 0.0 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNG2 "KCNF2, Kv6.2" ENSG00000178342 "Potassium voltage-gated channel modifier subfamily G member 2" Q9UJ96 18 79863668-79900184 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.3" "Cell type enriched" "Detected in some" 16 "Horizontal cells: 108.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "hippocampal formation: 31.7" HPA048628 Enhanced NA NA "HPA048628: AB_2680466" "unprognostic (1.07e-2)" "unprognostic (1.34e-2)" "unprognostic (8.39e-2)" "unprognostic (4.41e-1)" "unprognostic (1.99e-1)" "unprognostic (9.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (2.40e-1)" "unprognostic (3.78e-1)" "unprognostic (3.61e-3)" "unprognostic (1.09e-1)" "unprognostic (3.18e-5)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "unprognostic (4.08e-2)" "unprognostic (3.63e-2)" 0.2 0.1 1.5 0.8 2.2 0.6 0.0 0.1 2.4 0.0 0.3 1.1 0.3 0.0 0.1 0.0 0.0 0.0 5.3 1.0 0.9 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.2 0.3 0.3 1.2 0.0 0.0 0.5 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 108.1 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.3 2.1 0.0 5.3 0.0 0.0 0.0 KCNK15 "dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5" ENSG00000124249 "Potassium two pore domain channel subfamily K member 15" Q9H427 20 44745780-44752313 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.2" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 47.5" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "MCF7: 32.2" "Region enriched" "Detected in single" 18 "olfactory region: 8.4" "Region enriched" "Detected in many" 8 "olfactory region: 9.3" HPA064861 Uncertain NA NA "HPA064861: AB_2685373" "unprognostic (8.70e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.05e-2)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.50e-2)" "unprognostic (4.22e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.11e-2)" "unprognostic (7.38e-4)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (2.21e-3)" "unprognostic (2.11e-1)" 6.0 4.5 0.4 1.3 3.4 0.5 5.9 0.0 1.2 6.2 2.3 0.0 24.2 1.1 4.3 10.6 3.2 15.1 10.7 3.8 0.6 0.4 3.5 7.0 3.0 2.2 0.6 0.0 12.6 7.4 0.6 4.2 1.1 1.1 2.7 0.8 2.1 3.4 9.6 2.6 2.0 0.9 3.8 0.3 0.6 4.1 10.6 0.0 0.0 6.5 0.5 0.9 2.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.3 0.0 0.9 0.4 3.1 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 0.0 1.2 0.6 0.4 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.6 5.1 0.0 0.0 8.7 0.0 0.0 0.0 3.2 0.2 0.7 0.0 0.0 6.4 0.0 1.3 2.3 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.4 0.6 0.0 0.0 0.8 7.0 KRT27 KRT25C ENSG00000171446 "Keratin 27" Q7Z3Y8 17 40776808-40782534 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 37.4" "Cell type enhanced" "Detected in some" 24 "Ito cells: 1.8;Melanocytes: 8.5;Muller glia cells: 2.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9" "Region enriched" "Detected in single" 9 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "EFO-21: 5.7;SK-BR-3: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "hippocampal formation: 104.2" HPA055114 Enhanced NA NA "HPA055114: AB_2682700" "unprognostic (1.13e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (5.75e-4)" "unprognostic (5.11e-2)" "unprognostic (3.08e-2)" "unprognostic (8.41e-2)" "unprognostic (4.16e-1)" "unprognostic (1.53e-1)" "unprognostic (4.90e-1)" "unprognostic (1.56e-1)" "unprognostic (5.64e-3)" 1.1 0.0 0.1 0.1 1.2 0.0 4.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 37.4 0.2 0.1 0.1 0.1 0.0 1.0 0.1 2.8 0.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.3 0.0 8.5 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.4 0.4 0.2 0.0 0.0 0.0 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LHFPL1 ENSG00000182508 "LHFPL tetraspan subfamily member 1" Q86WI0 X 112630648-112680054 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SK-MEL-30: 5.4;SuSa: 8.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 6.1" HPA003029 Uncertain NA NA "HPA003029: AB_1079248" "unprognostic (2.23e-2)" "unprognostic (2.78e-3)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "unprognostic (2.65e-1)" "unprognostic (1.54e-1)" "unprognostic (5.31e-3)" "unprognostic (1.29e-1)" "unprognostic (4.41e-3)" "unprognostic (5.19e-5)" "unprognostic (1.33e-1)" "unprognostic (7.63e-3)" "unprognostic (4.83e-2)" "unprognostic (1.21e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-1)" 0.2 0.6 3.1 0.4 13.7 0.1 2.0 0.1 3.8 1.5 0.3 0.6 0.9 0.3 0.6 0.9 0.5 1.3 0.2 2.2 2.8 2.5 0.6 0.2 0.2 0.4 4.5 1.5 1.1 0.1 0.3 15.9 0.5 3.8 1.2 0.4 0.0 8.2 3.3 0.5 0.3 0.5 0.3 0.5 0.4 0.2 0.4 1.6 0.3 6.1 0.1 0.5 0.5 0.2 0.7 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 1.2 0.2 0.7 0.1 0.3 0.1 0.2 0.0 0.0 5.4 8.6 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.7 1.0 2.6 0.0 0.6 0.2 0.8 0.0 0.8 0.0 0.0 0.1 0.4 3.1 13.7 0.1 2.7 2.8 2.5 4.5 1.5 3.8 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 341.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 1.7 0.0 0.0 0.9 1.2 0.0 0.3 0.0 0.0 0.0 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.5;epididymis: 9.7;testis: 22.0" "Group enriched" "Detected in some" 84 "Early spermatids: 168.6;Late spermatids: 330.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 5 "basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "THP-1: 3.5;WM-115: 1.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 1.0" HPA077128 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 1.7 0.0 0.4 0.0 2.4 2.7 0.4 0.1 1.9 0.0 0.1 0.2 15.5 0.0 0.0 9.7 0.1 1.7 0.1 0.5 0.2 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.4 4.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.0 0.7 0.1 22.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.4 2.4 0.1 1.9 0.2 0.1 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 168.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 330.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 LPL LIPD ENSG00000175445 "Lipoprotein lipase" P06858 8 19901717-19967258 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation, FDA approved drug targets, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8" "Cancer enhanced" "Detected in all" "glioma: 39.2" "Region enhanced" "Detected in many" "basal ganglia: 16.3" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Lineage enriched" "Detected in many" 5 "monocytes: 7.1" "Cell line enriched" "Detected in some" 5 "AF22: 91.4" "Region enhanced" "Detected in many" "basal ganglia: 40.6" "Region enriched" "Detected in many" 4 "basal ganglia: 64.0" HPA048749 Supported Vesicles "Secreted to blood" NA NA 880000 Vesicles "HPA048749: AB_2680511" "unprognostic (5.52e-2)" "unprognostic (3.16e-1)" "unprognostic (6.41e-2)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-4)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (8.20e-2)" "unprognostic (2.54e-2)" "unprognostic (5.28e-1)" "unprognostic (1.18e-1)" "unprognostic (4.20e-3)" "unprognostic (4.16e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.07e-4)" 178.6 4.3 2.0 11.4 16.3 0.6 146.2 3.9 8.0 1.0 16.9 0.3 27.3 0.8 1.3 1.1 1.1 0.7 8.2 121.4 2.8 2.3 4.8 0.6 20.7 7.0 4.5 0.7 2.7 1.8 32.6 0.9 7.1 1.7 0.9 1.8 8.4 9.2 85.1 53.8 1.8 3.1 1.3 2.8 0.8 1.8 0.7 3.4 0.0 2.7 9.7 1.0 3.2 6.1 0.0 0.7 1.3 7.1 0.0 0.1 0.4 0.0 0.0 91.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 14.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.4 0.0 1.6 1.3 0.0 2.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.4 2.0 16.3 3.9 2.3 2.8 2.3 4.5 0.7 1.7 3.4 11.9 93.6 0.0 0.1 1.3 1.0 482.3 0.0 5.3 1.2 0.0 2.0 0.3 13.3 0.0 0.6 5.4 0.0 0.0 0.0 0.6 3.1 0.3 5.8 0.0 114.1 195.5 0.0 4.3 13.4 1.0 1.1 23.8 13.5 2.8 0.0 1.7 0.0 0.0 0.0 0.0 2.2 232.8 19.1 0.3 0.2 0.5 0.3 0.0 0.0 0.1 LTBP2 "C14orf141, LTBP3" ENSG00000119681 "Latent transforming growth factor beta binding protein 2" Q14767 14 74498170-74612378 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Disease mutation, Dwarfism, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Fibroblasts: 19.4;Peritubular cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 44.9;HUVEC TERT2: 24.5;LHCN-M2: 24.4;TIME: 107.9" "Group enriched" "Detected in some" 10 "cerebellum: 5.9;olfactory region: 3.0" "Region enriched" "Detected in some" 5 "olfactory region: 31.6" HPA003415 Approved Approved Nucleoplasm "Secreted to extracellular matrix" NA NA 13000000 Nucleoplasm "HPA003415: AB_1079284" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (5.10e-2)" "unprognostic (3.92e-3)" "unprognostic (2.08e-3)" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (4.43e-2)" "unprognostic (1.08e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (3.77e-1)" "unprognostic (1.98e-3)" "unprognostic (2.22e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.94e-4)" 25.0 1.7 0.8 8.0 1.3 0.0 21.5 1.0 1.0 50.3 5.0 1.2 4.8 1.2 18.0 11.8 16.2 6.2 20.1 20.3 0.8 0.8 2.4 1.4 29.5 4.8 1.6 1.9 32.1 3.9 0.4 4.2 19.0 3.1 15.7 0.9 51.8 13.6 9.7 20.5 6.0 3.2 8.6 2.6 2.5 4.3 12.2 0.4 2.2 44.8 14.4 6.0 14.7 11.6 0.4 1.7 0.3 0.2 0.0 1.2 0.2 0.5 0.9 0.2 0.0 7.2 13.3 0.0 9.0 3.1 1.7 1.1 0.0 3.3 0.0 2.7 44.9 0.8 0.9 0.0 3.3 0.7 0.0 0.1 0.1 0.4 0.3 1.7 0.0 0.1 13.7 1.4 9.6 5.6 13.3 24.5 0.0 0.0 0.0 24.4 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 2.1 1.2 0.2 0.6 6.4 0.0 0.2 0.6 0.2 0.0 107.9 0.6 10.8 3.3 3.3 0.1 0.1 0.0 2.4 0.0 0.3 0.1 0.1 0.1 1.2 0.1 1.0 0.2 0.6 0.2 0.2 0.4 0.7 0.6 0.3 0.0 0.2 1.7 0.0 0.2 0.8 1.3 1.0 1.0 0.8 0.8 1.6 1.9 3.1 0.4 0.0 2.1 0.0 14.7 4.9 2.3 5.0 0.0 0.0 10.3 0.0 0.0 0.3 5.0 1.2 1.2 3.5 0.0 0.0 0.3 0.4 19.4 1.6 1.1 0.2 4.1 3.2 0.0 12.9 0.0 4.5 15.3 1.5 0.0 0.0 0.0 0.4 2.8 0.0 77.4 0.0 0.6 6.5 6.2 0.7 2.7 0.9 1.0 0.0 0.0 1.7 LURAP1 "C1orf190, FLJ25163, LRAP35a" ENSG00000171357 "Leucine rich adaptor protein 1" Q96LR2 1 46203334-46221261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Early spermatids: 111.8;Late spermatids: 227.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 7.8;RPTEC TERT1: 7.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 110.5" "HPA030060, HPA030061" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA030060: AB_10599997, HPA030061: AB_10601990" "unprognostic (3.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.22e-3)" "unprognostic (8.82e-2)" "unprognostic (1.91e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.47e-2)" "unprognostic (2.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.14e-2)" "unprognostic (1.33e-1)" "prognostic favorable (8.81e-8)" "unprognostic (1.32e-2)" "unprognostic (2.80e-1)" "unprognostic (3.11e-2)" "unprognostic (2.39e-2)" 3.0 7.3 7.1 2.2 13.2 3.4 3.9 12.7 12.7 5.8 3.8 15.2 2.2 2.0 5.5 4.9 4.0 4.0 3.7 8.7 6.7 5.8 7.4 1.1 3.2 1.6 18.8 6.0 7.2 1.1 21.5 3.2 2.3 11.2 7.5 2.5 4.7 5.2 9.8 2.5 4.2 1.9 5.6 17.5 3.5 3.7 10.8 13.6 0.0 19.6 0.0 2.1 5.6 5.3 1.0 0.7 6.2 1.1 1.9 0.8 0.3 0.2 0.2 3.0 0.2 4.0 5.5 3.1 2.0 5.3 2.8 3.4 0.1 0.2 0.2 0.1 5.0 1.0 0.3 3.2 6.7 2.4 0.6 1.5 0.2 0.6 0.3 1.2 0.2 0.1 2.8 4.5 5.6 2.6 7.8 4.2 0.8 2.5 0.5 1.6 0.3 0.3 0.3 1.1 0.0 0.5 1.0 1.5 0.0 7.5 0.1 0.4 1.2 0.1 0.2 4.8 1.3 1.5 0.2 0.2 1.8 2.3 1.4 0.4 0.3 0.1 0.3 1.7 0.3 0.4 1.3 1.1 0.4 0.3 0.5 0.8 0.5 0.4 0.3 0.4 1.0 0.8 0.6 6.2 1.9 0.5 0.7 0.1 0.3 7.1 13.2 12.7 12.7 6.7 5.8 18.8 6.0 11.2 13.6 0.0 0.0 0.0 13.1 4.4 0.0 2.2 0.0 0.0 0.0 10.4 0.0 1.9 13.3 0.0 111.8 2.8 0.0 0.0 0.4 1.9 2.3 7.3 0.0 0.0 3.6 0.0 1.2 0.0 0.3 227.3 8.6 1.5 13.5 1.0 0.0 1.6 0.0 0.0 9.2 2.6 0.0 6.5 6.2 8.2 2.0 3.0 6.4 0.0 0.0 4.8 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 143.1;Late spermatids: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 46.2;RPMI-8226: 27.9;RT4: 28.9" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favorable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.6 0.1 0.3 0.2 1.2 5.7 2.7 1.6 0.2 0.2 0.5 16.3 19.4 4.7 1.2 1.5 2.8 15.2 0.0 46.2 0.4 12.0 5.2 0.1 0.5 16.2 2.0 0.1 1.2 4.9 16.4 3.0 0.6 2.3 3.0 0.5 0.3 5.3 0.5 10.3 0.1 1.2 0.1 19.4 0.3 11.6 0.2 27.9 9.0 28.9 19.6 0.3 1.7 0.3 0.1 0.6 22.0 2.5 4.1 1.4 0.2 0.5 0.3 0.3 7.0 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 26.8 24.1 11.5 34.8 24.3 0.8 1.6 22.9 1.4 22.7 27.9 5.9 41.4 13.3 48.4 89.5 2.3 143.1 0.0 102.6 8.3 3.2 28.0 2.3 1.6 35.8 0.0 63.0 0.6 6.1 214.3 6.6 6.4 16.9 22.6 80.8 1.5 76.0 89.2 9.2 7.9 2.2 0.0 1.0 6.1 1.5 46.5 27.0 20.2 93.7 47.8 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.7;fallopian tube: 16.3" "Group enriched" "Detected in many" 6 "Early spermatids: 136.6;Horizontal cells: 119.2;Late spermatids: 159.9" "Cancer enhanced" "Detected in some" "glioma: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HEK 293: 3.6;RPTEC TERT1: 12.7;SCLC-21H: 9.9" "Region enriched" "Detected in many" 4 "cerebellum: 39.2" "Region enriched" "Detected in all" 7 "cerebellum: 62.2" NA NA "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.6 0.8 8.7 0.9 5.4 1.3 0.6 34.7 17.1 0.6 0.7 5.3 0.0 0.6 0.8 2.3 0.7 16.3 0.7 0.6 11.6 5.7 4.6 0.6 1.6 0.9 6.5 2.5 0.7 1.0 0.5 1.5 0.6 9.2 0.7 0.6 3.4 0.6 0.8 0.6 3.2 0.7 0.6 9.2 0.9 1.0 2.6 5.5 0.0 0.7 0.0 0.7 0.6 0.2 0.3 0.1 0.5 0.2 0.0 1.5 0.0 0.0 0.1 0.5 4.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.8 0.0 0.3 0.1 0.3 0.0 0.1 0.2 3.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.5 0.0 0.1 12.7 0.3 9.9 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.5 0.5 0.0 0.0 0.1 0.1 0.0 8.7 5.4 34.7 4.7 11.6 5.7 6.5 2.5 9.2 5.5 0.0 3.0 0.0 0.5 1.9 4.9 0.6 0.0 1.4 0.0 3.5 7.9 0.2 0.0 0.0 136.6 0.7 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 119.2 0.0 1.3 0.3 159.9 2.3 0.9 0.0 0.0 0.0 3.5 0.1 0.0 1.4 0.8 25.0 0.0 0.5 2.1 2.0 3.3 0.5 0.0 0.0 0.4 MEI1 "MGC40042, SPATA38" ENSG00000167077 "Meiotic double-stranded break formation protein 1" Q5TIA1 22 41699499-41799456 "Predicted intracellular proteins, Predicted secreted proteins" Meiosis "Disease mutation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 26.8;lymphoid tissue: 20.3;testis: 34.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 50.5;Late spermatids: 37.4;monocytes: 22.6;T-cells: 22.5" "Cancer enhanced" "Detected in many" "cervical cancer: 5.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 7.9;HMC-1: 6.4;Karpas-707: 21.4;U-266/70: 22.7" "Group enriched" "Detected in many" 17 "amygdala: 1.6;basal ganglia: 1.7;cerebral cortex: 2.6;hippocampal formation: 1.7;olfactory region: 1.9" "Region enriched" "Detected in single" 4 "olfactory region: 4.2" HPA049240 Approved "Secreted in male reproductive system" NA NA "HPA049240: AB_2680689" "unprognostic (1.95e-3)" "prognostic favorable (1.59e-6)" "unprognostic (6.13e-3)" "unprognostic (1.86e-2)" "unprognostic (9.70e-2)" "unprognostic (2.97e-3)" "unprognostic (9.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (5.96e-2)" "unprognostic (9.65e-2)" "unprognostic (2.62e-1)" "unprognostic (2.45e-10)" "unprognostic (2.82e-1)" "unprognostic (3.02e-1)" "unprognostic (1.85e-1)" "unprognostic (7.39e-2)" 2.1 0.9 1.4 7.7 1.4 12.4 3.1 1.7 3.3 1.6 6.3 0.5 0.9 2.6 0.8 3.6 1.6 1.2 1.9 1.5 1.2 1.8 2.2 1.3 3.5 20.3 1.1 0.4 0.9 1.0 0.0 1.0 1.6 1.6 1.2 3.3 3.3 6.0 1.0 0.7 1.1 6.5 0.6 1.1 15.5 4.5 34.7 0.3 3.8 1.9 1.8 17.1 4.0 1.3 11.0 3.2 7.3 3.7 7.8 26.8 8.8 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.7 0.0 0.2 0.4 0.1 0.4 0.4 0.1 0.2 0.1 0.0 0.0 0.0 5.0 0.0 1.4 7.9 0.9 1.3 1.0 6.4 0.1 0.1 0.0 0.0 0.3 0.3 0.6 0.2 21.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.7 0.4 0.0 0.0 0.0 22.7 3.6 0.9 0.3 2.1 0.1 6.2 3.7 7.3 15.8 2.7 15.2 11.0 15.8 13.3 3.2 7.3 11.7 12.8 0.7 7.8 1.1 1.2 26.8 8.8 1.4 1.4 1.7 3.3 1.2 1.8 1.1 0.4 1.6 0.3 0.0 5.6 14.9 0.2 0.8 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 50.5 1.0 0.0 0.0 0.0 0.1 1.4 0.2 13.9 0.8 7.4 0.0 0.0 1.8 1.9 37.4 0.6 6.3 16.9 22.6 0.3 0.0 3.2 0.0 1.1 0.3 0.6 0.0 2.5 19.7 19.0 0.9 0.0 22.5 0.0 0.2 MEOX2 "GAX, MOX2" ENSG00000106511 "Mesenchyme homeobox 2" P50222 7 15611212-15686812 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 45.3" "Cell type enhanced" "Detected in some" 13 "Leydig cells: 37.4;Peritubular cells: 23.7;Sertoli cells: 25.8;Smooth muscle cells: 32.1" "Cancer enriched" "Detected in many" 8 "glioma: 15.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 72.3;U-138 MG: 18.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 4.4" HPA053793 Enhanced NA NA "HPA053793: AB_2682264" "unprognostic (1.10e-1)" "unprognostic (4.72e-2)" "unprognostic (9.82e-3)" "unprognostic (4.22e-2)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (3.12e-2)" "unprognostic (1.21e-1)" "unprognostic (5.56e-2)" "unprognostic (1.47e-3)" "unprognostic (4.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-5)" "unprognostic (3.67e-3)" "unprognostic (1.13e-1)" "unprognostic (5.86e-2)" "unprognostic (1.46e-4)" 45.3 0.9 0.7 6.0 0.6 0.0 22.7 0.4 0.6 6.9 5.4 0.0 3.9 0.3 8.1 13.3 9.8 3.2 4.4 10.5 0.5 0.8 0.6 1.4 12.0 6.1 0.7 0.0 4.5 1.5 0.9 1.2 33.8 1.5 7.5 1.5 0.6 6.7 3.1 16.5 5.5 2.1 6.3 3.2 0.6 2.3 7.6 0.0 1.1 7.4 19.4 7.0 14.2 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.3 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.4 0.6 0.5 0.8 0.7 0.0 1.5 0.0 0.0 0.3 0.0 0.0 7.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 37.4 0.3 3.3 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 25.8 32.1 0.0 0.2 6.0 0.1 0.0 0.0 0.0 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MPPE1 PGAP5 ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11909223 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 22.1;neutrophil: 66.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.2" "Cell line enhanced" "Detected in all" "OE19: 34.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 10 "basal ganglia: 104.4" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favorable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 15.0 13.7 11.8 16.5 16.0 19.9 15.2 11.4 20.9 14.1 16.4 20.1 18.2 13.5 18.7 22.1 13.4 15.8 23.6 17.2 11.5 14.4 23.7 20.8 24.7 29.0 19.8 12.2 11.7 24.6 22.2 16.5 15.2 14.1 13.1 17.2 14.8 16.8 26.6 19.3 22.4 19.7 14.0 15.1 17.5 17.7 6.7 14.8 22.7 37.1 14.6 17.6 14.9 13.9 4.5 8.5 66.2 9.5 6.3 6.0 6.7 3.9 5.7 4.3 10.5 12.5 14.8 4.1 9.4 13.7 5.6 8.9 10.6 11.3 7.8 20.8 9.1 5.6 4.3 3.0 5.3 5.3 8.6 5.2 2.2 11.5 2.4 17.6 10.1 16.3 21.9 7.0 4.9 3.6 8.4 3.3 7.1 2.8 7.6 9.3 9.3 7.4 6.8 3.0 34.0 1.5 3.0 2.7 9.5 9.2 6.0 6.2 3.5 8.8 6.9 8.2 5.0 5.1 13.2 6.8 11.4 4.4 10.9 5.2 11.9 10.5 9.9 8.5 5.3 11.2 4.1 9.5 22.1 6.0 7.7 4.3 4.0 3.7 5.6 8.5 4.5 4.5 5.7 66.2 6.3 5.2 6.7 5.8 6.7 11.8 16.0 11.4 20.9 11.5 14.4 19.8 12.2 14.1 14.8 53.6 33.6 15.2 11.9 16.0 17.3 1.6 20.4 28.1 18.2 21.0 11.8 22.8 18.3 24.9 15.7 14.7 31.5 23.3 36.6 26.4 17.4 11.4 26.6 23.6 22.2 7.9 9.2 9.8 29.2 25.1 11.8 25.8 18.6 10.0 18.0 19.8 30.1 15.9 14.2 23.0 17.9 12.9 13.7 3.4 7.2 17.6 14.0 30.5 13.7 16.6 MPZ "CMT1, CMT1B, CMT2I, CMT2J, HMSNIB" ENSG00000158887 "Myelin protein zero" P25189 1 161304735-161309972 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.7;retina: 60.6" "Cell type enhanced" "Detected in many" 5 "monocytes: 5.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 11 "melanoma: 83.9" "Region enriched" "Detected in many" 4 "midbrain: 118.7" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.9" "Cell line enriched" "Detected in some" 5 "WM-115: 68.2" "Group enriched" "Detected in some" 5 "olfactory region: 3.6;pons and medulla: 1.4" "Region enriched" "Detected in single" 58 "midbrain: 262.7" HPA068925 Enhanced NA NA "HPA068925: AB_2732123" "unprognostic (6.77e-2)" "unprognostic (2.98e-1)" "unprognostic (9.27e-2)" "unprognostic (1.46e-1)" "unprognostic (3.35e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "unprognostic (7.88e-3)" "unprognostic (1.51e-1)" "unprognostic (6.62e-8)" "unprognostic (6.75e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (8.32e-2)" 14.3 12.6 2.2 3.4 2.9 1.3 4.7 6.0 2.2 4.5 6.1 2.6 9.9 2.6 1.7 7.5 8.7 1.5 4.3 7.2 2.4 4.3 3.2 7.9 3.1 1.3 118.7 0.7 1.9 2.2 0.5 7.4 0.8 28.4 7.3 5.0 60.6 6.4 15.6 4.2 2.3 6.3 5.6 40.9 6.8 2.1 2.7 0.8 0.2 2.8 26.3 3.0 9.3 3.3 0.1 0.0 1.9 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.3 0.1 12.6 0.4 1.5 1.2 1.4 0.0 2.1 0.1 0.0 0.9 0.6 3.2 0.0 1.4 0.0 0.2 2.5 0.5 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 6.5 0.3 0.0 3.1 0.9 0.1 0.1 0.9 0.0 0.3 0.3 0.4 1.6 5.7 68.2 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.2 0.1 2.2 2.9 6.0 2.2 2.4 4.3 118.7 0.7 28.4 0.8 3.0 1.1 0.0 2.3 0.5 2.8 0.2 0.0 0.0 0.0 3.5 2.0 0.4 0.0 0.1 4.2 0.8 0.0 0.0 1.0 0.5 0.2 1.3 0.0 0.8 1.6 1.6 1.7 3.1 2.7 1.1 1.4 1.2 3.3 5.4 0.4 0.7 0.1 0.0 0.4 0.3 1.1 6.5 0.8 0.5 0.7 0.4 0.2 0.5 0.4 1.4 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MTCL1 "CCDC165, KIAA0802, SOGA2" ENSG00000168502 "Microtubule crosslinking factor 1" Q9Y4B5 18 8705661-8832778 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 61.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 7.6;Early spermatids: 18.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 61.5" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" HPA046245 Uncertain NA NA "HPA046245: AB_10962580" "unprognostic (2.64e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.35e-1)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-1)" "unprognostic (4.41e-4)" "unprognostic (1.30e-2)" "unprognostic (7.19e-2)" "unprognostic (9.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.82e-1)" "unprognostic (3.67e-1)" "unprognostic (7.17e-3)" "unprognostic (1.08e-2)" 1.4 1.2 1.8 3.2 3.4 0.4 1.4 61.5 10.0 5.5 8.5 2.4 4.1 2.3 3.4 2.0 3.8 1.3 12.5 3.8 1.7 2.4 1.4 1.3 1.4 0.9 2.4 3.8 1.3 3.4 4.8 2.7 3.0 5.2 1.7 2.3 8.4 1.5 4.4 2.4 1.6 2.7 7.0 3.3 1.1 4.9 8.2 1.2 1.4 1.1 1.1 0.6 9.9 4.8 0.6 1.1 0.0 0.0 0.0 0.0 0.0 8.7 18.8 9.4 5.5 4.2 7.9 0.3 12.2 9.1 10.2 7.4 5.5 3.1 5.5 7.0 8.5 7.6 1.3 2.9 5.0 4.7 1.1 2.4 2.7 5.0 4.9 6.1 0.0 4.0 4.6 3.7 5.7 4.0 6.6 7.9 4.7 0.6 9.6 4.7 2.6 0.3 1.3 4.3 21.1 8.2 7.3 6.8 2.0 14.6 15.9 21.5 4.8 5.6 1.6 1.4 8.2 0.5 0.3 15.0 18.7 9.8 14.9 12.5 1.8 1.4 2.7 4.6 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.8 3.4 61.5 10.0 1.7 2.4 2.4 3.8 5.2 1.2 0.0 0.6 0.0 2.4 0.0 0.0 5.7 7.6 0.0 1.2 1.8 0.0 3.7 1.7 4.6 18.9 0.5 0.1 0.0 3.1 0.4 0.9 1.3 2.3 0.9 0.5 0.0 1.2 5.5 1.2 6.3 1.1 0.0 0.0 0.0 1.1 0.0 6.4 0.0 0.4 1.0 0.0 0.0 0.6 1.0 6.6 0.0 0.8 0.0 1.0 1.0 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 162.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in single" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073447: AB_2732225" "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 1.6 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.1 0.2 2.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 0.0 3.5 0.0 0.7 0.0 0.5 162.4 0.0 16.0 6.8 0.0 2.0 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.2 0.4 1.4 0.6 1.1 0.0 0.4 0.0 0.0 0.6 0.0 3.2 0.6 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.0 0.2 MYO15A "DFNB3, MYO15" ENSG00000091536 "Myosin XVA" Q9UKN7 17 18108706-18179806 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 46.1" "Group enriched" "Detected in many" 6 "Early spermatids: 72.6;Late spermatids: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;EFO-21: 2.7;HSkMC: 2.1;RPMI-8226: 3.2;SuSa: 3.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "hippocampal formation: 2.7" HPA078501 Enhanced NA NA "HPA078501: AB_2732383" "unprognostic (2.48e-3)" "unprognostic (5.31e-2)" "unprognostic (2.87e-3)" "unprognostic (7.35e-3)" "unprognostic (4.92e-3)" "unprognostic (2.33e-1)" "unprognostic (8.32e-4)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-3)" "unprognostic (8.38e-2)" "unprognostic (4.18e-3)" "unprognostic (5.69e-3)" "unprognostic (9.89e-2)" "unprognostic (1.47e-1)" "unprognostic (2.21e-2)" 0.5 0.0 0.5 0.6 0.7 0.0 0.5 2.3 1.6 0.5 0.5 0.5 0.5 0.2 1.7 3.4 0.5 1.0 0.5 0.5 0.5 1.2 0.5 0.8 1.5 0.5 0.5 0.5 3.0 0.5 2.2 46.1 0.5 0.7 0.5 0.4 0.5 0.5 1.6 0.5 0.1 0.9 0.5 0.5 0.5 0.6 7.4 0.5 0.5 0.9 0.5 0.5 0.5 0.5 0.7 0.4 3.8 0.9 0.6 0.3 0.1 0.1 0.0 1.4 0.0 0.8 2.5 0.4 0.1 0.8 0.0 0.0 0.5 0.3 0.1 2.7 0.8 0.1 0.4 0.0 0.7 0.0 1.3 0.6 0.0 0.3 0.0 0.4 0.0 0.0 2.1 0.0 0.4 0.6 0.4 0.0 0.4 0.0 0.4 0.0 0.5 0.1 0.5 0.1 1.0 0.0 0.2 0.4 3.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 3.4 1.4 0.3 0.2 0.0 0.1 0.0 0.0 0.9 1.4 0.1 0.0 0.1 0.4 3.8 0.5 0.5 0.2 0.9 0.3 0.7 0.1 0.1 0.2 0.4 0.2 0.3 1.4 0.6 0.2 0.4 0.1 0.1 0.5 0.7 2.3 1.5 0.5 1.2 0.5 0.5 0.7 0.5 0.0 1.4 0.0 2.0 1.3 1.8 2.5 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.5 72.6 0.7 0.0 0.0 0.7 0.2 0.9 1.5 5.8 1.6 0.5 9.5 4.1 0.6 0.3 42.1 1.1 1.1 3.3 1.0 0.3 3.1 0.4 0.0 1.1 0.4 2.7 0.0 1.0 4.8 8.1 1.1 0.6 0.0 0.4 1.0 NEB "NEB177D, NEM2" ENSG00000183091 Nebulin P20929 2 151485336-151734487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 505.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 32.0;Cholangiocytes: 22.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.8;RH-30: 27.2;U-266/70: 10.2" "Group enriched" "Detected in some" 7 "cerebellum: 7.4;olfactory region: 4.9" "Region enriched" "Detected in single" 7 "cerebellum: 25.3" HPA016601 Enhanced NA NA "HPA016601: AB_1854361" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (2.13e-2)" "unprognostic (2.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-3)" "unprognostic (2.54e-2)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-13)" "unprognostic (6.80e-2)" "unprognostic (2.22e-2)" "unprognostic (4.07e-3)" "unprognostic (4.06e-2)" 9.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.2 4.0 0.0 0.8 1.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 3.8 0.0 505.8 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 3.0 65.9 2.6 0.1 0.0 1.3 0.5 1.7 0.6 0.8 0.9 0.3 0.3 0.4 0.6 0.5 0.1 0.1 1.7 0.3 0.0 0.0 0.0 4.7 0.5 1.2 1.0 0.1 0.1 1.0 0.1 0.0 0.0 0.6 0.7 0.4 0.7 1.5 0.0 0.8 1.1 4.1 0.2 0.0 0.0 0.2 0.7 0.4 0.9 6.8 0.4 0.5 0.4 0.7 1.1 2.3 0.8 1.2 27.2 0.1 0.1 0.9 1.5 0.2 0.2 0.3 0.1 1.1 0.7 0.8 0.6 0.7 0.9 0.1 0.9 10.2 1.5 0.3 0.1 0.6 1.1 1.2 0.6 1.7 0.9 0.0 0.9 1.2 0.8 0.5 0.0 1.3 0.3 0.4 1.1 0.8 0.0 0.5 0.4 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.9 0.8 0.7 2.0 32.0 22.9 0.0 1.2 0.0 0.0 0.3 0.0 0.3 5.7 0.0 0.0 0.0 0.0 0.4 1.0 1.7 1.1 1.9 0.7 3.2 1.7 0.6 1.3 1.8 0.6 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 1.7 0.0 0.4 1.6 0.9 1.1 0.7 0.0 0.0 0.1 NEUROD1 "BETA2, BHF-1, bHLHa3, MODY6, NeuroD" ENSG00000162992 "Neuronal differentiation 1" Q13562 2 181673088-181680876 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 101.9" "Cell type enhanced" "Detected in some" 26 "Cone photoreceptor cells: 141.4;Intestinal endocrine cells: 408.1;Rod photoreceptor cells: 170.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.3" "Region enriched" "Detected in many" 16 "cerebellum: 101.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 72 "SCLC-21H: 81.2" "Region enriched" "Detected in many" 14 "cerebellum: 242.4" "Region enriched" "Detected in many" 20 "cerebellum: 447.6" "HPA003278, CAB022450" Approved NA NA "CAB022450: , HPA003278: AB_1845331" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" "unprognostic (6.92e-3)" "unprognostic (1.27e-1)" 0.2 0.2 6.3 0.2 0.8 0.1 0.2 101.9 5.6 0.2 3.1 0.0 0.0 8.9 0.2 0.1 0.2 0.2 0.0 0.2 4.7 0.4 0.2 0.2 0.2 0.0 0.4 1.2 0.2 13.3 0.0 0.8 0.0 3.9 0.2 1.9 14.4 0.2 0.0 0.2 0.2 5.8 0.0 1.4 0.2 7.6 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.1 1.0 3.5 1.8 1.4 1.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.6 1.0 0.8 1.1 1.5 1.1 1.1 0.8 0.8 1.0 1.3 1.4 1.8 1.4 1.8 1.0 1.0 0.7 6.3 0.8 101.9 2.5 4.7 0.4 0.4 1.2 3.9 0.0 0.0 0.0 0.0 0.1 0.0 61.1 0.3 0.0 0.0 0.0 0.0 141.4 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 408.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 17.4 2.8 0.2 0.0 0.0 170.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.1 NEUROG2 "Atoh4, bHLHa8, Math4A, ngn-2, NGN2" ENSG00000178403 "Neurogenin 2" Q9H2A3 4 112513516-112516172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 5.1" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 8.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 68.9" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 18 "hippocampal formation: 17.3" CAB012342 Uncertain NA NA "CAB012342: " "unprognostic (1.09e-1)" "unprognostic (2.52e-2)" "unprognostic (7.51e-2)" "unprognostic (4.10e-1)" "unprognostic (1.62e-1)" "unprognostic (7.75e-2)" "unprognostic (1.04e-1)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (3.30e-1)" 0.4 0.1 3.0 0.0 3.6 0.1 1.2 4.1 1.6 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.6 4.1 0.8 3.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 NFE2 NF-E2 ENSG00000123405 "Nuclear factor, erythroid 2" Q16621 12 54292111-54301121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2" "Group enriched" "Detected in some" 6 "Erythroid cells: 93.5;Kupffer cells: 38.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 119.7;neutrophil: 80.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 119.7" "Group enriched" "Detected in some" 4 "HEL: 85.6;K-562: 37.0;NB-4: 26.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 1.4" HPA001914 Enhanced Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA001914: AB_1079475" "unprognostic (2.68e-4)" "unprognostic (2.93e-2)" "unprognostic (2.20e-2)" "unprognostic (2.31e-2)" "unprognostic (2.33e-2)" "unprognostic (1.85e-1)" "unprognostic (1.20e-2)" "unprognostic (4.55e-2)" "unprognostic (4.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-3)" "unprognostic (9.90e-6)" "unprognostic (1.81e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-2)" "unprognostic (3.46e-2)" 2.3 0.3 0.9 3.5 1.5 54.3 0.5 0.4 1.7 0.9 0.4 0.2 0.0 0.5 0.4 0.4 0.7 2.0 0.9 7.8 1.5 0.4 0.9 2.6 9.6 20.9 5.2 0.2 1.2 0.6 1.2 0.8 15.9 1.2 1.0 0.3 1.2 0.5 0.2 1.0 2.9 0.5 1.1 1.0 32.2 0.7 0.9 0.7 1.8 1.7 0.2 0.5 1.2 8.1 0.0 15.2 119.7 23.1 0.0 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.5 0.1 0.2 1.2 2.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 85.6 0.2 1.9 0.0 1.2 11.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 37.0 0.0 0.0 0.0 3.3 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.2 4.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 5.1 0.0 119.7 23.1 21.7 0.0 6.4 0.1 0.0 0.0 0.0 15.2 0.0 0.1 0.0 80.0 0.0 3.8 0.2 0.0 12.9 0.9 1.5 0.4 1.7 1.5 0.4 5.2 0.2 1.2 0.7 0.0 4.8 0.0 0.0 0.1 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 93.5 0.0 0.4 0.0 0.0 3.5 0.0 0.9 0.0 0.0 0.0 38.4 11.0 0.0 1.6 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.3 1.0 0.0 0.0 0.0 NHLH1 "bHLHa35, HEN1, NSCL, NSCL1" ENSG00000171786 "Nescient helix-loop-helix 1" Q02575 1 160367067-160372848 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 10.8;skin 1: 4.2" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 2.0;Horizontal cells: 3.2;Intestinal endocrine cells: 1.7;Kupffer cells: 1.5;Rod photoreceptor cells: 1.3" "Group enriched" "Detected in some" 6 "glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 24.8" "Region enhanced" "Detected in single" "hippocampal formation: 1.1" "Region enriched" "Detected in some" 12 "cerebellum: 37.9" HPA017943 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA017943: AB_2732421" "unprognostic (6.95e-2)" "unprognostic (3.02e-1)" "unprognostic (3.81e-1)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-2)" "unprognostic (7.06e-2)" "unprognostic (1.96e-2)" "unprognostic (4.21e-8)" "unprognostic (4.09e-2)" "unprognostic (2.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.36e-1)" 1.0 0.5 0.9 1.1 4.1 0.4 0.3 10.8 2.0 0.3 0.8 0.3 0.3 0.4 0.3 0.5 0.3 0.2 0.4 0.3 3.2 2.2 0.3 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.2 0.4 0.3 2.3 0.3 0.3 0.6 1.3 0.3 0.6 4.2 0.6 0.5 2.5 1.0 0.4 0.8 0.3 0.3 0.3 0.3 0.4 0.4 0.3 0.1 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.1 2.5 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.2 1.1 0.5 0.2 0.5 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.4 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.0 24.8 0.2 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.7 0.6 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 4.1 10.8 1.6 3.2 2.2 0.8 0.3 2.3 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 3.2 1.7 0.6 1.5 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 1.3 0.0 0.2 0.7 0.5 0.0 0.2 0.0 0.0 0.0 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406331 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "pituitary gland: 1.0;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 0.2" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-4 "NKX2.4, NKX2D" ENSG00000125816 "NK2 homeobox 4" Q9H2Z4 20 21395367-21398028 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;pituitary gland: 1.2;testis: 5.2" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 1.2;Early spermatids: 2.4;Late spermatids: 1.9;Spermatocytes: 3.8;Spermatogonia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HEK 293: 7.8;SCLC-21H: 5.1;SK-MEL-30: 5.9;WM-115: 1.8" "Region enriched" "Detected in single" 22 "hypothalamus: 3.1" "Region enriched" "Detected in single" 32 "hypothalamus: 1.4" HPA074996 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA074996: AB_2686725" "unprognostic (3.77e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.0 0.0 NPFF FMRFAL ENSG00000139574 "Neuropeptide FF-amide peptide precursor" O15130 12 53506690-53507638 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 28 "epididymis: 154.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebellum: 2.0;hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HHSteC: 17.7" "Region enriched" "Detected in single" 7 "pons and medulla: 11.9" "Region enriched" "Detected in all" 7 "cerebellum: 143.2" "Secreted in male reproductive system" NA NA 0.3 0.1 0.1 0.1 0.3 0.0 0.1 2.0 0.1 0.5 0.2 0.1 1.1 0.2 0.1 154.7 0.1 0.2 0.1 0.1 0.1 1.4 0.1 0.1 0.5 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.5 0.2 0.1 1.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.7 0.2 0.8 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.3 0.1 2.0 0.4 0.0 0.8 0.3 0.0 0.3 0.2 0.5 2.0 0.1 0.0 0.2 0.0 0.7 0.2 2.4 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.0 0.1 0.1 1.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPPC CNP ENSG00000163273 "Natriuretic peptide C" P23582 2 231921820-231926403 "Predicted secreted proteins, Transporters" Osteogenesis "Hormone, Vasoactive" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 34.2;retina: 24.7" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 28.5;Collecting duct cells: 10.4;Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "HEK 293: 7.9;NTERA-2: 3.7;SCLC-21H: 5.2;SK-MEL-30: 22.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 33.4" HPA035362 Uncertain "Secreted to blood" NA NA 6140 "HPA035362: AB_10671103" "unprognostic (9.70e-2)" "unprognostic (4.45e-2)" "unprognostic (1.99e-1)" "unprognostic (1.06e-2)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.83e-1)" "unprognostic (3.22e-3)" "unprognostic (9.81e-3)" "unprognostic (9.16e-2)" "unprognostic (2.10e-2)" "unprognostic (4.06e-2)" "unprognostic (1.17e-1)" "unprognostic (6.58e-2)" "unprognostic (1.18e-1)" "unprognostic (3.72e-1)" "unprognostic (1.91e-1)" 1.4 0.9 4.1 6.3 4.4 4.5 1.4 5.4 12.0 3.0 5.0 2.9 0.7 0.9 1.6 34.2 7.3 1.8 0.6 3.9 6.9 6.3 0.9 0.5 0.8 4.5 2.8 2.2 1.8 0.5 0.5 3.8 1.1 12.4 13.1 1.3 24.7 4.4 2.0 2.4 0.8 1.6 2.2 13.3 1.7 4.3 1.0 0.9 13.7 2.1 9.3 6.0 0.5 0.6 0.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.9 0.0 3.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.2 0.3 0.2 0.2 22.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.1 4.4 5.4 12.0 6.9 6.3 2.8 2.2 12.4 0.9 0.0 0.0 0.0 28.5 3.1 1.1 1.6 0.0 0.0 0.0 10.4 9.8 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.3 0.3 1.7 0.0 1.3 5.8 0.6 2.5 0.0 0.0 3.7 0.0 0.9 0.3 3.4 1.0 0.2 0.0 0.6 2.6 NPS ENSG00000214285 "Neuropeptide S" P0C0P6 10 127549369-127552639 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 1.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "head and neck cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "midbrain: 6.5;pons and medulla: 5.3" "Region enriched" "Detected in some" 8 "cerebral cortex: 5.8" CAB020139 Uncertain "Secreted - unknown location" NA NA "CAB020139: AB_776718" "unprognostic (2.83e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPVF "C7orf9, RFRP" ENSG00000105954 "Neuropeptide VF precursor" Q9HCQ7 7 25224570-25228486 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "brain: 9.5;lymphoid tissue: 2.9;retina: 7.0" "Cell type enriched" "Detected in some" 44 "Muller glia cells: 336.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 95 "hypothalamus: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "hypothalamus: 7.2" "Region enriched" "Detected in some" 4 "hypothalamus: 3.8" HPA041733 Enhanced "Secreted in other tissues" NA NA "HPA041733: AB_10794524" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 336.5 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY2R ENSG00000185149 "Neuropeptide Y receptor Y2" P49146 4 155208629-155217078 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.2;breast: 4.1" "Cell type enriched" "Detected in some" 11 "Leydig cells: 19.5" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;ASC diff: 3.6;HSkMC: 1.7;SH-SY5Y: 12.9" "Group enriched" "Detected in many" 5 "amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7" "Region enriched" "Detected in all" 5 "hippocampal formation: 19.7" NA NA "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (7.08e-2)" "unprognostic (5.50e-2)" "unprognostic (9.35e-2)" 0.8 1.1 3.4 1.3 6.9 0.1 4.1 0.1 8.6 0.4 2.7 1.8 0.0 1.1 0.2 0.4 0.2 0.5 0.2 0.7 7.3 5.5 0.3 0.1 0.2 0.2 0.8 0.0 0.4 0.1 0.1 0.2 0.2 7.8 0.5 2.8 0.2 2.0 0.2 0.1 0.5 1.5 0.6 10.2 0.6 0.3 2.5 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 6.9 0.1 8.6 7.3 5.5 0.8 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 36.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 14.7;Cone photoreceptor cells: 13.7;Exocrine glandular cells: 20.5;Pancreatic endocrine cells: 14.0;Rod photoreceptor cells: 22.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.7;HL-60: 3.2;THP-1: 2.9;U-698: 2.9;U-937: 5.3" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebellum: 282.0" HPA010957 Uncertain "Secreted to digestive system" NA NA "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.4 0.5 3.5 0.2 1.3 0.8 0.3 6.9 2.7 0.3 0.4 0.5 0.0 0.2 0.3 2.1 0.8 2.2 0.2 0.4 1.4 1.0 0.5 1.1 0.7 0.2 0.5 1.8 0.3 36.6 0.2 2.5 0.8 2.1 1.2 0.3 0.0 1.5 0.3 4.8 0.6 0.3 0.2 0.5 0.4 3.0 6.3 0.3 0.0 0.4 0.5 0.2 0.5 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.8 0.0 0.0 1.3 0.4 0.1 0.0 0.1 1.5 0.1 8.7 0.4 0.0 3.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 2.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 5.3 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.3 6.9 2.7 1.4 1.0 0.5 1.8 2.1 0.3 0.0 0.0 2.2 0.9 6.6 2.2 0.2 0.0 14.7 3.4 1.8 13.7 2.0 1.7 0.2 12.2 0.3 0.3 0.0 20.5 1.9 0.4 1.7 2.3 2.9 0.3 6.4 1.2 1.3 0.0 7.0 0.6 0.3 1.7 0.0 0.0 1.5 14.0 2.9 0.0 0.0 22.2 0.0 0.1 6.1 0.7 1.1 0.7 0.0 0.3 3.8 NTN5 ENSG00000142233 "Netrin 5" Q8WTR8 19 48661407-48673081 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 7.0" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 4.3;Early spermatids: 3.9;Horizontal cells: 7.9;Late spermatids: 8.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 3.1;Karpas-707: 4.1;U-266/70: 3.1;U-266/84: 2.6" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Region enriched" "Detected in single" 5 "cerebellum: 7.5" "Secreted in brain" NA NA "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "unprognostic (5.26e-6)" "unprognostic (4.48e-2)" "unprognostic (2.23e-1)" "unprognostic (4.33e-2)" "unprognostic (3.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.89e-3)" "unprognostic (9.40e-3)" "unprognostic (1.74e-3)" "unprognostic (4.60e-1)" "unprognostic (5.11e-2)" "unprognostic (1.60e-3)" "unprognostic (3.51e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-3)" 0.3 0.8 1.1 0.3 1.6 0.6 1.5 1.6 0.9 1.1 0.3 0.3 2.6 1.6 0.8 3.9 1.8 0.1 0.9 0.6 0.6 0.1 0.3 1.9 0.7 3.7 0.0 2.1 7.0 0.0 3.1 0.0 3.2 2.4 0.6 3.5 0.4 0.1 0.7 1.3 0.6 0.3 2.3 0.7 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.7 0.1 0.1 0.1 0.4 0.0 1.0 0.0 0.0 0.5 0.9 1.8 0.7 0.0 0.0 2.0 0.0 0.8 3.1 0.3 0.0 0.0 1.1 0.7 1.3 0.0 4.1 0.0 1.2 0.9 0.8 0.0 0.3 2.2 0.6 0.0 0.0 1.1 0.7 0.3 0.4 0.0 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.0 3.1 2.6 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 7.9 0.0 0.0 0.0 8.1 0.6 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.4 0.0 2.1 0.0 0.0 2.5 0.2 0.1 0.1 0.0 0.0 0.1 NXPH3 NPH3 ENSG00000182575 "Neurexophilin 3" O95157 17 49575858-49583827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "monocytes: 7.2;Muller glia cells: 8.9;Peritubular cells: 13.4;Smooth muscle cells: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 18.1;BJ: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 61.3" HPA073819 Approved "Vesicles,Mitotic spindle" "Secreted in brain" NA NA Vesicles "Mitotic spindle" "HPA073819: " "unprognostic (2.39e-2)" "unprognostic (4.75e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-1)" "unprognostic (1.92e-1)" "unprognostic (3.30e-1)" "unprognostic (1.97e-1)" "unprognostic (8.01e-2)" "unprognostic (4.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-2)" "unprognostic (6.33e-2)" "unprognostic (4.62e-4)" "unprognostic (2.59e-2)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (5.05e-3)" 4.5 2.4 3.2 2.9 7.4 0.3 3.9 23.5 16.4 18.9 8.9 3.4 0.0 1.2 11.3 3.8 4.5 8.0 4.0 5.0 4.7 3.4 0.8 0.4 5.1 1.3 2.7 7.7 9.2 1.6 0.7 7.2 4.1 5.1 11.2 1.6 6.8 6.0 12.3 2.6 2.1 1.7 11.0 1.7 1.2 3.6 3.5 3.2 0.0 1.4 3.9 1.2 15.9 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 18.1 5.7 0.6 0.4 0.2 0.9 0.0 0.0 0.3 0.1 1.2 0.1 0.6 0.2 0.1 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.2 0.1 0.5 0.0 0.0 2.0 0.1 0.0 0.0 0.4 0.3 0.1 0.0 1.9 0.1 0.0 0.0 0.0 0.7 1.8 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.4 23.5 11.4 4.7 3.4 2.7 7.7 5.1 3.2 0.0 2.2 0.0 0.2 0.3 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.9 2.5 0.3 0.0 0.0 0.2 0.0 0.0 1.8 0.3 0.0 4.0 0.0 1.7 7.2 0.0 8.9 0.0 0.0 13.4 0.0 1.1 0.0 12.5 0.1 0.6 1.0 0.1 0.0 0.0 0.1 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.3" "Group enriched" "Detected in some" 42 "Early spermatids: 22.0;Late spermatids: 19.1;Spermatocytes: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 1.0;SK-BR-3: 1.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 4 "hypothalamus: 1.3" HPA026084 Supported NA NA "HPA026084: AB_2671807" "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 OR13G1 ENSG00000197437 "Olfactory receptor family 13 subfamily G member 1" Q8NGZ3 1 247670812-247679739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;NB-4: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 0.1" NA NA 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2S2 ENSG00000278889 "Olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)" Q9NQN1 9 35957108-35958154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;BJ: 1.3;BJ hTERT+: 1.9;fHDF/TERT166: 1.3;HeLa: 1.3;HHSteC: 1.6;U-138 MG: 2.2" "Region enriched" "Detected in single" 8 "cerebellum: 0.6" NA NA 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I1 ENSG00000167359 "Olfactory receptor family 51 subfamily I member 1" Q9H343 11 5440570-5441514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.0;U-2197: 1.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "olfactory region: 6.3" NA NA "unprognostic (2.36e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.2 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51M1 ENSG00000184698 "Olfactory receptor family 51 subfamily M member 1" Q9H341 11 5383812-5393263 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "RT4: 4.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 0.4" HPA056773 Uncertain NA NA "HPA056773: AB_2683233" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "RT4: 8.0" "Region enriched" "Detected in single" 11 "olfactory region: 4.5" HPA044998 Uncertain NA NA "HPA044998: AB_10794780" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51V1 OR51A12 ENSG00000176742 "Olfactory receptor family 51 subfamily V member 1" Q9H2C8 11 5199735-5200700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HMC-1: 1.0" "Region enriched" "Detected in single" 9 "olfactory region: 0.3" NA NA 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B1 OR7-3 ENSG00000221813 "Olfactory receptor family 6 subfamily B member 1" O95007 7 144000320-144008793 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 3.2;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;RPMI-8226: 2.1;U-266/84: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 20 "olfactory region: 0.1" HPA053164 Uncertain NA NA "HPA053164: AB_2682065" 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 4.2 7.9 4.9 6.0 0.1 22.1 12.7 7.0 7.7 0.3 0.0 0.0 0.3 8.3 0.2 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.4 0.5 0.0 6.5 0.2 3.4 1.9 15.7 7.4 0.7 2.0 0.0 3.3 0.0 0.0 0.2 15.7 0.0 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.4 2.1 0.1 0.1 12.9 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 28.3 9.0 2.5 2.7 3.4 5.2 94.2 0.3 1.7 1.6 0.7 2.3 0.0 0.0 2.3 0.4 7.4 4.6 0.0 0.0 1.2 41.3 1.2 3.7 0.0 1.3 46.1 0.0 0.0 1.8 2.5 4.8 1.9 0.0 36.0 0.3 26.9 6.5 9.2 0.7 0.9 0.0 0.8 0.0 0.4 1.4 PABPN1L ePABP2 ENSG00000205022 "Poly(A) binding protein nuclear 1 like, cytoplasmic" A6NDY0 16 88863333-88866660 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.6;bone marrow: 3.0;brain: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 5.0;NB-4: 3.5;SCLC-21H: 9.6;T-47d: 2.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 3.6" HPA043415 Uncertain NA NA "HPA043415: AB_10981610" "unprognostic (2.19e-1)" "unprognostic (1.50e-2)" "unprognostic (1.40e-3)" "unprognostic (8.96e-3)" "unprognostic (1.57e-1)" "unprognostic (3.19e-1)" 0.5 3.6 0.0 0.2 1.1 3.0 0.1 5.3 0.5 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.2 1.1 0.0 0.1 1.8 0.0 0.3 0.0 0.8 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 5.0 0.6 3.5 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 9.6 0.2 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Cell line enhanced" "Detected in many" "THP-1: 36.5" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in all" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.7 4.6 20.8 19.2 5.8 9.5 3.7 12.4 7.1 8.7 6.2 5.9 9.4 4.7 1.5 9.9 8.9 3.6 11.7 5.0 17.2 5.0 8.3 4.0 3.5 2.3 7.4 4.4 7.3 4.8 5.7 6.8 4.4 19.2 9.7 3.2 0.2 4.5 17.9 2.5 4.1 2.1 15.3 5.7 3.1 7.7 31.0 0.6 6.6 2.8 11.2 19.4 8.6 1.6 3.8 8.2 7.1 36.5 11.7 17.6 4.8 10.3 23.2 3.2 5.0 4.9 8.4 6.2 9.0 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 8.9 14.7 3.2 9.5 20.1 6.8 52.9 2.5 9.4 13.6 12.2 35.3 0.3 6.6 9.5 11.1 10.8 0.9 0.0 2.2 0.8 11.1 16.7 16.1 9.6 14.6 39.7 11.1 11.1 29.5 8.8 18.4 15.9 6.8 9.0 6.2 8.0 2.8 15.9 10.6 1.5 38.9 0.0 12.0 12.2 7.9 23.1 0.3 7.2 2.3 7.6 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3770.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in some" 18 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.7 0.8 1.2 0.0 0.0 1.4 0.0 0.2 0.0 0.8 0.6 2.8 2.5 0.1 0.0 0.3 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.6 0.0 0.3 0.4 18.4 0.4 0.3 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.5 1.6 0.0 0.4 4.0 3.4 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 0.0 2.9 0.0 0.8 0.7 166.8 0.0 0.0 0.0 2.3 5.2 21.6 0.2 8.3 0.6 765.5 0.0 0.6 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.4 22.3 0.0 0.0 1.2 3770.2 9.8 1.0 1.7 1.8 0.2 24.5 0.5 0.0 12.4 0.3 79.8 19.4 0.0 11.1 6.4 1.0 0.0 1.5 0.5 0.6 PDE1B PDES1B ENSG00000123360 "Phosphodiesterase 1B" Q01064 12 54549350-54579239 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Kupffer cells: 11.5;Sertoli cells: 12.9;Smooth muscle cells: 9.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 52.6" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 11.5;HL-60: 6.4;HMC-1: 12.3;NB-4: 8.1;THP-1: 7.8;U-937: 6.5" "Region enriched" "Detected in all" 6 "basal ganglia: 895.2" "Region enriched" "Detected in all" 7 "basal ganglia: 253.8" HPA018492 Enhanced NA NA "HPA018492: AB_1855119" "unprognostic (2.90e-1)" "unprognostic (1.51e-1)" "unprognostic (7.67e-4)" "unprognostic (5.63e-3)" "unprognostic (7.02e-2)" "unprognostic (7.51e-2)" "unprognostic (1.97e-1)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "unprognostic (5.11e-2)" "unprognostic (3.84e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (6.64e-4)" "unprognostic (2.14e-1)" "unprognostic (3.09e-1)" "unprognostic (2.83e-2)" 12.3 1.4 9.9 4.6 52.6 5.6 2.7 3.1 19.4 2.6 3.7 1.4 0.0 1.2 3.9 2.5 1.7 2.4 2.9 1.9 3.7 3.8 1.3 1.6 2.9 1.6 3.0 9.3 12.5 0.6 11.0 0.5 0.5 5.8 1.0 1.7 0.5 1.3 2.1 0.7 1.0 2.6 4.9 1.2 4.8 2.5 1.1 7.7 0.0 2.7 0.0 1.1 2.8 1.1 0.2 0.3 0.1 0.3 0.1 1.6 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.5 0.3 4.7 0.0 0.0 0.0 6.4 12.3 0.7 0.0 0.0 0.0 0.0 0.0 4.6 0.0 1.9 0.0 0.0 0.7 8.1 3.4 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.4 0.0 6.5 1.3 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.4 9.9 52.6 3.1 19.4 3.7 3.8 3.0 9.3 5.8 7.7 0.0 0.6 0.0 0.2 0.9 0.1 3.1 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 4.8 0.3 0.0 23.3 0.0 0.0 0.4 0.3 0.0 0.0 7.3 4.8 1.7 0.0 11.5 3.4 2.0 5.2 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.1 12.9 9.5 0.9 0.5 0.4 0.2 1.5 0.0 0.1 PENK ENSG00000181195 Proenkephalin P01210 8 56436674-56446734 "Plasma proteins, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 124.3;brain: 171.5" "Cell type enhanced" "Detected in some" 32 "Leydig cells: 1053.7;Peritubular cells: 212.2;Spermatocytes: 309.0" "Cancer enhanced" "Detected in many" "lung cancer: 4.5" "Region enriched" "Detected in many" 12 "basal ganglia: 171.5" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Group enriched" "Detected in many" 19 "B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 16.6;ASC TERT1: 9.9;BJ: 9.2;THP-1: 8.6" "Region enriched" "Detected in all" 7 "basal ganglia: 3244.3" "Region enriched" "Detected in all" 7 "basal ganglia: 1049.6" "HPA013138, CAB016390" Enhanced "Secreted in other tissues" NA NA 35000 "CAB016390: AB_2161515, HPA013138: AB_1855191" "unprognostic (6.89e-2)" "unprognostic (1.21e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "unprognostic (1.56e-2)" "unprognostic (3.58e-3)" "unprognostic (1.31e-2)" "unprognostic (3.60e-1)" "unprognostic (6.34e-2)" "unprognostic (5.73e-2)" "unprognostic (3.47e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-3)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.98e-3)" 2.5 124.3 2.8 1.7 171.5 0.3 0.9 3.9 7.8 14.3 2.2 0.9 0.1 0.6 3.0 0.9 0.9 2.6 4.0 9.1 1.2 9.1 0.3 0.2 1.0 0.3 2.5 0.4 8.2 0.6 0.2 1.5 1.1 8.4 11.7 0.9 2.2 0.9 8.1 1.1 0.5 0.9 1.7 7.0 0.3 1.1 29.9 14.7 0.0 0.6 0.3 0.3 0.5 0.6 3.1 1.2 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 16.6 9.9 0.0 9.2 2.9 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 3.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 2.8 171.5 3.9 7.8 1.2 9.1 2.5 0.4 8.4 14.7 0.0 1.0 0.0 0.0 0.1 0.0 0.6 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 56.7 0.5 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 37.9 1053.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 212.2 0.0 0.0 6.5 0.4 309.0 17.5 0.4 0.0 0.0 0.0 0.0 PHOX2B "NBPhox, Phox2b, PMX2B" ENSG00000109132 "Paired like homeobox 2b" Q99453 4 41744082-41748970 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.5;brain: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 99 "pons and medulla: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "SH-SY5Y: 53.6" "Region enriched" "Detected in single" 17 "pons and medulla: 5.9" "Region enriched" "Detected in single" 27 "pons and medulla: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 14.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 24.8 0.2 1.4 0.8 0.0 0.0 0.0 0.0 3.2 0.5 0.4 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PITX3 ASMD ENSG00000107859 "Paired like homeodomain 3" O75364 10 102230186-102241474 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 19.9;tongue: 13.7" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 5.4;Late spermatids: 2.4;Spermatocytes: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "midbrain: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "RH-30: 26.3" "Region enhanced" "Detected in single" "midbrain: 0.3" "Region enriched" "Detected in single" 5 "midbrain: 13.2" NA NA "unprognostic (8.13e-2)" "unprognostic (4.07e-1)" "unprognostic (5.15e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (6.04e-5)" "unprognostic (6.30e-3)" "unprognostic (2.02e-1)" "unprognostic (6.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.73e-2)" "unprognostic (1.76e-2)" "unprognostic (6.76e-3)" "unprognostic (4.13e-2)" 1.5 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.1 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.4 13.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 1.4 1.0 0.1 0.0 0.0 0.0 0.0 PMCH MCH ENSG00000183395 "Pro-melanin concentrating hormone" P20382 12 102196459-102197845 "Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein, Hormone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 124.8" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 1.6;monocytes: 1.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Region enriched" "Detected in some" 27 "hypothalamus: 124.8" "Cell type enriched" "Detected in some" 8 "T-reg: 11.3" "Lineage enriched" "Detected in single" 81 "T-cells: 11.3" "Cell line enriched" "Detected in some" 8 "HDLM-2: 31.3" "Group enriched" "Detected in some" 131 "hypothalamus: 737.6;thalamus: 373.6" "Region enriched" "Detected in some" 30 "hypothalamus: 98.6" "HPA046055, HPA061884" Enhanced Supported "Secreted to blood" NA NA 274000 "HPA046055: AB_2679517, HPA061884: AB_2684632" "unprognostic (3.23e-3)" "unprognostic (8.04e-2)" "unprognostic (3.96e-4)" "unprognostic (2.09e-2)" "unprognostic (1.75e-1)" "unprognostic (7.73e-2)" "unprognostic (4.31e-3)" "unprognostic (1.43e-2)" "unprognostic (3.18e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-1)" "unprognostic (2.16e-6)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "unprognostic (5.10e-2)" "unprognostic (3.53e-2)" 0.1 0.0 0.3 2.1 2.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.1 1.0 0.0 0.2 0.6 0.8 124.8 0.1 0.1 0.2 6.4 0.4 0.1 0.1 0.1 0.0 1.4 0.2 4.5 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.9 1.1 2.0 0.2 0.7 1.0 0.1 0.1 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.1 11.3 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 31.3 0.1 0.5 0.6 0.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.2 3.8 0.4 0.7 0.1 0.0 0.0 0.6 1.0 0.5 0.5 1.2 0.3 0.6 1.2 0.0 0.2 0.3 0.4 0.4 0.6 0.1 0.3 0.2 0.1 0.4 0.4 0.4 0.1 0.5 0.1 0.6 0.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 0.3 2.0 0.1 0.1 0.8 124.8 0.4 0.1 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 POMC "ACTH, CLIP, LPH, MSH, NPP, POC" ENSG00000115138 Proopiomelanocortin P01189 2 25160853-25168903 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Endorphin, Hormone" "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "pituitary gland: 811.1" "Group enriched" "Detected in many" 5 "Early spermatids: 92.7;Late spermatids: 265.2;Spermatocytes: 70.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 18.5" "Region enriched" "Detected in single" 5 "hypothalamus: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 2.7;HMC-1: 4.2;HSkMC: 1.2;NTERA-2: 1.2;THP-1: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "hypothalamus: 77.9" "CAB002762, HPA046135, HPA063644, CAB079881" Enhanced "Secreted to blood" NA NA 380000 "CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071" "unprognostic (8.02e-2)" "unprognostic (1.47e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-3)" "unprognostic (3.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (4.30e-2)" "unprognostic (8.74e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.70e-4)" "unprognostic (8.02e-2)" "unprognostic (4.29e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (3.84e-2)" 1.0 3.2 0.3 0.8 0.3 0.5 0.3 0.3 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.3 0.0 0.3 0.3 0.3 1.8 0.5 0.3 0.3 0.6 0.3 0.3 0.3 22.2 0.0 811.1 0.9 0.3 0.3 0.0 0.3 0.4 0.3 3.6 0.9 0.3 0.3 0.3 1.3 0.4 2.9 0.3 0.3 0.3 0.4 0.3 0.3 0.3 13.7 22.2 6.6 10.1 12.6 10.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 4.2 1.2 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.9 6.6 9.8 10.1 7.7 12.8 7.5 9.3 12.5 13.7 9.9 10.5 3.1 12.6 5.9 22.2 7.9 7.6 0.3 0.3 0.3 0.3 0.3 1.8 0.3 0.3 0.3 0.3 0.0 2.1 11.0 1.4 3.9 1.8 2.6 0.0 0.0 1.2 0.0 0.0 0.3 13.3 7.0 92.7 6.9 0.0 0.0 14.7 5.6 3.3 3.9 6.9 1.3 29.5 6.4 0.0 9.8 6.3 265.2 4.4 7.2 16.9 8.2 0.0 4.1 9.1 0.0 12.4 2.1 7.1 12.9 3.1 70.4 22.9 4.8 0.3 8.7 0.0 3.0 PPP1R17 "C7orf16, GSBS" ENSG00000106341 "Protein phosphatase 1 regulatory subunit 17" O96001 7 31686715-31708455 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 10.5;blood: 24.5;brain: 29.7" "Group enriched" "Detected in some" 126 "Early spermatids: 30.6;Late spermatids: 68.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 6 "cerebellum: 29.7;hypothalamus: 8.5" "Cell type enriched" "Detected in some" 4 "non-classical monocyte: 24.5" "Lineage enriched" "Detected in many" 19 "monocytes: 24.5" "Group enriched" "Detected in some" 197 "NTERA-2: 15.7;SCLC-21H: 47.7" "Region enriched" "Detected in some" 32 "cerebellum: 483.2" "Region enriched" "Detected in many" 4 "cerebellum: 339.5" "HPA047819, HPA073123" Enhanced NA NA "HPA047819: AB_2680166, HPA073123: AB_2732219" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "unprognostic (6.56e-2)" "unprognostic (5.55e-2)" "unprognostic (2.33e-1)" 0.6 10.5 0.9 0.6 1.3 0.8 0.1 29.7 4.6 0.1 0.1 1.7 0.0 0.1 0.8 0.3 0.1 0.1 0.1 0.4 0.6 8.5 0.1 0.2 1.1 0.1 1.1 0.9 0.1 0.1 0.1 2.9 0.1 2.6 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.4 1.0 0.3 0.3 1.7 3.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 1.2 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.9 1.3 29.7 3.3 0.6 8.5 1.1 0.9 2.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 68.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 PPP1R1B "DARPP-32, FLJ20940" ENSG00000131771 "Protein phosphatase 1 regulatory inhibitor subunit 1B" Q9UD71 17 39626740-39636626 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 173.9;salivary gland: 105.3" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 128.2;Mucus-secreting cells: 299.8;Undifferentiated cells: 342.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 173.9" "Cell type enriched" "Detected in single" 37 "eosinophil: 3.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;OE19: 10.7;SCLC-21H: 19.3" "Region enriched" "Detected in many" 8 "basal ganglia: 1113.7" "Region enriched" "Detected in all" 20 "basal ganglia: 1698.9" "CAB004026, HPA048630, HPA061142" Approved Approved NA NA "CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438" "unprognostic (2.71e-1)" "unprognostic (4.09e-2)" "unprognostic (6.91e-3)" "unprognostic (2.42e-1)" "unprognostic (3.01e-1)" "unprognostic (7.69e-2)" "unprognostic (6.00e-3)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.13e-2)" "unprognostic (6.07e-2)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.52e-3)" "unprognostic (1.55e-1)" 26.2 10.0 25.6 5.8 173.9 0.6 23.3 14.6 24.1 7.4 64.1 16.2 39.4 25.7 1.8 2.2 1.9 9.4 4.6 0.7 17.3 11.2 2.0 0.5 5.1 0.5 21.9 22.2 2.6 19.1 0.6 1.7 0.5 17.9 19.9 63.3 6.9 105.3 49.6 0.5 5.7 20.9 4.1 12.4 0.5 13.6 4.6 40.0 0.0 0.5 0.3 0.8 3.6 1.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 3.3 0.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 10.7 0.6 0.0 0.0 0.4 0.0 0.0 19.3 0.4 0.0 1.0 0.0 1.8 0.4 0.7 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 173.9 14.6 24.1 17.3 11.2 21.9 22.2 17.9 40.0 0.0 26.7 0.0 99.4 1.1 0.3 1.1 0.0 0.0 0.0 1.8 0.0 0.0 102.8 13.3 0.7 0.1 36.6 0.0 3.1 0.0 1.3 59.5 4.6 0.0 0.2 0.0 92.9 3.1 0.0 2.2 31.9 1.0 128.2 0.0 299.8 28.7 1.0 94.7 5.3 0.4 0.9 0.0 0.6 0.5 3.2 0.4 0.0 0.0 342.5 101.6 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;heart muscle: 4.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;MCF7: 4.4;RPMI-8226: 3.7;SK-BR-3: 1.8;T-47d: 2.1;U-87 MG: 2.4" "Group enriched" "Detected in some" 58 "hypothalamus: 13.4;pons and medulla: 22.5" "Region enriched" "Detected in single" 13 "pons and medulla: 5.1" HPA014976 Approved "Secreted - unknown location" NA NA "HPA014976: AB_2732413" "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 26.1;Urothelial cells: 72.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.9;CAPAN-2: 39.5;HBEC3-KT: 25.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 32.0" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 2.7 1.1 0.7 1.8 1.4 9.5 9.8 1.0 1.3 3.7 2.5 0.4 2.4 1.2 2.5 1.7 6.2 3.0 2.2 1.4 1.5 0.7 8.6 40.8 10.2 0.2 1.4 0.3 1.7 21.7 0.0 1.5 9.2 1.2 7.3 2.0 9.9 4.5 2.7 1.7 3.2 1.1 1.3 1.0 8.2 7.1 7.5 0.5 4.3 12.0 3.6 5.6 6.5 9.9 0.0 1.9 0.0 1.0 0.0 0.7 0.9 32.9 4.7 0.3 0.1 1.0 1.3 1.9 1.5 0.7 1.2 0.6 10.9 39.5 0.0 6.1 0.1 0.5 8.7 3.3 25.2 0.6 0.0 8.1 3.8 2.0 7.0 5.9 0.0 2.4 1.4 5.5 7.1 8.1 0.1 3.6 0.6 5.6 0.0 1.7 4.5 0.0 1.2 2.1 4.4 2.7 5.3 4.3 0.0 2.6 1.6 0.0 0.4 2.4 10.0 4.2 1.7 5.2 2.0 2.5 0.0 8.0 13.2 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 1.0 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.9 0.7 1.4 1.0 1.3 1.5 0.7 1.4 0.3 1.2 0.5 8.9 5.1 0.0 22.8 5.0 0.0 0.9 20.4 6.7 5.7 5.2 0.0 4.7 5.0 9.6 2.5 2.8 0.8 0.0 3.3 16.0 3.1 21.4 0.0 26.1 0.7 0.0 1.7 1.8 0.8 2.3 1.7 0.3 3.3 0.0 1.3 0.0 13.3 0.0 4.2 0.3 0.0 0.0 1.0 1.7 2.8 4.1 0.6 0.0 3.3 72.6 PRSS21 "ESP-1, TEST1" ENSG00000007038 "Serine protease 21" Q9Y6M0 16 2817180-2826304 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 21.0;salivary gland: 20.9;testis: 37.5" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 257.7;Spermatocytes: 426.2;Spermatogonia: 234.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 23.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 10.5;eosinophil: 21.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.4;HEL: 11.6;HeLa: 29.8;K-562: 13.7;U-698: 42.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 27 "basal ganglia: 6.7" HPA008477 Enhanced Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA008477: AB_1079697" "unprognostic (4.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.06e-2)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (2.33e-1)" "unprognostic (5.21e-2)" "unprognostic (8.83e-3)" "unprognostic (1.52e-3)" "unprognostic (2.97e-2)" "unprognostic (1.14e-2)" "unprognostic (5.07e-2)" "unprognostic (7.79e-2)" "unprognostic (2.99e-1)" 0.8 0.0 0.2 0.2 0.2 5.5 1.0 0.4 0.4 1.4 0.4 0.2 1.4 0.2 0.3 0.2 0.8 2.2 2.1 0.2 0.2 0.0 0.2 0.2 2.1 3.3 0.2 0.2 0.3 0.9 1.7 0.2 0.3 0.4 1.8 0.2 0.2 20.9 0.2 0.5 0.4 0.4 0.2 0.2 0.9 0.4 37.5 0.2 0.9 0.2 1.2 1.1 0.3 0.6 0.8 1.4 21.0 2.3 1.0 3.3 1.3 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.6 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 10.5 2.3 21.0 2.2 1.6 3.3 0.8 1.1 1.8 0.6 0.6 1.5 2.2 0.2 1.0 0.3 1.4 0.5 1.3 0.2 0.2 0.4 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 10.2 29.2 1.0 0.0 81.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 1.1 94.4 0.0 0.2 0.0 0.3 6.3 0.2 21.6 0.0 0.0 11.5 0.0 0.0 0.0 0.0 257.7 6.1 1.8 0.0 0.0 0.9 0.0 0.8 0.0 3.5 0.0 0.0 45.3 1.1 426.2 234.2 0.5 0.1 2.5 1.6 11.1 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.5 2.7 3.3 4.3 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.5 1.3 1.1 1.0 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 5.0 4.9 1.9 1.6 3.3 1.5 4.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 5.6 2.5 4.8 2.8 2.4 0.5 1.3 0.3 1.5 3.9 3.4 3.0 1.5 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 3.0 5.1 0.0 1.0 5.6 0.0 10.8 5.1 0.0 1.2 1.8 0.0 0.8 0.0 0.3 0.0 4.4 0.5 0.0 0.5 0.6 2.5 2.1 0.0 1.0 0.9 0.0 0.0 4.9 1.8 0.0 3.1 1.2 3.3 0.0 0.3 2.7 0.5 0.9 4.2 1.3 0.0 0.0 2.6 0.2 0.7 3.6 2.3 1.3 1.4 0.9 PTH2 TIP39 ENSG00000142538 "Parathyroid hormone 2" Q96A98 19 49422414-49423441 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "blood: 2.4;brain: 4.1;testis: 1.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 1.6;Late spermatids: 1.1;Muller glia cells: 2.6;Spermatocytes: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 18 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;REH: 3.8;SCLC-21H: 3.3;U-266/84: 1.1;U-937: 1.0" "Region enriched" "Detected in single" 10 "olfactory region: 3.5" "Region enriched" "Detected in many" 4 "cerebellum: 36.9" "Secreted in brain" NA NA "unprognostic (3.41e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 1.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 PTPN7 "HEPTP, LC-PTP" ENSG00000143851 "Protein tyrosine phosphatase, non-receptor type 7" P35236 1 202147013-202161588 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.5;lymphoid tissue: 63.7" "Group enriched" "Detected in many" 5 "B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basal ganglia: 9.4;thalamus: 2.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6" "Cell line enhanced" "Detected in some" "HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2" "Region enriched" "Detected in single" 10 "basal ganglia: 5.5" "Region enriched" "Detected in all" 4 "basal ganglia: 10.9" "CAB009530, HPA019118" Approved Supported "Microtubules,Mitotic spindle,Cytosol" NA NA Cytosol "Microtubules, Mitotic spindle" "CAB009530: AB_2173845, HPA019118: AB_1855755" "unprognostic (4.19e-3)" "unprognostic (1.08e-3)" "unprognostic (3.09e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.91e-2)" "prognostic favorable (1.84e-4)" "unprognostic (3.01e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.42e-8)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" 2.6 3.1 0.5 27.1 9.4 24.5 0.6 0.4 0.5 0.6 2.3 0.6 0.0 3.0 0.7 0.6 1.7 0.8 2.9 0.5 0.6 0.8 1.1 0.9 3.2 16.5 1.2 0.2 0.6 0.6 0.0 0.7 0.4 0.8 1.3 1.9 0.7 5.3 0.3 0.4 0.6 3.7 0.9 1.6 15.4 1.4 12.7 2.9 63.7 0.9 0.6 24.8 2.9 0.8 2.6 2.6 17.0 1.1 9.9 10.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 16.7 0.0 0.0 0.0 36.3 48.9 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.7 1.5 0.0 0.0 4.9 15.8 0.0 0.0 0.0 0.7 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.1 0.0 0.0 7.4 1.8 10.5 0.0 26.2 0.0 11.5 1.1 17.0 10.6 1.1 9.5 1.9 7.1 10.5 2.0 2.6 5.3 6.4 7.1 9.9 0.4 2.6 9.0 2.8 0.5 9.4 0.4 0.5 0.6 0.8 1.2 0.2 0.8 2.9 3.0 9.0 40.6 1.0 2.1 2.4 0.7 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.4 2.9 0.0 0.0 0.0 0.1 1.7 0.5 137.4 0.5 15.6 0.0 0.0 4.9 6.2 1.3 4.9 23.4 8.5 9.0 0.0 5.6 0.1 0.0 2.1 0.6 4.4 0.0 0.9 0.9 0.4 2.0 0.7 156.8 0.0 0.5 RAB44 "dJ431A14.3, RASD3, RASL13" ENSG00000255587 "RAB44, member RAS oncogene family" 6 36697810-36733183 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.0;bone marrow: 36.0" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.9;granulocytes: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "basophil: 10.0;eosinophil: 7.8" "Lineage enriched" "Detected in single" 10 "granulocytes: 10.0" "Cell line enhanced" "Detected in some" "HEL: 8.7;HL-60: 12.2;HMC-1: 37.2;NB-4: 30.6;THP-1: 12.1;U-937: 24.4" "Region enriched" "Detected in single" 4 "basal ganglia: 0.3" NA NA "unprognostic (8.86e-2)" "unprognostic (5.58e-3)" "unprognostic (5.09e-2)" "unprognostic (4.66e-2)" "unprognostic (1.37e-1)" "unprognostic (1.28e-3)" "unprognostic (9.56e-2)" "unprognostic (6.35e-4)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" "unprognostic (2.57e-1)" "unprognostic (3.02e-2)" "unprognostic (3.13e-3)" "unprognostic (3.03e-2)" "unprognostic (9.67e-3)" "unprognostic (5.79e-2)" 1.4 0.0 0.0 1.2 0.1 36.0 0.2 0.0 0.0 1.9 1.0 0.0 0.9 0.4 3.5 0.7 0.6 0.3 7.2 2.6 0.0 0.0 0.2 6.6 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 2.4 0.2 1.1 0.0 1.0 0.0 0.3 0.5 0.5 0.0 0.9 0.4 0.5 0.0 0.9 0.0 1.8 0.3 1.5 0.0 0.0 0.8 10.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 12.2 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 10.0 0.9 7.8 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 7.9 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAP1GAP "KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII" ENSG00000076864 "RAP1 GTPase activating protein" P47736 1 21596215-21669363 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.3;thyroid gland: 72.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 66.1;Distal tubular cells: 61.3;Horizontal cells: 87.4;Mucus-secreting cells: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 16.5;OE19: 57.5;SCLC-21H: 19.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 286.1" "HPA001922, CAB003851" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB003851: AB_562338, HPA001922: AB_1079743" "unprognostic (1.17e-2)" "unprognostic (4.33e-2)" "unprognostic (7.84e-2)" "unprognostic (2.45e-2)" "unprognostic (4.52e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (8.33e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (3.43e-2)" "unprognostic (1.35e-2)" "prognostic favorable (1.12e-6)" "unprognostic (1.11e-1)" "unprognostic (9.85e-3)" "unprognostic (4.86e-3)" "unprognostic (3.64e-2)" 0.9 38.2 30.2 1.9 89.3 1.1 3.1 27.1 40.1 4.7 10.5 5.7 0.0 6.9 1.7 1.8 2.9 3.0 13.4 2.7 17.8 12.9 33.2 10.3 7.8 1.2 8.6 20.6 1.6 49.3 7.1 8.2 5.8 14.6 7.4 9.4 2.4 43.9 1.2 0.7 2.1 11.6 1.1 3.2 0.9 28.4 2.1 14.2 0.0 72.5 0.9 1.6 2.5 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.1 16.5 0.1 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 2.3 0.0 1.7 0.0 11.1 2.8 1.6 0.1 0.0 0.3 0.8 0.7 1.5 7.7 0.2 0.0 2.4 0.1 1.1 0.0 0.0 0.0 0.0 8.0 10.2 0.4 0.0 5.5 2.6 0.2 1.0 57.5 2.5 1.5 0.4 0.3 3.8 1.2 19.2 3.4 2.7 10.0 3.2 0.7 1.0 1.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 30.2 89.3 27.1 30.4 17.8 12.9 8.6 20.6 14.6 14.2 8.9 21.1 0.5 0.9 1.1 66.1 3.3 25.5 0.0 6.8 14.0 0.0 0.1 61.3 10.9 0.6 0.0 4.2 23.3 24.6 1.1 0.6 8.3 0.0 5.6 0.2 87.4 6.4 0.0 0.8 0.0 0.0 0.7 15.1 1.0 97.4 10.0 20.3 10.2 0.0 10.2 6.2 0.0 0.4 1.0 3.4 1.0 1.3 0.0 6.9 1.1 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavorable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.8 0.0 0.5 0.0 0.0 0.1 0.7 0.2 1.1 0.9 0.1 0.5 0.0 0.2 2.4 4.3 0.1 0.2 0.0 1.0 0.0 0.7 0.0 0.1 0.0 1.4 0.0 0.0 0.2 3.3 2.2 0.3 13.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 1.3 0.0 0.9 0.0 0.0 2.0 0.3 2.2 7.6 0.0 0.2 0.6 0.2 0.1 1.8 4.4 0.2 0.8 1.9 0.6 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 0.0 0.0 0.0 0.2 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 0.7 0.0 0.1 45.3 4.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 161.0;pancreas: 107.4;retina: 85.3" "Group enriched" "Detected in many" 7 "Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 136.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 56.8" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 1.9 43.1 6.5 3.3 11.3 0.1 7.5 5.1 7.8 7.8 3.2 11.5 8.4 4.5 26.8 11.3 3.3 58.4 42.7 7.5 7.7 8.1 3.7 20.1 4.9 6.5 10.4 4.9 161.0 107.4 4.3 26.2 20.6 31.5 9.8 2.1 85.3 4.7 6.4 1.8 2.9 4.8 17.5 8.7 4.7 2.8 12.9 4.3 0.9 3.3 2.6 2.0 7.7 7.2 0.5 0.5 2.1 0.9 0.7 0.4 0.2 1.2 0.3 1.1 26.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 8.7 0.0 0.4 0.0 6.1 0.1 0.0 0.0 0.7 0.0 0.4 11.2 25.8 0.0 0.0 0.4 0.0 0.0 0.0 26.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 3.2 136.6 5.6 0.0 0.0 2.3 0.5 0.1 0.0 0.0 20.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.9 0.8 0.4 0.8 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 2.1 0.7 0.5 0.5 0.1 0.2 6.5 11.3 5.1 7.8 7.7 8.1 10.4 4.9 31.5 4.3 29.8 5.1 10.5 43.6 15.7 12.3 15.5 63.7 5.3 12.5 22.7 2.0 2.6 11.6 920.8 3.9 54.2 0.0 0.0 932.2 6.9 95.1 21.2 0.0 6.6 16.2 3.2 41.3 319.8 11.5 8.3 25.0 2.8 8.5 23.4 0.5 79.7 450.0 0.0 4.2 2.7 7.0 25.8 22.5 2.3 4.1 30.6 3.2 2.5 0.8 27.7 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077027-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 63.9" "Cell type enriched" "Detected in some" 44 "Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;monocytes: 6.7" "Cell line enhanced" "Detected in some" "MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "midbrain: 95.5" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 260000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 15.2 1.1 1.8 1.3 0.7 1.2 4.1 9.0 1.9 3.1 0.9 1.1 1.5 0.9 0.6 1.2 0.7 1.0 1.2 1.5 5.8 1.0 11.7 0.7 0.8 17.5 1.2 0.8 1.3 63.9 6.3 0.8 16.8 2.2 1.5 2.8 13.6 2.0 4.5 1.1 2.6 1.1 2.8 0.6 2.1 2.0 0.0 0.1 0.8 5.1 0.6 1.9 1.4 0.2 2.1 0.0 6.7 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 11.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 91.8 0.0 0.0 0.0 0.1 1.3 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.7 2.1 0.3 0.4 1.1 1.3 4.1 9.0 1.5 5.8 17.5 1.2 16.8 0.0 0.0 0.3 0.0 0.5 0.2 0.1 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 1.7 1.0 1.2 1.1 0.8 0.1 74.7 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.4 1.1 0.5 0.0 0.0 0.0 0.1 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Group enriched" "Detected in some" 4 "HDLM-2: 23.2;HEL: 9.5" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in all" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.1 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.0 0.1 0.0 0.1 0.2 23.2 0.5 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 3.6 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 3.0 1.0 0.0 0.9 0.3 21.5 0.4 0.0 1.4 2.3 1.8 306.3 0.0 3.3 6.8 0.6 0.3 0.0 0.0 2.8 0.1 2.3 0.2 0.0 0.0 0.1 49.3 57.3 1.8 0.0 1.7 0.9 3.2 1.7 33.3 2.2 27.8 3.9 0.0 4.6 8.1 472.2 0.0 0.9 0.0 0.4 0.1 0.1 9.2 0.4 0.1 RLN3 "H3, RXN3, ZINS4" ENSG00000171136 "Relaxin 3" Q8WXF3 19 14028148-14031042 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.7;parathyroid gland: 5.6;testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.0;K-562: 4.1;SCLC-21H: 1.5;THP-1: 2.3;U-266/70: 1.0;U-698: 1.2" "Group enriched" "Detected in some" 11 "midbrain: 14.0;pons and medulla: 28.5" "Region enriched" "Detected in many" 10 "pons and medulla: 34.0" "Secreted to blood" NA NA 60000000 "unprognostic (1.96e-2)" "unprognostic (2.54e-2)" "unprognostic (3.94e-1)" 0.3 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.9 1.3 0.1 0.0 5.6 0.2 0.0 0.7 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.0 1.0 0.1 5.0 0.0 0.4 0.2 0.0 2.7 1.8 0.0 1.3 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.1 0.0 0.9 0.9 1.8 2.7 2.0 1.2 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF17 "FLJ11045, Mmip-2, SPATA23, TDRD4" ENSG00000132972 "Ring finger protein 17" Q9BXT8 13 24764152-24879921 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 44.3" "Group enriched" "Detected in some" 16 "Early spermatids: 17.4;Late spermatids: 20.7;Spermatocytes: 39.8;Spermatogonia: 22.7" "Cancer enriched" "Detected in single" 41 "testis cancer: 4.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Group enriched" "Detected in some" 4 "BEWO: 2.6;HHSteC: 1.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 4 "olfactory region: 3.8" "HPA039699, HPA040111" Approved NA NA "HPA039699: AB_10795254, HPA040111: AB_10795414" "unprognostic (2.57e-1)" "unprognostic (1.87e-2)" "unprognostic (1.37e-1)" "unprognostic (4.44e-1)" "unprognostic (4.26e-1)" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (8.61e-2)" "unprognostic (5.04e-1)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.1 0.5 0.2 0.1 0.1 0.0 0.1 0.2 1.0 0.2 0.1 0.0 0.0 0.0 0.2 1.2 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.2 0.1 0.0 0.2 2.2 0.2 1.0 0.0 0.0 0.9 0.1 3.7 0.1 0.1 0.0 1.5 0.1 0.2 44.3 0.6 0.0 0.1 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 1.0 0.3 0.1 1.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 39.8 22.7 0.0 0.8 0.0 0.0 0.0 ROR2 "BDB, BDB1, NTRKR2" ENSG00000169071 "Receptor tyrosine kinase like orphan receptor 2" Q01974 9 91563091-91950162 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 9.7;Fibroblasts: 9.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 6.6" "Cell type enriched" "Detected in single" 6 "MAIT T-cell: 3.9" "Lineage enriched" "Detected in single" 6 "T-cells: 3.9" "Cell line enhanced" "Detected in many" "AF22: 12.3;HHSteC: 32.4;HSkMC: 26.9;U-266/70: 18.7;U-266/84: 12.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 13.5" HPA021868 Uncertain NA NA "HPA021868: AB_1856406" "unprognostic (9.38e-3)" "unprognostic (4.69e-1)" "unprognostic (2.26e-1)" "unprognostic (8.48e-3)" "unprognostic (1.23e-1)" "unprognostic (2.38e-1)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (8.03e-2)" "unprognostic (2.03e-1)" "unprognostic (5.76e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (2.16e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (1.25e-2)" 4.4 4.3 0.7 5.3 1.1 0.0 3.6 0.2 0.8 23.4 20.7 2.9 11.1 1.9 29.1 9.1 8.0 8.1 18.7 8.5 1.0 0.9 2.0 0.5 4.2 0.7 0.3 0.0 19.1 3.1 20.3 1.3 7.1 6.6 20.3 2.1 11.0 1.2 13.1 1.1 2.9 6.2 30.0 0.3 4.7 10.5 5.2 0.3 2.6 7.9 1.9 3.3 23.7 18.1 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 12.3 0.0 2.7 0.2 3.5 0.2 3.2 2.1 3.9 0.0 0.0 0.0 0.0 0.6 1.9 0.1 2.5 0.0 0.9 0.0 2.0 0.0 9.4 0.0 32.4 0.0 0.0 26.9 0.0 2.8 0.0 0.0 0.0 0.1 6.8 0.0 0.0 0.2 0.0 1.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.6 0.2 0.0 0.0 2.7 7.3 0.1 0.0 0.0 2.4 1.0 0.0 18.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.2 0.8 1.0 0.9 0.3 0.0 6.6 0.3 0.0 0.0 0.0 9.7 2.7 1.9 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 3.5 1.1 0.0 0.0 1.3 0.1 9.1 8.3 1.1 0.0 0.7 0.0 2.9 0.6 0.0 6.0 5.5 0.0 5.0 2.8 2.8 6.8 0.8 0.0 8.5 0.0 0.2 6.5 3.9 1.0 6.8 1.9 0.3 0.0 0.8 4.4 RTP2 "MGC78665, Z3CXXC2" ENSG00000198471 "Receptor transporter protein 2" Q5QGT7 3 187698259-187702557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "skeletal muscle: 5.7;testis: 3.1" "Cell type enhanced" "Detected in some" 34 "Distal tubular cells: 1.7;Early spermatids: 8.7;Late spermatids: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SK-BR-3: 6.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 27 "olfactory region: 0.3" NA NA "unprognostic (5.86e-2)" "unprognostic (1.12e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RXFP2 "GPR106, GREAT, INSL3R, LGR8, RXFPR2" ENSG00000133105 "Relaxin/insulin like family peptide receptor 2" Q8WXD0 13 31739542-31803388 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;epididymis: 28.4" "Cell type enriched" "Detected in single" 32 "Early spermatids: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 8.3" "Cell type enriched" "Detected in single" 11 "classical monocyte: 5.0" "Lineage enriched" "Detected in single" 23 "monocytes: 5.0" "Group enriched" "Detected in some" 6 "U-2197: 2.1;U-87 MG: 4.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 7 "basal ganglia: 2.0" NA NA "unprognostic (1.77e-2)" 0.5 3.3 1.5 0.1 8.3 2.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.9 28.4 0.0 1.5 0.1 0.5 0.6 0.5 0.3 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.6 0.0 0.2 0.0 3.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.5 8.3 0.0 0.5 0.6 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.6;thyroid gland: 9.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7" "Region enriched" "Detected in single" 85 "olfactory region: 1210.8" "Region enriched" "Detected in single" 30 "olfactory region: 16.8" HPA064184 Approved Nucleoplasm Yes NA Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.5 0.1 0.8 2.4 0.2 0.9 0.4 0.2 0.9 0.6 0.3 0.2 0.2 2.3 1.0 0.2 1.3 0.7 1.6 0.2 0.4 0.1 2.3 0.2 3.0 4.6 0.2 0.2 0.2 0.2 0.0 0.4 1.1 0.2 1.5 0.0 0.2 3.8 0.2 0.2 6.0 0.5 0.2 0.2 1.1 1.9 0.2 0.2 1.6 9.1 0.2 2.6 1.8 0.6 0.9 4.6 2.3 1.2 0.0 7.6 1.2 1.5 4.1 0.0 0.0 0.4 0.3 0.3 0.7 0.9 0.5 1.0 0.4 3.0 0.0 2.7 1.5 0.3 1.2 0.1 0.7 0.6 0.3 0.0 1.9 1.5 0.1 0.3 0.0 2.5 0.0 0.8 2.0 0.6 0.3 0.4 0.0 0.5 0.1 2.2 0.1 0.3 0.9 0.1 24.3 7.1 0.0 1.3 0.7 8.6 14.2 12.7 0.0 0.1 6.5 0.6 1.2 0.0 0.4 0.3 0.1 0.9 1.9 1.2 0.0 0.6 0.0 0.4 0.5 0.2 0.0 1.2 2.3 2.0 0.2 7.6 0.9 4.2 2.2 2.8 0.5 2.4 1.1 1.9 0.0 0.6 4.6 6.1 1.2 0.8 0.2 0.2 0.9 0.4 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 7.2 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.4 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;pancreas: 39.7;pituitary gland: 47.9" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 576.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2" "Group enriched" "Detected in many" 11 "cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 23.6" "Region enriched" "Detected in single" 16 "olfactory region: 100.5" "Region enriched" "Detected in some" 9 "olfactory region: 282.4" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 1.5 2.1 0.7 6.0 0.8 0.1 2.0 22.3 1.5 0.4 10.5 0.5 0.9 7.2 0.1 0.3 0.3 0.0 0.5 5.0 6.2 22.0 3.8 2.5 0.4 0.1 0.5 1.2 0.2 39.7 0.0 47.9 1.8 1.4 1.1 11.7 1.8 3.7 3.0 0.1 0.3 8.0 0.7 1.0 0.1 12.5 0.6 0.1 0.5 1.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 23.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 22.3 1.5 6.2 22.0 0.5 1.2 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 99.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.1 0.0 4.7 0.0 0.0 0.1 0.0 576.5 1.8 0.0 0.0 0.6 0.0 0.0 1.8 2.8 0.0 7.8 2.9 0.0 2.2 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 SCX "bHLHa41, bHLHa48, SCXA, SCXB" ENSG00000260428 "Scleraxis bHLH transcription factor" Q7RTU7 8 144266560-144268481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "skeletal muscle: 18.8;thyroid gland: 33.2" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 15.8;Horizontal cells: 15.9;Muller glia cells: 8.1;Spermatogonia: 10.7" "Group enriched" "Detected in all" 6 "endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Cell line enhanced" "Detected in many" "BEWO: 8.0;HaCaT: 8.6" "Region enhanced" "Detected in some" "cerebellum: 12.0" "Region enriched" "Detected in single" 4 "cerebellum: 4.7" HPA043183 Uncertain NA NA "HPA043183: AB_2678357" "unprognostic (5.32e-2)" "unprognostic (1.06e-2)" "unprognostic (7.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-2)" "unprognostic (6.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (7.89e-3)" 0.5 1.1 0.4 1.3 0.0 0.8 0.0 3.0 0.9 4.8 2.8 0.0 0.0 1.4 2.2 4.5 1.7 0.2 3.7 5.5 0.0 0.4 0.1 0.4 0.7 0.0 0.0 0.9 2.8 2.7 2.3 0.3 10.3 1.8 0.3 4.2 3.3 0.5 18.8 1.6 1.8 0.9 0.0 1.3 2.3 4.7 0.0 7.6 33.2 4.5 0.5 1.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.8 0.2 0.9 0.0 0.1 8.0 0.2 0.1 0.2 0.1 0.3 2.4 2.3 2.4 0.4 0.5 8.6 0.0 0.0 0.0 1.2 1.5 0.5 2.8 0.4 0.3 0.2 3.7 0.1 0.9 0.1 0.4 1.2 0.0 0.5 0.4 1.0 0.2 5.1 0.9 1.8 2.0 0.7 3.8 2.8 0.4 1.4 0.2 3.5 0.3 1.5 0.9 3.2 3.4 0.2 4.0 1.6 0.5 0.7 6.0 2.8 0.5 2.6 0.8 0.5 1.5 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.1 0.0 15.8 4.8 2.5 0.0 2.3 3.5 0.0 1.1 1.7 0.6 0.2 0.5 0.4 0.0 1.2 0.5 0.3 1.8 0.0 0.2 0.4 15.9 2.4 0.6 0.6 0.0 0.3 0.0 0.0 0.0 3.1 8.1 1.0 2.5 0.7 0.0 1.6 0.0 1.1 1.2 10.7 0.0 0.9 0.0 1.6 0.9 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 74.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "Daudi: 65.9;OE19: 49.9;U-698: 43.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 4.8 5.3 3.9 1.3 0.6 0.8 0.6 2.4 6.6 1.8 6.0 3.3 22.7 65.9 11.7 16.6 15.9 3.1 2.9 10.5 2.5 3.5 1.7 0.7 8.8 4.5 17.1 9.0 0.4 1.3 8.5 6.6 2.6 7.5 24.8 1.3 4.3 0.0 1.3 3.7 0.0 0.6 11.4 49.9 4.7 0.3 21.7 9.1 14.5 16.4 9.8 1.9 16.1 0.2 1.6 5.7 0.8 11.2 10.8 0.1 7.9 0.1 6.9 0.4 0.1 43.0 30.0 3.8 4.5 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 11.9 29.0 65.6 3.0 0.8 2.1 1.2 63.7 8.1 55.7 3.5 0.0 23.3 0.0 64.6 46.5 8.4 31.3 23.3 28.5 1.3 1.5 12.0 2.3 1.7 4.6 0.0 11.1 13.5 16.0 58.1 1.4 6.4 8.5 15.4 74.5 32.9 37.4 24.6 0.4 9.7 29.0 0.0 1.4 0.6 2.4 1.4 13.7 26.1 35.6 4.2 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 3314.2" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 29973.4" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0" "Group enriched" "Detected in many" 5 "granulocytes: 139.3;monocytes: 203.0" "Cell line enriched" "Detected in some" 8 "Hep G2: 326.1" "Region enriched" "Detected in many" 6 "cerebellum: 334.2" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 2070000000000 210000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favorable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 0.9 0.4 0.7 4.9 1.4 3.0 2.4 0.2 0.7 2.6 7.5 0.5 3.1 6.3 0.8 8.6 0.4 0.7 14.2 1.0 0.4 0.5 74.1 3314.2 13.6 5.3 1.0 0.2 0.6 7.4 0.0 0.4 0.8 0.8 0.6 4.1 0.6 0.9 3.6 0.2 0.3 36.2 1.4 1.3 8.9 7.0 0.8 0.8 0.5 0.8 0.2 0.9 0.5 0.6 0.3 33.5 139.3 203.0 0.2 0.3 100.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 12.9 41.0 0.1 1.1 0.0 0.1 0.1 0.0 0.8 0.0 5.0 0.0 0.2 0.1 326.1 0.0 1.1 0.1 0.3 0.4 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.5 0.1 1.1 0.1 22.1 0.2 0.0 0.1 0.4 0.1 0.1 0.0 19.4 0.2 0.1 0.1 5.1 0.1 0.6 0.2 0.1 0.5 0.3 2.8 0.0 0.4 110.2 29.1 0.2 165.9 0.3 0.3 0.1 0.2 33.5 0.1 0.2 0.1 139.3 0.2 203.0 0.7 0.2 100.0 0.7 1.4 0.2 0.7 0.4 0.5 1.0 0.2 0.8 0.8 32.8 233.5 435.3 1.1 2.1 0.0 2.8 4603.8 45.5 60.3 143.1 0.0 1.4 58.0 1848.5 0.1 6.6 53.3 817.7 189.3 1.7 1.6 5.0 1.1 29973.4 171.4 0.0 11.6 922.6 1276.8 0.0 0.0 188.6 1.7 107.4 659.1 0.3 1376.2 37.4 0.0 447.0 0.2 0.0 5.1 0.0 0.1 1.5 5.4 46.5 24.7 7.1 SERPINA12 "OL-64, Vaspin" ENSG00000165953 "Serpin family A member 12" Q8IW75 14 94487274-94517844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 81.9" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 4.6;Suprabasal keratinocytes: 18.2" "Cancer enhanced" "Detected in some" "liver cancer: 1.8;melanoma: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 7.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "cerebellum: 0.2" "Secreted in other tissues" NA NA 570000 "unprognostic (1.82e-3)" "unprognostic (6.44e-2)" "unprognostic (3.25e-1)" "unprognostic (1.00e-2)" "unprognostic (5.98e-2)" "unprognostic (2.97e-2)" "unprognostic (7.64e-3)" "unprognostic (6.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell type enhanced" "Detected in some" 33 "Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 9.3;MOLT-4: 29.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "hypothalamus: 2.5" HPA001403 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834561 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 17.8" "Group enriched" "Detected in some" 6 "Early spermatids: 16.7;Late spermatids: 23.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "cerebellum: 17.8;pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 5.9;U-266/84: 4.7;U-698: 5.1" "Group enriched" "Detected in some" 11 "cerebellum: 4.2;pons and medulla: 1.3" "Region enriched" "Detected in some" 5 "cerebellum: 9.0" HPA071150 Enhanced NA NA "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 1.1 0.6 0.7 0.4 1.3 1.7 0.7 17.8 2.4 0.5 0.7 0.4 0.4 1.4 1.0 0.5 0.4 0.6 0.7 0.4 0.6 1.1 0.5 0.4 0.7 0.4 0.5 0.4 1.2 1.3 0.1 1.3 0.9 4.4 0.8 0.3 0.4 0.7 0.9 1.5 0.7 0.9 0.6 5.4 0.7 0.4 2.4 0.4 0.4 0.5 0.4 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.4 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.0 0.1 0.2 0.4 0.0 0.4 0.9 1.0 0.3 0.0 0.2 2.4 0.7 0.1 0.2 0.0 0.1 0.4 0.0 1.8 0.1 0.8 0.0 0.2 0.5 1.0 0.0 0.2 0.2 0.6 0.3 1.3 0.0 0.1 0.2 2.1 0.1 0.0 0.4 0.3 0.3 1.1 0.3 0.1 0.5 0.2 0.3 5.9 4.7 5.1 0.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 1.3 17.8 1.2 0.6 1.1 0.5 0.4 4.4 0.4 0.0 0.0 0.0 0.0 0.1 0.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.5 0.2 0.4 0.0 0.0 0.0 0.0 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.7 16.3 0.1 9.9 6.4 3.4 3.1 0.2 5.9 5.1 2.3 16.7 3.2 0.5 0.6 1.2 5.2 1.4 0.3 9.2 10.4 0.3 5.6 14.9 0.1 8.4 3.2 0.9 9.8 6.1 1.2 6.2 0.1 11.2 5.5 2.1 4.3 2.2 0.6 1.0 3.1 0.3 0.0 2.4 7.6 14.4 2.6 0.6 0.0 0.2 4.7 0.6 0.3 1.8 0.0 8.1 2.7 14.8 0.3 10.8 0.1 8.6 9.3 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 26.8 21.3 14.7 5.7 9.0 23.7 116.7 104.4 24.1 15.9 43.6 9.8 0.2 19.9 46.2 85.1 7.1 0.7 0.0 57.0 0.2 12.5 1.9 9.3 10.5 3.0 7.9 0.0 11.1 27.7 90.6 6.4 8.4 3.3 1.8 24.4 1.3 30.7 0.0 9.6 1.0 5.3 6.5 16.0 4.1 3.0 11.0 0.6 20.8 0.9 2.8 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446177 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 8 "cerebellum: 20.4" "Cell type enriched" "Detected in single" 8 "basophil: 2.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 8 "basal ganglia: 9.5" NA NA "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 1.3 1.0 0.6 0.3 0.7 2.3 3.1 20.4 0.8 0.6 0.3 0.5 0.0 0.9 0.5 0.0 0.2 0.4 0.2 0.4 0.8 0.4 0.7 0.9 2.2 1.2 1.3 0.4 0.4 0.7 2.5 4.6 0.1 2.6 3.1 0.1 0.9 1.4 1.0 0.6 2.2 0.5 1.2 2.9 0.9 3.2 0.9 0.2 0.0 1.8 0.0 0.2 3.2 0.4 0.2 0.0 2.7 0.1 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.1 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 2.9 0.0 1.2 0.8 0.3 0.1 0.5 2.6 0.3 0.1 0.4 0.0 0.8 0.9 1.5 0.3 0.3 0.0 0.6 0.7 0.0 0.0 0.6 0.6 1.8 0.4 0.8 0.4 0.4 0.2 0.2 0.3 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.7 20.4 0.8 0.8 0.4 1.3 0.4 2.6 0.2 6.0 1.6 0.0 0.0 0.2 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236395 "Enzymes, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 168.1" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 27 "basophil: 27.3" "Lineage enriched" "Detected in many" 27 "granulocytes: 27.3" "Cell line enhanced" "Detected in many" "A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 6 "hippocampal formation: 2.5" HPA026089 Enhanced NA NA "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favorable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.40e-4)" 1.1 8.1 0.7 4.1 0.8 1.2 3.4 1.5 1.0 0.5 4.2 0.4 1.3 2.5 0.2 17.5 1.2 2.6 1.3 0.2 1.1 1.1 39.4 168.1 1.7 0.8 0.3 1.0 0.7 6.3 2.0 10.4 7.4 3.0 1.2 4.0 3.2 0.6 0.3 0.2 0.6 5.3 0.1 0.3 0.4 0.4 0.7 0.1 0.1 1.0 0.2 1.3 1.4 0.8 0.1 0.0 27.3 0.0 1.0 0.5 0.2 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.5 9.3 2.5 0.0 0.2 0.4 0.2 32.2 8.2 0.2 0.8 12.6 10.1 13.2 16.6 8.3 0.1 23.1 9.5 0.0 0.7 0.0 0.0 0.0 0.0 6.1 4.0 0.0 0.0 2.9 0.6 15.6 0.6 36.0 0.6 0.0 0.0 0.6 1.7 16.3 14.9 0.9 3.1 0.4 0.0 0.4 1.7 8.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 27.3 0.0 0.4 0.4 0.0 0.4 0.1 0.4 0.4 0.0 0.1 0.1 0.1 0.2 1.0 0.0 0.0 0.5 0.2 0.7 0.8 1.5 1.0 1.1 1.1 0.3 1.0 3.0 0.1 0.0 0.6 0.9 0.8 0.9 0.7 0.3 0.0 54.9 6.8 8.7 0.0 236.8 10.0 0.3 0.4 0.1 20.6 0.0 1.7 2.6 0.0 1.8 5.8 188.9 14.3 1.6 4.1 3.7 2.5 0.0 0.3 0.1 0.0 0.0 18.6 0.5 1.6 28.1 0.0 112.0 1.5 0.0 0.1 1.8 2.5 0.3 45.9 4.3 21.1 4.4 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922264-136925639 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;retina: 16.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Group enriched" "Detected in some" 4 "basal ganglia: 9.9;hypothalamus: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 18.7" "Group enriched" "Detected in many" 5 "basal ganglia: 26.6;olfactory region: 10.4" "Region enriched" "Detected in many" 6 "basal ganglia: 24.4" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: AB_2685854" "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.1 4.9 0.0 0.4 9.9 1.2 0.1 0.0 0.4 2.0 0.4 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 0.4 0.0 4.8 4.0 0.0 2.1 0.0 1.7 0.0 0.8 1.2 0.0 0.0 0.1 0.5 4.3 0.6 16.4 0.2 0.1 0.0 0.2 1.3 0.3 0.0 0.2 3.2 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 18.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 9.9 0.0 0.4 0.0 4.8 1.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Group enriched" "Detected in some" 5 "Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 107.1" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.4 4.7 0.0 0.0 0.0 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 2.9" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 138 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles NA NA Vesicles "CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.1 3.8 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599400-20659285 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 21.3" "Group enriched" "Detected in some" 27 "Early spermatids: 20.8;Late spermatids: 40.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.6" "Region enriched" "Detected in some" 9 "pons and medulla: 51.6" "Region enriched" "Detected in some" 9 "pons and medulla: 33.2" CAB079052 Supported NA NA "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.1 0.1 0.1 0.0 0.0 0.0 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 5.1 0.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 6.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.4 0.3 0.1 0.1 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782283-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 14.3" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 2.9;Glandular cells: 2.4;Spermatocytes: 1.2;Spermatogonia: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HUVEC TERT2: 5.9;NTERA-2: 12.2;PC-3: 20.6" "Group enriched" "Detected in some" 13 "basal ganglia: 15.7;olfactory region: 66.8" "Region enriched" "Detected in some" 11 "olfactory region: 72.4" HPA054006 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054006: AB_2682340" "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.1 0.1 2.3 0.1 2.8 0.1 0.2 0.1 3.2 0.3 0.3 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.5 0.3 0.1 0.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.2 0.7 14.3 0.1 0.0 0.1 0.1 0.1 2.4 0.8 0.1 0.2 0.2 0.3 0.5 0.7 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.0 4.3 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 12.2 0.1 20.6 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 0.1 3.2 2.4 0.5 0.1 1.7 0.7 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.7 SP9 ZNF990 ENSG00000217236 "Sp9 transcription factor" P0CG40 2 174334946-174338492 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 5.1;skin 1: 4.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.0;fHDF/TERT166: 6.8;HEK 293: 2.8;THP-1: 14.4" "Group enriched" "Detected in some" 6 "basal ganglia: 6.0;olfactory region: 14.4" "Region enriched" "Detected in many" 4 "olfactory region: 44.8" HPA062616 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062616: AB_2684808" "unprognostic (2.04e-2)" "unprognostic (6.94e-3)" "unprognostic (1.44e-1)" "unprognostic (3.95e-1)" "unprognostic (7.55e-3)" "unprognostic (8.54e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" 0.7 0.3 4.6 0.3 12.4 0.3 1.1 0.0 6.1 0.6 0.3 0.4 0.0 0.3 0.4 0.3 0.3 5.1 0.3 0.3 2.3 2.2 0.3 0.3 0.3 0.4 1.1 4.3 0.3 0.3 0.3 0.0 1.1 1.0 0.3 0.3 0.0 0.4 0.3 0.6 4.5 0.3 0.3 0.5 0.3 0.3 2.0 1.4 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 9.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 6.8 0.0 0.1 0.2 0.0 0.0 0.0 2.8 0.6 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 12.4 0.0 6.1 2.3 2.2 1.1 4.3 1.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "testis: 82.0" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3891.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.6;U-698: 1.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 11 "cerebellum: 11.0" HPA018254 Enhanced NA NA "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.2 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.0 0.2 3.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.5 0.1 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.1 0.0 0.9 0.0 0.2 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.2 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.2 0.5 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 761.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3891.5 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 6.5 0.0 21.5 10.9 0.0 0.0 0.0 0.0 0.0 SPATC1 "MGC61633, SPATA15, SPERIOLIN" ENSG00000186583 "Spermatogenesis and centriole associated 1" Q76KD6 8 144012414-144047085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "bone marrow: 10.9;testis: 36.6" "Group enriched" "Detected in some" 24 "Early spermatids: 70.9;Late spermatids: 269.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "U-937: 13.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 30.1" NA NA "unprognostic (2.96e-1)" "unprognostic (1.41e-3)" "unprognostic (3.34e-1)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (4.59e-3)" "unprognostic (6.96e-2)" "unprognostic (4.30e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (4.12e-2)" "unprognostic (4.39e-2)" "unprognostic (1.34e-3)" "unprognostic (2.74e-1)" "unprognostic (5.81e-3)" "unprognostic (2.19e-1)" "unprognostic (2.74e-1)" 0.2 0.1 0.2 2.2 0.3 10.9 0.1 0.2 0.3 0.1 0.1 0.5 0.0 0.1 0.0 0.7 0.5 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.7 0.7 0.1 0.0 0.0 0.1 0.0 0.9 0.3 0.4 0.5 0.0 0.5 0.5 0.0 0.1 0.0 0.6 0.1 0.6 1.8 0.2 36.6 0.0 0.9 0.1 0.3 1.9 0.5 0.1 1.8 1.3 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 13.4 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.5 1.8 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 269.9 2.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 89.4;monocytes: 99.2;Muller glia cells: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.4;hTEC/SVTERT24-B: 30.0;TIME: 30.0;U-138 MG: 30.2;U-251 MG: 38.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 11.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 9.3 2.2 4.7 10.5 3.5 15.0 20.4 0.4 3.2 5.5 5.0 4.0 0.4 1.9 6.3 8.3 13.8 5.3 12.7 10.5 5.3 2.1 4.1 2.4 12.9 10.1 4.4 1.5 5.5 15.1 3.1 2.7 7.4 4.7 4.3 1.1 11.0 11.5 1.7 6.8 8.7 6.3 5.2 4.0 2.7 3.8 3.7 6.3 3.0 9.4 16.2 12.1 5.6 7.0 0.2 8.0 2.4 3.4 0.1 1.4 1.3 9.8 1.0 4.3 0.2 2.2 2.0 4.4 22.8 15.1 19.2 11.6 5.3 1.0 0.4 2.1 16.8 8.2 2.1 3.2 29.2 4.7 0.4 1.7 0.1 7.3 34.4 4.8 0.3 0.8 3.9 0.6 30.0 11.8 8.2 18.5 1.0 4.6 0.0 3.7 12.6 0.9 0.1 0.2 2.2 8.3 0.6 1.1 0.7 1.0 0.1 0.5 1.0 2.3 0.2 19.7 2.7 0.8 1.4 30.0 30.2 5.8 23.1 38.5 0.4 0.1 0.4 22.9 1.7 4.5 2.4 3.4 0.0 1.4 1.7 0.4 0.0 0.2 0.4 1.0 0.2 0.0 0.3 0.4 0.1 0.3 8.0 0.0 1.3 4.7 3.5 0.4 3.2 5.3 2.1 4.4 1.5 4.7 6.3 0.0 0.0 0.5 42.7 11.2 1.3 3.9 33.1 0.0 3.4 1.8 0.0 0.6 0.0 89.4 0.2 35.0 0.7 0.0 10.7 14.8 17.3 28.4 6.9 0.0 31.0 31.8 0.0 4.3 5.7 0.9 3.4 17.1 11.8 99.2 1.1 144.5 62.5 0.3 18.7 1.1 1.8 0.0 39.2 0.0 7.7 9.4 1.1 5.7 0.2 22.4 SSPO "FLJ36112, KIAA0543, SCO-spondin" ENSG00000197558 SCO-spondin 7 149776042-149833979 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7;salivary gland: 1.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 24.9;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9;Muller glia cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;hTERT-RPE1: 1.4;RPMI-8226: 2.7" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 13 "midbrain: 44.5" "Secreted in brain" NA NA "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.95e-4)" "unprognostic (5.81e-3)" "unprognostic (3.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.41e-3)" "unprognostic (9.17e-2)" "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.59e-5)" "unprognostic (1.04e-1)" "unprognostic (2.65e-10)" "unprognostic (1.19e-1)" "unprognostic (2.94e-1)" "unprognostic (8.15e-3)" "unprognostic (2.46e-2)" 0.6 0.0 0.3 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 1.7 0.1 0.1 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.7 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.5 0.7 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 2.7 0.1 0.0 0.4 0.5 0.0 0.1 0.0 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.9 3.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.9 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 SVEP1 "bA427L11.3, C9orf13, FLJ13529, POLYDOM" ENSG00000165124 "Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" Q4LDE5 9 110365251-110579880 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 141.1" "Group enriched" "Detected in some" 6 "Fibroblasts: 33.2;Leydig cells: 38.9;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 51.6;ASC TERT1: 30.0;BJ hTERT+: 21.1;HHSteC: 18.9;HSkMC: 23.4" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 7 "cerebellum: 31.1" "HPA020610, HPA021520" Enhanced "Intracellular and membrane" NA NA 160000000 "HPA020610: AB_2197021, HPA021520: AB_1855533" "unprognostic (4.47e-2)" "unprognostic (6.01e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.62e-2)" "unprognostic (9.13e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (3.31e-3)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (9.84e-2)" "unprognostic (2.21e-1)" "unprognostic (1.55e-3)" 18.8 2.5 1.0 3.9 1.8 0.0 11.9 6.7 0.9 7.1 8.6 0.5 3.6 0.6 6.1 7.8 4.7 4.4 5.4 4.4 1.1 0.7 2.1 1.5 8.6 5.8 1.1 0.5 4.2 2.7 2.2 0.7 141.1 0.7 4.3 3.1 1.5 2.2 1.3 7.4 3.5 3.3 5.7 0.6 3.4 3.6 4.0 0.9 0.0 3.5 2.3 1.3 9.6 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 51.6 30.0 0.0 5.4 21.1 0.4 0.6 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.1 0.3 0.0 0.1 0.0 0.4 0.0 18.9 0.0 1.0 23.4 0.0 4.1 1.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.7 0.0 3.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.4 0.8 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 6.7 0.9 1.1 0.7 1.1 0.5 0.7 0.9 0.0 0.3 0.0 0.5 5.0 0.0 1.2 7.6 0.0 0.0 0.0 0.0 7.6 0.0 0.6 0.2 2.1 0.0 0.0 0.2 1.1 33.2 0.2 0.0 0.0 2.7 0.0 0.0 3.1 0.0 0.0 38.9 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.1 1.4 2.9 56.3 0.0 0.0 0.1 SYNDIG1L "capucin, IFITMD4, TMEM90A" ENSG00000183379 "Synapse differentiation inducing 1 like" A6NDD5 14 74405893-74426102 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 27 "brain: 78.1;epididymis: 20.1" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 2.4;Bipolar cells: 8.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 78.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.2;NTERA-2: 1.3;SuSa: 1.8;U-266/70: 1.7;U-266/84: 1.9" "Region enriched" "Detected in many" 8 "basal ganglia: 251.1" "Region enriched" "Detected in many" 6 "basal ganglia: 71.7" "HPA042594, HPA048487" Uncertain NA NA "HPA042594: AB_2678069, HPA048487: AB_2680416" "unprognostic (5.75e-2)" "unprognostic (9.96e-3)" "unprognostic (2.25e-2)" "unprognostic (5.51e-2)" "unprognostic (3.08e-3)" "unprognostic (5.72e-2)" "unprognostic (5.83e-2)" "unprognostic (4.51e-2)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (8.85e-2)" "unprognostic (1.63e-1)" "unprognostic (3.85e-2)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" 0.6 0.4 0.3 0.4 78.1 0.2 0.6 0.0 4.0 0.5 0.6 1.1 0.0 0.3 0.6 20.1 0.5 0.4 0.7 0.4 2.4 1.6 0.6 0.3 1.8 0.4 3.5 0.2 0.4 0.5 0.2 0.0 0.3 0.5 0.6 0.6 0.1 0.4 0.6 0.3 0.5 0.9 0.8 0.4 0.4 0.3 0.4 16.6 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.0 0.5 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.7 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.3 78.1 0.0 4.0 2.4 1.6 3.5 0.2 0.5 16.6 0.0 2.4 0.0 0.0 0.3 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TAC1 "NKNA, NPK, TAC2" ENSG00000006128 "Tachykinin precursor 1" P20366 7 97731908-97740472 "Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 61.3;lymphoid tissue: 62.9" "Group enriched" "Detected in some" 7 "Cholangiocytes: 7.6;Glandular cells: 3.3;Proximal tubular cells: 8.4;Smooth muscle cells: 2.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "U-266/70: 22.5" "Region enhanced" "Detected in many" "basal ganglia: 557.4" "Region enriched" "Detected in many" 9 "basal ganglia: 312.7" HPA014429 Enhanced "Secreted to blood" NA NA "HPA014429: AB_1857722" "unprognostic (9.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (2.08e-1)" "unprognostic (7.95e-2)" "unprognostic (3.24e-1)" "unprognostic (1.70e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (3.86e-2)" 1.8 6.5 4.1 7.7 61.3 0.3 1.7 0.3 39.8 0.7 3.7 0.1 0.0 6.0 0.9 1.6 0.3 0.7 4.9 0.5 9.3 21.5 1.6 0.6 0.3 0.3 8.0 4.5 0.3 0.7 0.3 0.3 0.3 24.5 1.0 2.9 0.3 4.5 2.0 0.4 1.2 7.6 5.3 6.7 62.9 0.9 0.6 9.4 0.0 1.6 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 61.3 0.3 9.2 9.3 21.5 8.0 4.5 24.5 9.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 8.4 0.0 0.0 2.1 0.1 0.4 0.1 0.0 0.0 0.5 0.1 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Cell type enhanced" "Detected in single" 24 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 5.2;U-2197: 1.6" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in many" 7 "midbrain: 16.3" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGM6 "dJ734P14.3, SCA35, TGM3L, TGY" ENSG00000166948 "Transglutaminase 6" O95932 20 2380908-2432753 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 1.8" HPA059196 Uncertain NA NA "HPA059196: AB_2683943" "unprognostic (1.18e-1)" "unprognostic (2.84e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171877 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "adrenal gland: 83.5;brain: 41.4" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 4.0" "Group enriched" "Detected in many" 6 "hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "PC-3: 35.9;SK-BR-3: 12.8" "Region enhanced" "Detected in many" "olfactory region: 220.1" "Region enriched" "Detected in many" 19 "midbrain: 692.0" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374" "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 1.3 83.5 0.0 0.3 5.4 0.2 0.2 0.0 0.7 1.8 0.2 6.2 0.0 0.2 0.3 0.3 0.2 0.3 0.4 0.2 0.3 15.5 0.2 0.2 0.2 0.2 41.4 0.0 0.3 0.3 0.2 0.2 0.9 41.2 0.6 0.2 0.3 0.2 2.0 0.2 0.5 0.4 0.2 0.0 0.3 0.2 0.3 1.5 0.0 0.2 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 35.9 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.7 0.3 15.5 41.4 0.0 41.2 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.1 THEM5 FLJ37964 ENSG00000196407 "Thioesterase superfamily member 5" Q8N1Q8 1 151847263-151853697 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skin 1: 59.8;tongue: 24.7" "Cell type enriched" "Detected in some" 18 "Suprabasal keratinocytes: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.2" "Lineage enriched" "Detected in single" 7 "T-cells: 4.2" "Cell line enriched" "Detected in some" 6 "HDLM-2: 39.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "basal ganglia: 20.0" NA NA "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (3.41e-2)" "unprognostic (2.58e-3)" "unprognostic (9.55e-3)" "unprognostic (1.27e-1)" "unprognostic (1.93e-1)" "unprognostic (1.83e-1)" "unprognostic (7.86e-3)" "unprognostic (3.07e-3)" "unprognostic (9.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.34e-2)" "unprognostic (1.62e-2)" 0.1 0.6 0.3 0.5 0.2 0.0 1.8 0.2 1.6 3.6 0.1 0.2 0.1 0.3 0.8 0.1 4.4 0.1 1.0 1.1 0.3 0.2 0.3 0.2 0.3 1.9 0.2 0.8 0.1 0.3 0.0 0.2 5.8 0.1 0.1 0.0 0.1 1.5 0.1 0.2 59.8 0.1 0.1 0.3 0.1 0.5 0.3 0.1 0.4 0.1 24.7 1.7 0.6 1.1 0.0 0.5 0.5 0.2 0.0 4.2 5.6 4.4 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 39.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.0 1.2 0.1 0.0 4.7 0.7 0.3 0.0 0.2 0.5 0.0 0.0 0.3 0.1 6.0 1.4 0.8 1.0 1.0 1.4 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.8 0.2 4.2 0.0 1.6 1.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 1.9 5.6 0.3 0.2 0.2 1.3 0.3 0.2 0.2 0.8 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.9 0.0 0.0 0.0 TIMP4 ENSG00000157150 "TIMP metallopeptidase inhibitor 4" Q99727 3 12153051-12159351 "Plasma proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 72.2;breast: 97.5" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Ito cells: 14.7;Sertoli cells: 32.3" "Cancer enriched" "Detected in many" 13 "glioma: 66.4" "Region enriched" "Detected in all" 5 "cerebellum: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 54.7;ASC TERT1: 13.7;HSkMC: 23.7;NTERA-2: 13.6;U-87 MG: 13.9" "Region enhanced" "Detected in all" "cerebellum: 118.9" "Region enriched" "Detected in all" 5 "cerebellum: 100.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.99e-2)" "unprognostic (5.14e-3)" "unprognostic (1.02e-2)" "unprognostic (2.10e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-4)" "unprognostic (9.33e-3)" "unprognostic (4.26e-3)" "unprognostic (1.36e-1)" "unprognostic (1.74e-2)" "unprognostic (3.78e-1)" "unprognostic (6.81e-2)" "unprognostic (4.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (6.66e-5)" "unprognostic (2.86e-1)" 72.2 4.3 1.9 2.2 1.6 0.7 97.5 17.8 11.2 2.6 11.7 2.4 0.7 1.1 1.9 0.9 3.2 1.6 2.9 10.9 1.7 1.5 1.9 0.8 2.6 6.0 3.1 1.5 1.2 1.5 1.2 3.2 4.6 3.8 2.9 2.4 2.4 3.1 1.6 7.7 1.7 2.4 2.4 2.9 0.8 2.3 1.8 1.2 0.1 6.1 3.8 0.6 3.7 9.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 6.0 0.2 0.0 54.7 13.7 6.7 0.2 2.2 0.2 0.3 0.1 0.0 0.0 0.5 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 3.5 0.2 8.5 0.0 0.0 23.7 0.5 1.4 0.0 0.4 0.0 0.0 0.1 4.4 0.0 0.1 0.0 0.0 13.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 13.9 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 17.8 1.3 1.7 1.5 3.1 1.5 3.8 1.2 0.0 0.0 0.0 1.2 0.1 0.3 4.8 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.7 1.1 2.9 0.7 23.3 2.4 1.9 1.4 5.6 0.0 0.0 2.9 0.0 6.3 14.7 0.6 4.8 11.2 0.1 3.3 0.0 2.6 0.7 2.7 2.8 2.5 0.3 0.0 32.3 3.4 0.0 0.0 0.1 0.1 0.0 2.3 2.0 TLDC2 "C20orf118, dJ132F21.2" ENSG00000101342 "TBC/LysM-associated domain containing 2" A0PJX2 20 36876121-36894235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.9" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 13.4;granulocytes: 14.0;Paneth cells: 13.3;Undifferentiated cells: 6.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "basophil: 7.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.1" "Cell line enriched" "Detected in some" 6 "HMC-1: 28.0" "Region enriched" "Detected in many" 4 "cerebellum: 6.3" "Region enriched" "Detected in single" 12 "cerebellum: 15.5" HPA047468 Enhanced NA NA "HPA047468: AB_2680059" "unprognostic (9.06e-3)" "unprognostic (3.35e-4)" "unprognostic (4.60e-1)" "unprognostic (1.07e-3)" "unprognostic (1.40e-1)" "unprognostic (6.51e-3)" "unprognostic (1.09e-3)" "unprognostic (5.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.82e-2)" "unprognostic (3.67e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.97e-5)" "unprognostic (7.25e-2)" "unprognostic (6.20e-2)" "unprognostic (5.59e-2)" "unprognostic (4.87e-2)" 5.5 1.2 0.9 11.3 0.9 1.4 3.4 0.9 0.9 2.1 21.1 0.9 1.6 18.4 2.5 1.8 1.8 2.7 16.0 3.5 0.9 0.2 3.2 0.9 6.0 2.5 0.9 0.9 2.8 2.1 0.0 1.1 0.9 0.9 2.8 12.8 1.6 2.1 0.9 0.9 2.3 54.9 1.8 0.9 4.5 1.5 1.9 0.9 1.1 2.0 1.7 1.3 2.3 2.6 0.8 1.4 7.1 1.0 1.4 1.2 0.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.1 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.2 1.0 0.1 2.9 0.0 0.3 28.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.6 0.5 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.1 7.1 1.0 0.1 0.3 0.9 0.6 0.3 0.5 0.2 1.4 0.8 1.2 0.3 0.0 1.4 0.9 0.4 0.7 0.7 0.9 0.9 0.9 0.9 0.9 0.2 0.9 0.9 0.9 0.9 0.0 1.7 0.0 0.1 0.0 0.0 0.5 2.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 0.0 0.0 0.0 0.2 0.0 14.0 0.0 0.2 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.0 TLL1 ENSG00000038295 "Tolloid like 1" O43897 4 165873258-166103895 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 10 "cerebellum: 132.6" HPA060767 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA060767: AB_2684357" "unprognostic (2.17e-1)" "unprognostic (6.45e-4)" "unprognostic (8.60e-2)" "unprognostic (2.65e-5)" "unprognostic (9.85e-2)" "unprognostic (2.51e-4)" "unprognostic (3.37e-2)" "unprognostic (3.61e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-4)" "unprognostic (2.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.76e-2)" "unprognostic (6.91e-3)" "unprognostic (1.21e-5)" 10.1 1.3 1.2 2.6 2.8 0.0 7.9 40.6 2.9 5.0 5.4 0.2 4.2 1.4 3.0 2.7 2.5 2.4 5.4 2.4 2.2 1.7 3.3 0.5 3.1 3.0 1.1 0.6 1.6 4.6 1.1 2.2 13.8 8.5 3.1 2.2 3.3 1.9 1.9 1.6 2.7 4.4 3.3 0.9 0.4 1.7 1.5 0.1 0.0 3.2 1.4 1.6 3.6 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.2 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.6 1.5 0.0 1.8 0.0 1.4 0.0 0.0 13.6 0.0 0.0 0.0 0.2 1.2 0.0 4.9 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.8 40.6 2.9 2.2 1.7 1.1 0.6 8.5 0.1 0.0 1.1 0.0 0.2 1.5 15.1 4.1 0.0 1.4 1.2 0.0 0.0 3.9 0.0 1.5 0.0 11.3 0.0 0.0 1.9 0.9 1.6 0.8 0.0 0.0 0.2 7.9 0.0 1.8 0.0 0.0 2.8 0.0 1.7 0.0 0.0 0.0 0.1 0.0 4.2 0.8 0.5 0.0 0.3 0.1 0.0 1.5 1.6 0.0 0.0 0.1 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 5.2" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 10 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 TMEM190 MDAC1 ENSG00000160472 "Transmembrane protein 190" Q8WZ59 19 55376836-55378244 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 63.6;ovary: 17.7;testis: 21.5" "Group enriched" "Detected in some" 9 "Ciliated cells: 338.6;Early spermatids: 390.3;Late spermatids: 112.4" "Group enriched" "Detected in many" 8 "endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 14.0;hTERT-RPE1: 5.0;SCLC-21H: 7.0" "Region enriched" "Detected in single" 7 "cerebellum: 0.9" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" NA NA "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.00e-2)" "unprognostic (6.58e-2)" "unprognostic (6.24e-3)" "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (5.02e-1)" "unprognostic (2.08e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (5.38e-5)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.93e-1)" 0.1 0.7 0.1 0.1 0.3 0.1 0.1 0.2 0.5 5.7 0.1 0.5 0.1 0.1 1.4 1.1 0.1 63.6 0.1 0.1 0.6 2.7 0.1 0.1 11.8 0.1 0.1 0.1 17.7 0.1 0.0 3.0 0.3 1.0 0.1 0.0 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.5 21.5 0.3 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.4 2.5 0.0 0.5 0.0 0.0 0.2 0.7 0.3 0.6 0.1 1.8 1.5 2.6 0.2 0.7 0.4 4.5 0.0 0.0 0.0 4.3 0.2 0.0 2.7 14.0 0.9 0.0 0.1 0.2 0.0 0.1 0.0 5.0 0.0 0.2 0.0 3.4 0.0 2.0 0.3 0.0 0.5 1.7 0.8 0.2 1.6 1.4 0.0 1.3 7.0 1.3 1.4 1.8 0.6 1.3 0.8 0.0 0.0 0.2 1.1 0.2 0.7 0.5 3.2 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.5 0.6 2.7 0.1 0.1 1.0 0.3 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 338.6 33.0 0.0 0.0 0.1 0.0 0.1 390.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.0 0.1 0.0 8.5 0.0 0.0 112.4 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 2.4 1.7 0.0 0.3 0.0 0.0 0.0 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.9 0.1 0.8 0.8 0.0 2.0 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 2.7 0.0 1.8 9.8 12.8 1.7 0.0 5.9 0.0 0.0 0.0 0.2 1.7 0.7 0.8 0.0 0.0 4.2 1.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.5 7.6 6.5 0.0 0.5 2.1 0.0 4.9 0.0 0.0 0.4 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Cell type enriched" "Detected in single" 11 "Early spermatids: 4.2" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 20 "U-138 MG: 20.3;U-87 MG: 56.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.0 0.3 0.0 0.1 56.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TMPRSS6 FLJ30744 ENSG00000187045 "Transmembrane serine protease 6" Q8IU80 22 37065436-37109563 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 59.3" "Group enriched" "Detected in some" 14 "Early spermatids: 60.9;Hepatocytes: 67.0;Late spermatids: 87.3" "Group enriched" "Detected in many" 14 "liver cancer: 51.3;thyroid cancer: 14.1" "Region enriched" "Detected in single" 10 "basal ganglia: 1.8" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Hep G2: 7.7;SCLC-21H: 13.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 2.2" NA NA "unprognostic (3.93e-1)" "unprognostic (3.28e-1)" "unprognostic (8.62e-2)" "unprognostic (6.29e-5)" "unprognostic (7.95e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.16e-6)" "unprognostic (2.44e-1)" "unprognostic (3.07e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.58e-2)" "unprognostic (1.15e-7)" "unprognostic (2.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.39e-2)" "unprognostic (3.86e-5)" 0.1 0.0 0.1 0.1 1.8 0.0 0.8 0.1 0.1 0.1 0.3 0.1 0.1 1.1 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.0 0.1 59.3 1.9 0.1 0.1 0.1 0.5 0.9 0.0 5.3 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.6 0.1 0.1 0.1 2.3 2.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.2 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.9 2.3 0.3 0.1 7.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.6 0.0 1.3 0.0 0.0 0.3 0.2 0.1 0.5 0.2 0.3 0.0 0.0 13.2 0.4 0.2 1.0 0.0 0.2 0.1 0.0 0.6 0.5 1.6 0.1 0.0 1.6 0.4 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.5 0.2 1.3 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 60.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 67.0 0.1 0.0 5.1 2.5 2.9 87.3 0.3 0.0 0.0 0.0 1.0 0.0 0.3 1.5 0.4 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.6 0.0 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.8;pancreas: 45.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 109.1;Mucus-secreting cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.8;T-47d: 26.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.9" "HPA020899, HPA076667" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favorable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.2 3.8 8.5 5.0 16.8 3.2 3.3 26.1 17.9 3.4 18.5 32.8 2.3 23.6 2.8 1.8 8.2 4.2 4.8 3.6 11.2 7.0 12.1 10.0 5.8 3.0 25.3 7.1 4.7 45.3 2.8 2.7 4.3 11.0 4.4 8.1 13.1 8.7 4.8 5.0 8.0 29.0 2.4 11.9 3.7 10.8 4.7 21.7 0.2 2.5 2.3 3.5 3.8 2.7 1.2 2.3 0.2 2.9 2.9 2.2 0.6 4.5 5.2 1.7 7.9 2.5 2.6 14.1 3.2 2.0 3.3 1.8 17.4 5.6 8.4 4.8 1.6 4.3 14.0 3.6 1.8 0.4 5.3 5.1 3.9 7.8 11.4 3.7 6.0 5.1 2.2 3.5 2.9 2.0 2.1 2.0 3.8 7.1 3.0 0.9 27.8 3.9 13.0 6.3 25.0 6.8 11.8 4.2 12.7 7.3 9.6 11.5 4.2 4.9 23.2 5.7 1.4 26.9 9.5 2.3 6.0 2.8 9.4 6.8 2.5 4.8 4.3 4.3 5.4 3.3 0.0 2.9 0.2 1.3 2.6 0.4 1.1 1.3 1.8 2.1 1.2 0.6 1.2 0.0 2.9 1.5 2.3 2.2 0.6 8.5 16.8 26.1 17.9 11.2 7.0 25.3 7.1 11.0 21.7 17.9 5.6 2.7 1.1 1.5 15.5 7.3 12.7 1.4 1.2 15.7 5.9 4.7 6.6 7.1 2.3 1.9 109.1 23.3 38.5 1.1 1.6 2.8 1.1 14.4 3.1 11.1 8.6 4.3 3.2 3.8 3.1 2.1 5.0 1.8 43.9 10.9 16.4 23.2 4.2 16.6 5.9 6.5 1.7 1.0 5.5 2.5 1.6 0.0 21.2 1.7 TRIM10 "HERF1, RFB30, RNF9" ENSG00000204613 "Tripartite motif containing 10" Q9UDY6 6 30151945-30160934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8" "Cell type enriched" "Detected in some" 12 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "EFO-21: 1.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "hippocampal formation: 4.0" HPA043325 Uncertain NA NA "HPA043325: AB_2678428" "unprognostic (2.98e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (2.13e-1)" "unprognostic (2.98e-1)" "unprognostic (9.53e-3)" "unprognostic (6.32e-2)" "unprognostic (2.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.74e-3)" "unprognostic (1.46e-2)" "unprognostic (4.37e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.0 3.0 0.0 0.0 1.4 0.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 70.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.6 0.0 0.5 0.1 0.3 0.6 5.4 0.2 0.0 0.0 0.0 4.3 1.0 0.2 1.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.3 0.5 0.1 13.3 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 5.6 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.8 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 0.0 4.5 1.4 4.0 16.7 0.8 2.4 2.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 1.6 10.8 0.0 0.0 0.7 4.3 2.9 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 2.8 2.2 6.8 0.0 0.7 2.0 0.8 0.8 3.2 0.8 0.9 0.0 0.9 0.0 1.1 21.5 0.5 2.1 0.6 2.2 TSKS "PPP1R161, TSSKS" ENSG00000126467 "Testis specific serine kinase substrate" Q9UJT2 19 49739753-49763330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 54.3" "Group enriched" "Detected in some" 54 "Early spermatids: 789.1;Late spermatids: 761.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "classical monocyte: 1.4;intermediate monocyte: 1.3;memory CD4 T-cell: 2.5;myeloid DC: 2.5;naive CD4 T-cell: 1.2;non-classical monocyte: 3.0;plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 27 "dendritic cells: 2.5;monocytes: 3.0;T-cells: 2.5" "Cell line enriched" "Detected in some" 5 "NB-4: 15.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 6 "basal ganglia: 4.9" HPA045729 Enhanced NA NA "HPA045729: AB_10963430" "unprognostic (3.56e-1)" "unprognostic (3.75e-3)" "unprognostic (8.33e-2)" "unprognostic (1.67e-1)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-1)" "unprognostic (3.55e-1)" "unprognostic (1.54e-1)" "unprognostic (3.04e-2)" "unprognostic (2.44e-1)" "unprognostic (1.51e-8)" "unprognostic (7.89e-3)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-2)" 0.5 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.7 0.1 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.0 54.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 2.5 0.0 3.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 15.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.0 0.0 2.5 0.0 2.5 0.0 1.2 0.2 0.0 0.0 3.0 2.1 1.8 0.6 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.4 0.3 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 789.1 0.0 0.0 0.0 0.0 7.0 1.3 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.6 761.8 8.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 7.1 0.0 0.0 12.9 0.2 14.4 7.0 1.3 5.6 0.0 0.0 0.1 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 63.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 6.0 5.1 4.9 4.7 14.1 6.8 20.6 4.4 5.8 8.2 3.2 0.2 6.8 3.9 4.2 0.9 2.4 2.5 2.6 1.1 2.7 9.3 2.7 5.8 13.5 0.0 0.7 6.0 2.2 9.1 4.2 14.8 15.0 0.3 0.2 0.2 3.8 5.3 0.0 0.2 8.4 2.1 1.9 2.7 63.6 0.8 18.4 1.6 10.7 7.2 4.5 11.5 4.4 12.9 4.0 0.0 8.8 2.4 7.3 3.9 6.4 0.0 0.0 0.0 6.1 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 0.0 2.6 0.9 10.8 17.1 66.4 45.8 10.2 1.4 3.4 12.2 2.0 49.9 5.0 16.1 1.4 32.2 2.4 0.0 7.8 79.2 21.2 16.1 0.0 33.3 5.4 31.8 5.8 38.1 3.3 2.4 16.1 0.9 11.8 1.0 2.6 3.3 9.1 0.0 16.3 18.2 4.2 19.4 19.5 1.4 3.4 10.5 67.5 0.0 1.9 9.7 TUFT1 ENSG00000143367 "Tuftelin 1" Q9NNX1 1 151540305-151583583 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 54.9" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 72.2" "HPA028112, HPA054301" Approved Approved Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA028112: AB_10603224, HPA054301: AB_2682442" "unprognostic (6.16e-2)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.83e-4)" "unprognostic (4.49e-3)" "unprognostic (1.12e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-2)" "unprognostic (8.29e-3)" "unprognostic (9.06e-2)" "unprognostic (6.70e-3)" "unprognostic (7.88e-2)" "unprognostic (2.58e-3)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-3)" "unprognostic (4.53e-2)" 3.4 4.0 2.7 3.3 2.5 3.8 11.6 8.5 4.5 13.3 8.1 1.1 6.7 4.6 5.9 6.9 23.4 3.1 9.7 3.0 2.0 4.0 9.4 3.9 5.3 2.2 1.9 3.9 5.4 9.3 7.8 5.7 33.1 3.3 7.5 8.3 3.3 18.8 9.4 1.7 54.9 9.8 9.6 1.8 1.1 7.4 5.0 1.5 0.5 3.6 12.0 14.4 11.9 12.2 1.2 1.6 6.5 1.1 0.2 6.0 0.9 14.6 5.0 3.7 4.3 0.8 0.7 23.9 3.9 3.5 15.7 15.1 15.9 11.7 1.3 24.6 4.6 7.4 17.2 6.5 6.0 11.5 9.7 3.2 0.8 8.5 2.4 12.5 0.3 1.8 2.5 7.1 12.3 27.4 9.3 1.2 1.8 1.3 10.1 4.8 6.0 0.7 0.2 4.4 10.8 4.3 0.0 10.6 5.0 13.0 22.7 7.4 3.0 25.2 17.2 3.0 11.7 13.7 0.7 3.2 2.8 19.8 17.4 26.1 2.5 4.8 0.1 2.4 0.3 1.7 6.5 1.1 1.1 0.7 0.3 1.4 1.2 1.9 1.0 1.6 0.6 1.7 0.6 4.5 0.2 0.6 0.2 6.0 0.9 2.7 2.5 8.5 4.5 2.0 4.0 1.9 3.9 3.3 1.5 23.8 1.3 0.0 41.3 61.5 1.8 8.9 7.6 1.4 9.1 14.0 0.0 22.2 11.6 15.0 2.1 0.7 37.6 0.0 13.3 12.0 7.4 24.8 4.6 9.3 3.5 0.0 30.9 1.8 0.0 1.9 2.3 2.6 8.5 2.8 21.4 2.0 31.3 21.6 4.9 9.1 0.5 6.5 5.6 0.7 3.4 58.2 47.5 3.2 17.0 26.9 UCN3 "SPC, UCNIII" ENSG00000178473 "Urocortin 3" Q969E3 10 5365009-5374692 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6" "Cell type enriched" "Detected in some" 89 "Intestinal endocrine cells: 233.1" "Group enriched" "Detected in many" 5 "lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 5.5" "Region enhanced" "Detected in some" "hypothalamus: 5.9" "Region enriched" "Detected in single" 7 "hypothalamus: 4.7" HPA038281 Uncertain "Secreted to blood" NA NA "HPA038281: AB_10672408" "unprognostic (2.00e-2)" "unprognostic (2.31e-1)" "unprognostic (1.60e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-3)" "unprognostic (8.42e-2)" "unprognostic (3.55e-2)" "unprognostic (2.91e-2)" 0.1 0.9 0.1 0.1 0.4 0.0 0.1 0.4 0.4 0.1 14.4 0.1 0.1 11.6 0.1 0.1 0.1 1.2 1.2 0.1 0.1 1.7 0.8 0.1 1.3 0.1 0.1 0.5 0.1 10.6 0.0 5.6 0.1 1.6 0.2 3.1 0.3 0.1 0.1 0.1 0.0 14.9 0.1 0.5 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.4 0.1 1.7 0.1 0.5 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 233.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 54012904-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.7;testis: 11.6" "Group enriched" "Detected in some" 13 "Bipolar cells: 67.9;Early spermatids: 140.5;Late spermatids: 51.5;Rod photoreceptor cells: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 32.1;U-266/70: 42.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 419.8" NA NA "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.2 0.4 13.3 0.3 2.6 0.5 0.3 19.7 16.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.7 0.4 3.5 2.6 1.1 0.2 0.2 0.5 8.3 0.9 1.4 0.2 0.1 0.2 0.2 1.5 0.2 0.2 0.5 0.3 0.2 1.5 0.3 0.2 0.2 1.4 0.2 0.3 11.6 1.1 0.2 1.0 0.2 0.6 0.2 0.2 2.2 0.4 1.4 0.4 0.6 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.8 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.3 0.3 0.1 0.2 2.2 0.3 0.3 0.0 0.6 0.3 0.4 1.2 0.6 0.2 0.4 0.2 0.3 13.3 2.6 19.7 11.1 3.5 2.6 8.3 0.9 1.5 1.1 0.0 0.0 0.0 0.5 0.3 67.9 0.6 2.5 0.0 0.0 3.5 5.9 0.8 0.0 0.0 140.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 51.5 2.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 35.7 0.0 0.5 1.4 0.5 0.1 0.2 0.0 0.0 0.5 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "NB-4: 47.2" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm NA NA Nucleoplasm "HPA063294: AB_2684977" "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VSX2 "CHX10, HOX10, RET1" ENSG00000119614 "Visual system homeobox 2" P58304 14 74239472-74262738 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Repressor" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 29.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 128.4;Muller glia cells: 90.5" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;HAP1: 1.0;SK-BR-3: 1.2;U-698: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "pons and medulla: 2.3" HPA003436 Enhanced NA NA "HPA003436: AB_1078523" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-1)" "unprognostic (3.21e-4)" "unprognostic (7.77e-2)" "unprognostic (8.39e-4)" "unprognostic (3.13e-1)" 0.3 0.1 0.3 0.4 1.0 0.2 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 29.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.2 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.3 0.2 0.5 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 128.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 90.5 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 YIPF7 "FinGER9, FLJ39576" ENSG00000177752 "Yip1 domain family member 7" Q8N8F6 4 44622065-44678556 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enhanced" "Detected in single" 32 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.5;fHDF/TERT166: 1.3;GAMG: 1.8;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6" "Region enriched" "Detected in single" 6 "cerebellum: 0.7" "Region enriched" "Detected in single" 29 "cerebellum: 14.8" HPA030642 Uncertain NA NA "HPA030642: AB_10601027" "unprognostic (9.41e-4)" "unprognostic (2.27e-1)" "unprognostic (2.90e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.46e-2)" "unprognostic (9.81e-2)" "unprognostic (2.32e-2)" "unprognostic (3.05e-2)" "unprognostic (1.52e-2)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.98e-2)" 1.5 0.0 0.3 0.0 0.5 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.6 0.1 45.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 14.8 0.7 0.0 0.0 2.3 3.3 0.3 1.0 0.3 0.9 0.3 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.8 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.0 0.0 0.3 0.3 0.0 0.7 0.0 0.6 0.3 0.0 0.3 0.5 1.1 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 0.7 0.4 2.3 0.9 0.7 0.6 0.6 0.3 0.4 0.3 0.3 0.2 3.3 0.1 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 124.7" "Cell type enhanced" "Detected in some" 14 "Hepatocytes: 4.4;Leydig cells: 1.4;Muller glia cells: 4.2;Peritubular cells: 1.4;Rod photoreceptor cells: 1.5" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 8 "cerebellum: 124.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "AF22: 62.2" "Region enhanced" "Detected in many" "cerebellum: 232.6" "Region enriched" "Detected in many" 9 "cerebellum: 491.0" HPA004098 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 0.7 0.6 1.5 0.5 8.6 0.5 0.8 124.7 25.5 0.5 0.7 12.3 0.0 0.9 0.6 3.8 1.0 0.5 0.8 0.5 6.2 5.2 0.5 7.3 0.7 0.7 5.2 8.0 0.9 0.5 0.6 0.6 0.5 15.3 0.5 0.7 3.0 0.5 0.6 7.4 4.1 1.9 0.5 10.0 0.5 0.5 1.0 4.5 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.2 0.0 6.5 7.2 3.5 4.0 4.8 4.3 3.6 0.0 0.0 0.0 3.2 0.3 3.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.2 0.0 0.0 1.0 0.0 3.8 15.0 0.0 0.0 0.1 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 6.5 0.0 10.1 3.8 0.0 0.0 0.0 4.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 8.6 124.7 5.2 6.2 5.2 5.2 8.0 15.3 4.5 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.4 0.0 1.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ZIC2 HPE5 ENSG00000043355 "Zic family member 2" O95409 13 99981772-99986773 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 63.0" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 1.8;Cone photoreceptor cells: 5.9;Muller glia cells: 8.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 27.7;HDLM-2: 13.3;HEK 293: 21.0;NTERA-2: 25.8;SCLC-21H: 58.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 214.5" HPA055031 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA055031: AB_2682676" "unprognostic (6.43e-6)" "prognostic favorable (2.64e-4)" "unprognostic (5.73e-2)" "unprognostic (1.99e-2)" "unprognostic (4.39e-1)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (4.66e-2)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (9.36e-3)" "unprognostic (7.42e-2)" "unprognostic (0.00e+0)" "unprognostic (3.26e-1)" "unprognostic (2.11e-1)" "unprognostic (5.36e-3)" 0.6 0.5 3.9 0.5 2.9 0.5 0.7 63.0 14.7 0.5 0.8 7.7 0.0 0.6 0.8 0.5 0.8 0.5 0.5 0.5 6.1 2.1 0.6 0.5 0.7 0.6 1.7 7.4 0.5 0.6 0.5 0.5 0.5 13.4 0.6 0.6 3.8 0.5 0.5 0.5 0.8 0.5 0.6 2.2 0.5 0.6 2.5 1.0 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.5 27.7 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 1.8 0.0 2.3 0.0 1.4 0.0 1.2 0.0 0.0 13.3 21.0 1.9 1.2 1.3 0.0 0.0 1.3 0.0 2.0 0.0 1.2 0.1 0.0 0.6 2.0 0.0 0.0 0.9 0.1 10.5 25.8 0.0 0.6 6.0 1.0 0.0 0.1 0.7 58.0 0.0 0.8 0.1 0.0 1.1 1.3 10.3 0.0 6.5 0.0 1.1 1.7 0.2 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.9 63.0 7.1 6.1 2.1 1.7 7.4 13.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.8 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.9 0.5 0.1 0.0 0.0 0.0 0.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 0.0 5.3 2.2 4.0 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 4.4 2.0 0.0 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell type enhanced" "Detected in some" 29 "Muller glia cells: 1.7;Rod photoreceptor cells: 1.3;Spermatocytes: 5.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.2;HEK 293: 6.4;NTERA-2: 7.6;SCLC-21H: 43.8" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in all" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 11.2 0.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.5 0.0 2.2 0.0 0.0 1.9 6.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.0 0.8 7.6 0.0 0.1 0.9 0.4 0.0 0.0 0.0 43.8 0.0 1.2 1.0 0.0 0.8 0.0 1.4 0.0 0.6 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 ZNF385C ENSG00000187595 "Zinc finger protein 385C" 17 42025576-42098479 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 19.0;testis: 21.9" "Cell type enriched" "Detected in some" 9 "Early spermatids: 27.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "cerebellum: 19.0" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;JURKAT: 3.7;MOLT-4: 6.7;SCLC-21H: 5.5" "Region enriched" "Detected in single" 12 "cerebellum: 31.8" "Region enriched" "Detected in all" 7 "cerebellum: 44.2" NA NA "unprognostic (1.58e-3)" "unprognostic (3.38e-2)" "unprognostic (2.02e-3)" "unprognostic (3.95e-2)" "unprognostic (3.95e-2)" "unprognostic (2.61e-1)" "unprognostic (3.07e-1)" "unprognostic (2.64e-1)" "unprognostic (2.48e-1)" "unprognostic (8.67e-3)" "unprognostic (1.10e-1)" "unprognostic (8.90e-2)" "unprognostic (2.59e-1)" "unprognostic (8.71e-2)" "unprognostic (1.50e-1)" "unprognostic (6.22e-2)" "unprognostic (6.05e-2)" 0.4 0.0 0.7 1.6 0.7 0.5 1.6 19.0 0.8 0.5 0.4 0.4 0.4 0.1 1.0 0.5 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.4 0.8 0.4 2.0 0.4 3.4 3.1 0.6 2.1 0.4 1.4 1.4 0.2 0.4 2.3 0.5 2.9 0.7 0.4 0.4 0.9 0.6 0.5 21.9 0.4 0.9 0.4 0.9 1.5 0.4 0.5 0.4 3.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.5 2.4 0.0 1.2 0.0 0.1 0.8 0.3 0.0 0.0 3.9 2.4 0.0 0.0 0.8 0.1 0.0 1.0 0.0 2.9 0.0 1.4 0.1 0.0 3.7 0.2 0.0 0.0 0.5 6.7 0.1 0.5 1.2 0.0 0.5 0.0 1.1 0.1 0.4 5.5 0.6 0.2 0.5 0.3 0.7 3.1 1.2 0.0 0.0 0.4 0.0 0.0 2.6 0.5 0.4 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.7 0.7 19.0 0.8 0.5 0.4 2.0 0.4 1.4 0.4 0.0 0.3 0.0 1.6 0.3 2.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.4 27.8 0.0 0.4 0.0 0.4 0.1 0.6 2.3 0.0 0.0 0.6 1.6 0.0 0.0 0.0 3.1 1.4 0.0 0.0 0.0 0.5 2.9 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.9 1.9 0.5 0.0 0.0 0.4 0.8 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061926-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.1" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.9;Endothelial cells: 22.4;Horizontal cells: 14.3;Ito cells: 14.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 69.1" "Group enriched" "Detected in some" 5 "basophil: 8.8;plasmacytoid DC: 9.8" "Group enriched" "Detected in many" 5 "dendritic cells: 9.8;granulocytes: 8.8" "Cell line enhanced" "Detected in many" "AF22: 32.0;fHDF/TERT166: 15.0;HUVEC TERT2: 21.9;THP-1: 17.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 105.4" "HPA023056, HPA023849" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 9.2 11.3 5.2 2.8 7.0 1.9 9.1 69.1 11.5 11.0 3.4 9.1 4.7 1.7 19.8 5.9 3.8 9.0 10.0 7.0 5.8 5.1 3.1 1.2 6.4 4.0 8.4 2.8 20.5 1.4 1.4 16.8 8.0 12.2 4.4 3.5 6.7 8.7 3.0 3.8 4.6 3.2 13.3 12.2 18.5 2.4 3.4 8.9 0.5 5.3 6.9 2.6 7.4 5.4 0.0 9.8 8.8 0.1 1.7 0.0 0.1 0.0 0.0 32.0 0.0 5.1 9.0 0.1 4.6 6.7 1.6 1.0 0.0 0.0 0.0 0.0 15.0 0.0 0.1 0.0 0.0 1.3 0.0 1.9 6.3 0.3 0.2 0.9 0.0 9.6 11.1 0.0 0.1 0.0 0.0 21.9 7.6 0.1 0.0 2.8 0.0 4.1 0.0 2.2 0.0 0.0 0.0 7.2 0.5 0.0 0.0 4.1 2.6 0.4 0.0 0.0 3.0 0.0 17.8 12.4 12.7 1.0 3.7 0.7 0.0 0.0 0.1 4.8 0.0 10.4 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 9.8 0.0 0.1 5.2 7.0 69.1 4.3 5.8 5.1 8.4 2.8 12.2 8.9 0.0 4.8 0.0 0.1 3.3 27.9 9.1 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 1.6 22.4 0.0 0.0 0.0 0.0 7.2 0.2 12.7 0.0 0.1 14.3 1.2 14.1 1.6 3.6 9.2 0.9 13.5 0.0 0.0 0.7 0.0 0.0 7.4 3.1 2.7 0.0 3.3 0.1 1.5 3.9 0.1 0.0 0.0 0.1